| Ident. | Authors (with country if any) | Title |
|---|
| 000011 |
Katrina L. Paumier [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Peggy Auinger [États-Unis] ; David Oakes [États-Unis] ; Lalitha Madhavan [États-Unis] ; Alberto J. Espay [États-Unis] ; Fredy J. Revilla [États-Unis] ; Timothy J. Collier [États-Unis] | Tricyclic Antidepressants Delay the Need for Dopaminergic Therapy in Early Parkinson's Disease |
| 000015 |
TAO XIE [États-Unis] ; Robert Goodman [États-Unis] ; Nina Browner [États-Unis] ; Elizabeth Haberfeld [États-Unis] ; Linda Winfield [États-Unis] ; Jill Goldman [États-Unis] ; Blair Ford [États-Unis] | Treatment of Fragile X-Associated Tremor/Ataxia Syndrome with Unilateral Deep Brain Stimulation |
| 000040 |
Diego Garcia-Borreguero [Espagne] ; Birgit Högl [Autriche] ; Luigi Ferini-Strambi [Italie] ; John Winkelman [États-Unis] ; Christina Hill-Zabala [États-Unis] ; Afsaneh Asgharian [États-Unis] ; Richard Allen [États-Unis] | Systematic Evaluation of Augmentation during Treatment with Ropinirole in Restless Legs Syndrome (Willis-Ekbom Disease): Results from a Prospective, Multicenter Study over 66 Weeks |
| 000041 |
Susanne A. Schneider [Allemagne, Royaume-Uni] ; John Hardy [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Syndromes of Neurodegeneration with Brain Iron Accumulation (NBIA): an Update on Clinical Presentations, Histological and Genetic Underpinnings, and Treatment Considerations |
| 000042 |
Travis S. Tierney [États-Unis] ; Andres M. Lozano [Canada] | Surgical Treatment for Secondary Dystonia |
| 000045 |
Adriaan D. Coumou [Pays-Bas] ; J. Marc C. Van Dijk [Pays-Bas] ; Jeroen J. De Vries [Pays-Bas] ; Klaus L. Leenders [Pays-Bas] ; Jos M. A. Kuijlen [Pays-Bas] | Successful Surgical Treatment of an Arachnoid Cyst Inducing a Holmes' Tremor |
| 000061 |
M. Konno ; T. Haseqawa ; T. Baba | Selective Serotonin Reuptake Inhibitors Emerge as the Therapeutic Agent for Synucleinopathies |
| 000064 |
Robert Chinnapongse [États-Unis] ; Kristen Gullo [États-Unis] ; Paul Nemeth [États-Unis] ; YUXIN ZHANG [États-Unis] ; Lynn Griggs [États-Unis] | Safety and Efficacy of Botulinum Toxin Type B for Treatment of Sialorrhea in Parkinson's Disease: A Prospective Double-Blind Trial |
| 000069 |
Raffaella Di Giacopo [Italie] ; Alfonso Fasano [Italie] ; Davide Quaranta [Italie] ; Giacomo Della Marca [Italie] ; Francesco Bove [Italie] ; Anna Rita Bentivoglio [Italie] | Rivastigmine as Alternative Treatment for Refractory REM Behavior Disorder in Parkinson's Disease |
| 000088 |
Stewart A. Factor [États-Unis] | Propranolol Therapy for Tardive Dyskinesia Revisited |
| 000102 |
Charles S. Venuto [États-Unis] ; Andrew Mcgarry [États-Unis] ; QING MA [États-Unis] ; Karl Kieburtz [États-Unis] | Pharmacologic Approaches to the Treatment of Huntington's Disease |
| 000137 |
Joseph H. Friedman [États-Unis] | Melperone Is Ineffective in Treating Parkinson's Disease Psychosis |
| 000138 |
Tetsutaro Ozawa [Japon] ; Kanako Sekiya [Japon] ; Yumi Sekine [Japon] ; Takayoshi Shimohata [Japon] ; Masahiko Tomita [Japon] ; Hideaki Nakayama [Japon] ; Naotaka Aizawa [Japon] ; Ryoko Takeuchi [Japon] ; Takayoshi Tokurake [Japon] ; Shinichi Katada [Japon] ; Masatoyo Nishizawa [Japon] | Maintaining Glottic Opening in Multiple System Atrophy: Efficacy of Serotonergic Therapy |
| 000140 |
Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France] | Long-Term Outcomes of Surgical Therapies for Parkinson's Disease |
| 000227 |
Thomas C. Edwards [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] | Deep Brain Stimulation in the Treatment of Chorea |
| 000230 |
Donald L. Bliwise [États-Unis] ; Lynn Marie Trotti [États-Unis] ; Anthony G. Wilson [États-Unis] ; Sophia A. Greer [États-Unis] ; Cathy Wood-Siverio [États-Unis] ; Jorge J. Juncos [États-Unis] ; Stewart A. Factor [États-Unis] ; Alan Freeman [États-Unis] ; David B. Rye [États-Unis] | Daytime Alertness in Parkinson's Disease: Potentially Dose-Dependent, Divergent Effects by Drug Class |
| 000234 |
Scott Y. H. Kim [États-Unis] ; Renee M. Wilson [États-Unis] ; H. Myra Kim [États-Unis] ; Robert G. Holloway [États-Unis] ; Raymond G. De Vries [États-Unis] ; Samuel A. Frank [États-Unis] ; Karl Kieburtz [États-Unis] | Comparison of Enrollees and Decliners of Parkinson Disease Sham Surgery Trials |
| 000300 |
Fabrizio Stocchi [Italie] ; Rupam Borgohain [Inde] ; Marco Onofrj [Italie] ; Anthony H. V. Schapira [Royaume-Uni] ; Mohit Bhatt [Inde] ; Valentina Lucini [Italie] ; Rodolfo Giuliani [Italie] ; Ravi Anand [Suisse] | A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients |
| 000307 |
Roger Kurlan [États-Unis] ; Giovanna Crespi [États-Unis] ; Barbara Coffey [États-Unis] ; Kirsten Mueller-Vahl [Allemagne] ; Stephen Koval [États-Unis] ; Glen Wunderlich [Canada] | A Multicenter Randomized Placebo-Controlled Clinical Trial of Pramipexole for Tourette's Syndrome |
| 000323 |
Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Bichun Ouyang [États-Unis] | Visual Plus Nonvisual Hallucinations in Parkinson's Disease: Development and Evolution over 10 Years |
| 000341 |
Francisco Grandas [Espagne] ; Carlos Fernandez-Carballal [Espagne] ; Juan Guzman-De-Villoria [Espagne] ; Israel Ampuero [Espagne] | Treatment of a Dystonic Storm With Pallidal Stimulation in a Patient With PANK2 Mutation |
| 000342 |
Elina Tripoliti [Royaume-Uni] ; Laura Strong [Royaume-Uni] ; Freya Hickey [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] | Treatment of Dysarthria Following Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease |
| 000344 |
David H. Benninger [États-Unis, Suisse] ; Mikhail Lomarev [États-Unis, Russie] ; Grisel Lopez [États-Unis] ; Natassja Pal [États-Unis] ; David A. Luckenbaugh [États-Unis] ; Mark Hallett [États-Unis] | Transcranial Direct Current Stimulation for the Treatment of Focal Hand Dystonia |
| 000351 |
Vibeke Guldbrand Rasmussen [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] ; Steen Hvitfeldt Poulsen [Danemark] | The Risk of Valvular Regurgitation in Patients with Parkinson's Disease Treated with Dopamine Receptor Agonists |
| 000361 |
Klaus Seppi ; Daniel Weintraub ; Miguel Coelho ; Santiago Perez-Lloret ; Susan H. Fox ; Regina Katzenschlager ; Eva-Maria Hametner ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz ; Cristina Sampaio | The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease |
| 000362 |
Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal] | The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease |
| 000370 |
Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit [Turquie] ; Pinar Unsalan [Turquie] ; Hilal Horozoglu [Turquie] ; Nese Tuncer [Turquie] ; Aynur Feyzioglu [Turquie] ; Dilek Ince Gunal [Turquie] ; Gorsev G. Yener [Turquie] ; Raif Cakmur [Turquie] ; Huseyin A. Sahin [Turquie] ; Murat Emre [Turquie] | The Effects of Rasagiline on Cognitive Deficits in Parkinson's Disease Patients Without Dementia: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study |
| 000371 |
Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | The Effect of Drug Treatment on Neurogenesis in Parkinson's Disease |
| 000399 |
Carl E. Clarke [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Should Treatment for Parkinson's Disease Start Immediately on Diagnosis or Delayed until Functional Disability Develops? |
| 000402 |
Diego Santos-Garcia [Espagne] ; Mercedes Macias [Espagne] ; Miguel Llaneza [Espagne] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernandez [Canada] | Serum Vitamin B12 and Folate Levels in Parkinson's Disease Patients Treated with Duodenal Levodopa Infusion |
| 000406 |
Francisco J. Palomar [Espagne] ; Francisco Diaz-Corrales [Espagne] ; Fatima Carrillo [Espagne] ; Miguel Fernandez-Del-Olmo [Espagne] ; Giacomo Koch [Italie] ; Pablo Mir [Espagne] | Sensory Perception Changes Induced by Transcranial Magnetic Stimulation over the Primary Somatosensory Cortex in Parkinson's Disease |
| 000415 |
Alfonso Fasano [Italie] ; Alessandro Di Matteo [Italie] ; Carmine Vitale [Italie] ; Giovanna Squintani [Italie] ; Laura Ferigo [Italie] ; Federica Bombieri [Italie] ; Gabriella Santangelo [Italie] ; Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Michele Tinazzi [Italie] | Reversible Pisa Syndrome in Patients with Parkinson's Disease on Rasagiline Therapy |
| 000432 |
Marina Svetel [Serbie] ; Tatjana Pekmezovic [Serbie] ; Aleksandra Tomic [Serbie] ; Nikola Kresojevic [Serbie] ; Aleksandra Potrebic [Serbie] ; Rada Jesic [Serbie] ; Vladimir S. Kostic [Serbie] | Quality of Life in Patients with Treated and Clinically Stable Wilson's Disease |
| 000444 |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] | Predictors of Time to Requiring Dopaminergic Treatment in 2 Parkinson's Disease Cohorts |
| 000473 |
Fabrizio Stocchi [Italie] ; Luiqi Giorqi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni] | PREPARED: Comparison of Prolonged and Immediate Release Ropinirole in Advanced Parkinson's Disease |
| 000509 |
Rodger Elble [États-Unis] ; Gunther Deuschl [Allemagne] | Milestones in Tremor Research |
| 000512 |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's Disease Therapeutics |
| 000518 |
Ira Shoulson [États-Unis] ; Anne B. Young [États-Unis] | Milestones in Huntington Disease |
| 000520 |
Laurie J. Ozelius [États-Unis] ; Naomi Lubarr [États-Unis] ; Susan B. Bressman [États-Unis] | Milestones in Dystonia |
| 000533 |
Elisa Garbayo [Espagne] ; Eduardo Ansorena [Espagne] ; Jose Luis Lanciego [Espagne] ; Maria Jose Blanco-Prieto [Espagne] ; Maria S. Aymerich [Espagne] | Long-Term Neuroprotection and Neurorestoration by Glial Cell-Derived Neurotrophic Factor Microspheres for the Treatment of Parkinson's Disease |
| 000536 |
Codrin Lungu [États-Unis] ; Barbara I. Karp [États-Unis] ; Katharine Alter [États-Unis] ; Regina Zolbrod [États-Unis] ; Mark Hallett [États-Unis] | Long-Term Follow-up of Botulinum Toxin Therapy for Focal Hand Dystonia: Outcome at 10 Years or More |
| 000537 |
Mathias Toft [Norvège] ; Bard Lilleeng [Norvège] ; Jon Ramm-Pettersen [Norvège] ; Inger Marie Skogseid [Norvège] ; Vidar Gundersen [Norvège] ; Remo Gerdts [Norvège] ; Lena Pedersen [Norvège] ; Mona Skjelland [Norvège] ; Geir Ketil R Ste [Norvège] ; Espen Dietrichs [Norvège] | Long-Term Efficacy and Mortality in Parkinson's Disease Patients Treated with Subthalamic Stimulation |
| 000538 |
René Reese [Allemagne] ; Doreen Gruber [Allemagne] ; Thomas Schoenecker [Allemagne] ; Hansjörg Bazner [Allemagne] ; Christian Blahak [Allemagne] ; H. Holger Capelle [Allemagne] ; Daniela Falk [Allemagne] ; Jan Herzog [Allemagne] ; Marcus O. Pinsker [Allemagne] ; Gerd H. Schneider [Allemagne] ; Christoph Schrader [Allemagne] ; Gunther Deuschl [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Andreas Kupsch [Allemagne] ; Jens Volkmann [Allemagne] ; Joachim K. Krauss [Allemagne] | Long-Term Clinical Outcome in Meige Syndrome Treated with Internal Pallidum Deep Brain Stimulation |
| 000542 |
Jasper E. Visser [Pays-Bas] ; David J. Schretlen [États-Unis] ; Bastiaan R. Bloem [Pays-Bas] ; Hyder A. Jinnah [États-Unis] | Levodopa is Not a Useful Treatment for Lesch-Nyhan Disease |
| 000547 |
Alexandre Gironell [Espagne] ; Javier Pagonabarraga [Espagne] ; Berta Pascual-Sedano [Espagne] ; Jaime Kulisevsky [Espagne] | Lacosamide, Another Therapeutic Failure in Essential Tremor: An Open-Label Trial |
| 000553 |
Giovanna Zorzi [Italie] ; Federica Zibordi [Italie] ; Luisa Chiapparini [Italie] ; Enrico Bertini [Italie] ; Lidia Russo [Italie] ; Antonio Piga [Italie] ; Filomena Longo [Italie] ; Barbara Garavaglia [Italie] ; Domenico Aquino [Italie] ; Mario Savoiardo [Italie] ; Alessandra Solari [Italie] ; Nardo Nardocci [Italie] | Iron-Related MRI Images in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) Treated with Deferiprone: Results of a Phase II Pilot Trial |
| 000556 |
Nick H. G. Holford [Nouvelle-Zélande] ; John G. Nutt [États-Unis] | Interpreting the Results of Parkinson's Disease Clinical Trials: Time for a Change |
| 000595 |
Stefan J. Groiss [Allemagne] ; Mario Siebler [Allemagne] ; Alfons Schnitzler [Allemagne] | Full Recovery of Adult Onset Opsoclonus Myoclonus Syndrome After Early Immunotherapy: A Case Report |
| 000618 |
Joseph Jankovic [États-Unis] ; Cynthia Comella [États-Unis] ; Angelika Hanschmann [Allemagne] ; Susanne Grafe [Allemagne] | Efficacy and Safety of IncobotulinumtoxinA (NT 201, Xeomin) in the Treatment of Blepharospasm-A Randomized Trial |
| 000636 |
José Fidel Baizabal Carvallo [États-Unis] ; Richard Simpson [États-Unis] ; Joseph Jankovic [États-Unis] | Diagnosis and Treatment of Complications Related to Deep Brain Stimulation Hardware |
| 000638 |
Robert A. Hauser [États-Unis] ; Peggy Auinger [États-Unis] | Determination of Minimal Clinically Important Change in Early and Advanced Parkinson's Disease |
| 000639 |
Ping-Lei Pan [République populaire de Chine] ; He-Han Tang [République populaire de Chine] ; QIN CHEN [République populaire de Chine] ; WEI SONG [République populaire de Chine] ; Hui-Fang Shang [République populaire de Chine] | Desferrioxamine Treatment of Aceruloplasminemia: Long-term Follow-up |
| 000643 |
Diane Ruge [Royaume-Uni] ; Stephen Tisch [Royaume-Uni, Australie] ; Marwan I. Hariz [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] | Deep Brain Stimulation Effects in Dystonia: Time Course of Electrophysiological Changes in Early Treatment |
| 000657 |
Aristide Merola [Italie] ; Maurizio Zibetti [Italie] ; Serena Angrisano [Italie] ; Laura Rizzi [Italie] ; Michele Lanotte [Italie] ; Leonardo Lopiano [Italie] | Comparison of Subthalamic Nucleus Deep Brain Stimulation and Duodopa in the Treatment of Advanced Parkinson's Disease |
| 000729 |
Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Ilona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Therese Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 Treatment of Levodopa-Induced Dyskinesias: Results of 2 Randomized Controlled Trials |
| 000738 |
Domenico Italiano [Italie] ; Marianna Pezzella [Italie] ; Antonietta Coppola [Italie] ; Adriana Magaudda [Italie] ; Edoardo Ferlazzo [Italie] ; Placido Bramanti [Italie] ; Salvatore Striano [Italie] ; Federico Zara [Italie] ; Pasquale Striano [Italie] | A Pilot Open-Label Trial of Zonisamide in Unverricht-Lundborg Disease |
| 000761 |
Cristina Pecci [Argentine] ; Maria J. Rivas [Argentine] ; Carolina M. Moretti [Argentine] ; Gabriela Raina [Argentine] ; Carlos Zuniga Ramirez [Argentine] ; Sergio Diaz [Argentine] ; Claudia Uribe Roca [Argentine] ; Federico E. Micheli [Argentine] | Use of Complementary and Alternative Therapies in Outpatients with Parkinson's Disease in Argentina |
| 000770 |
Matthew Menza [États-Unis] ; Roseanne Defronzo Dobkin [États-Unis] ; Humberto Marin [États-Unis] ; Michael Gara [États-Unis] ; Karina Bienfait [États-Unis] ; Allison Dicke [États-Unis] ; Cynthia L. Comella [États-Unis] ; Charles Cantor [États-Unis] ; Lee Hyer [États-Unis] | Treatment of Insomnia in Parkinson's Disease: A Controlled Trial of Eszopiclone and Placebo |
| 000779 |
Ira Shoulson [États-Unis] | Therapeutic Directions for Parkinson's Disease |
| 000788 |
Márcio Moyses De Oliveira [Brésil] ; Cristiane Fiquene Conti [Brésil] ; Juliana Spelta Valbuza [Brésil] ; Luciane Bizari Coin De Carvalho [Brésil] ; Gilmar Fernandes Do Prado [Brésil] | The Pharmacological Treatment for Uremic Restless Legs Syndrome: Evidence-Based Review |
| 000790 |
Samyra H. J. Keus [Pays-Bas] ; Maarten J. Nijkrake [Pays-Bas] ; George F. Borm [Pays-Bas] ; Gert Kwakkel [Pays-Bas] ; Raymund A. C. Roos [Pays-Bas] ; Henk W. Berendse [Pays-Bas] ; Eddy M. Adang [Pays-Bas] ; Sebastiaan Overeem [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; Marten Munneke [Pays-Bas] | The ParkinsonNet Trial: Design and Baseline Characteristics |
| 000798 |
Tiago Mestre [Portugal] ; Anthony E. Lang [Canada] | The Grasp Reflex: A Symptom in Need of Treatment |
| 000802 |
Lynn Rochester [Royaume-Uni] ; Danny Rafferty [Royaume-Uni] ; Catherine Dotchin [Royaume-Uni] ; Oliva Msuya [Tanzanie] ; Victor Minde [Tanzanie] ; R. W. Walker [Royaume-Uni] | The Effect of Cueing Therapy on Single and Dual-Task Gait in a Drug Naïve Population of People with Parkinson's Disease in Northern Tanzania |
| 000815 |
Claire L. Tomlinson [Royaume-Uni] ; Rebecca Stowe [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Richard Gray [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] | Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease |
| 000819 |
Peter P. Urban [Allemagne] ; Ingmar Wellach [Allemagne] ; Siegbert Faiss [Allemagne] ; Peter Layer [Allemagne] ; Thorsten Rosenkranz [Allemagne] ; Karl Knop [Allemagne] ; Joachim Weis [Allemagne] | Subacute Axonal Neuropathy in Parkinson's Disease with Cobalamin and Vitamin B6 Deficiency Under Duodopa Therapy |
| 000831 |
P. David Charles [États-Unis] ; Chandler E. Gill [États-Unis] ; Henry M. Taylor [États-Unis] ; Michael S. Putman [États-Unis] ; Caralee R. Blair [États-Unis] ; Amanda G. Roberts [États-Unis] ; Gregory D. Ayers [États-Unis] ; Peter E. Konrad [États-Unis] | Spasticity Treatment Facilitates Direct Care Delivery for Adults with Profound Intellectual Disability |
| 000873 |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, Double-Blind, Multicenter Evaluation of Pramipexole Extended Release Once Daily in Early Parkinson's Disease |
| 000895 |
Mário Miguel Rosa [Portugal] ; Joaquim J. Ferreira [Portugal] ; Miguel Coelho [Portugal] ; Rita Freire [Portugal] ; Cristina Sampaio [Portugal] | Prescribing Patterns of Antiparkinsonian Agents in Europe |
| 000898 |
Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni] | Pramipexole Combined with Levodopa Improves Motor Function but Reduces Dyskinesia in MPTP-Treated Common Marmosets |
| 000901 |
Raquel Duran [Espagne] ; Francisco J. Barrero [Espagne] ; Blas Morales [Espagne] ; Juan D. Luna [Espagne] ; Manuel Ramirez [Espagne] ; Francisco Vives [Espagne] | Plasma α-Synuclein in Patients with Parkinson's Disease With and Without Treatment |
| 000916 |
Louisa Clare Johnston [Royaume-Uni] ; Michael John Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Andrew Christopher Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni] | Pardoprunox Reverses Motor Deficits but Induces Only Mild Dyskinesia in MPTP-Treated Common Marmosets |
| 000946 |
P. Ken Gillman [Australie] ; Mrc Psych [Australie] | Neuroleptic Malignant Syndrome: Mechanisms, Interactions, and Causality |
| 000963 |
Bobby Thomas [États-Unis] ; M. Flint Beal [États-Unis] | Mitochondrial Therapies for Parkinson's Disease |
| 000964 |
Richard Dodel [Allemagne] ; Annika Spottke [Allemagne] ; Alexander Gerhard [Royaume-Uni] ; Alexander Reuss [Allemagne] ; Sylvia Reinecker [Allemagne] ; Nicole Schimke [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Friederike Sixel-Döring [Allemagne] ; Birgit Herting [Allemagne] ; Christoph Kamm [Allemagne] ; Thomas Gasser [Allemagne] ; Martin Sawires [Autriche] ; Felix Geser [Autriche] ; Martin Köllensperger [Autriche] ; Klaus Seppi [Autriche] ; Manja Kloss [Allemagne] ; Martin Krause [Allemagne] ; Christine Daniels [Allemagne] ; Günther Deuschl [Allemagne] ; Silke Böttger [Allemagne] ; Markus Naumann [Allemagne] ; Axel Lipp [Royaume-Uni] ; Doreen Gruber [Allemagne] ; Andreas Kupsch [Allemagne] ; YANSHENG DU [États-Unis] ; Federico Turkheimer [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Thomas Klockgether [Allemagne] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Carmen Schade-Brittinger [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Karla Eggert [Allemagne] | Minocycline 1-Year Therapy in Multiple-System-Atrophy: Effect on Clinical Symptoms and [11C] (R)-PK11195 PET (MEMSA-Trial) |
| 000970 |
Fabrizio Stocchi [Italie] ; Mario Zappia [Italie] ; Valentina Dall'Armi [Italie] ; Jaime Kulisevsky [Espagne] ; Paolo Lamberti [Italie] ; José Angel Obeso [Espagne] | Melevodopa/Carbidopa Effervescent Formulation in the Treatment of Motor Fluctuations in Advanced Parkinson's Disease |
| 000980 |
Laura Cif [France] ; Xavier Vasques [France] ; Victoria Gonzalez [France] ; Patrice Ravel [France] ; Brigitte Biolsi [France] ; Gwenaelle Collod-Beroud [France] ; Sylvie Tuffery-Giraud [France] ; Hassan Elfertit [France] ; Mireille Claustres [France] ; Philippe Coubes [France] | Long-Term Follow-Up of DYT1 Dystonia Patients Treated by Deep Brain Stimulation: An Open-Label Study |
| 000A19 |
Rodger J. Elble [États-Unis] ; Oksana Suchowersky [Canada] ; Stephanie Shaftman [Canada, États-Unis] ; William J. Weiner [États-Unis] ; PENG HUANG [États-Unis] ; Barbara Tilley [États-Unis] | Impact of Belief in Neuroprotection on Therapeutic Intervention in Parkinson's Disease |
| 000A27 |
SEUNG HUN LEE [Corée du Sud] ; MI JUNG KIM [Corée du Sud] ; Beom-Jun Kim [Corée du Sud] ; SUNG REUL KIM [Corée du Sud] ; Sail Chun [Corée du Sud] ; JIN SOOK RYU [Corée du Sud] ; GHI SU KIM [Corée du Sud] ; MYOUNG CHONG LEE [Corée du Sud] ; Jung-Min Koh [Corée du Sud] ; SUN JU CHUNG [Corée du Sud] | Homocysteine-Lowering Therapy or Antioxidant Therapy for Bone Loss in Parkinson's Disease |
| 000A46 |
Kiyotoshi Hamasaki [Japon] ; Kazumichi Yamada [Japon] ; Tadashi Hamasaki [Japon] ; Jun-Ichi Kuratsu [Japon] | GPi-pallidal Stimulation to Treat Generalized Dystonia in Cockayne Syndrome |
| 000A53 |
Nico J. Diederich [Luxembourg (pays)] ; Fiona Zanini [Luxembourg (pays)] ; Wilfried Pilloy [Luxembourg (pays)] ; Michel Krueger [Luxembourg (pays)] ; Leo Verhagen Metman [États-Unis] | Freezing of Gait as Late-Onset Side Effect of Cerebral Radiotherapy |
| 000A54 |
Michelangelo Bartolo [Italie] ; Mariano Serrao [Italie] ; Cristina Tassorelli [Italie] ; Romildo Don [Italie] ; Alberto Ranavolo [Italie] ; Francesco Draicchio [Italie] ; Claudio Pacchetti [Italie] ; Simona Buscone [Italie] ; Armando Perrotta [Italie] ; Anna Furnari [Italie] ; Placido Bramanti [Italie] ; Luca Padua [Italie] ; Francesco Pierelli [Italie] ; Giorgio Sandrini [Italie] | Four-Week Trunk-Specific Rehabilitation Treatment Improves Lateral Trunk Flexion in Parkinson's disease |
| 000A83 |
Ashwini K. Rao [États-Unis] | Enabling Functional Independence in Parkinson's Disease: Update on Occupational Therapy Intervention |
| 000A91 |
Bonnie P. Hersh [États-Unis] ; Nancy L. Earl [États-Unis] ; Robert A. Hauser [États-Unis] ; Mark Stacy [États-Unis] | Early Treatment Benefits of Ropinirole Prolonged Release in Parkinson's Disease Patients with Motor Fluctuations |
| 000B23 |
C. Warren Olanow [États-Unis, Italie] ; Karl Kieburtz [États-Unis] | Defining Disease-Modifying Therapies for PD- A Road Map for Moving Forward |
| 000B24 |
Patric Blomstedt [Suède] ; Ulrika Sandvik [Suède] ; Stephen Tisch [Australie] | Deep Brain Stimulation in the Posterior Subthalamic Area in the Treatment of Essential Tremor |
| 000B29 |
Michele Poletti [Italie] ; Daniela Frosini [Italie] ; Claudio Lucetti [Italie] ; Paolo Del Dotto [Italie] ; Roberto Ceravolo [Italie] ; Ubaldo Bonuccelli [Italie] | Decision Making in De Novo Parkinson's Disease |
| 000B34 |
Pablo Arias [Espagne] ; Jamile Vivas [Espagne] ; Kenneth L. Grieve [Espagne, Royaume-Uni] ; Javier Cudeiro [Espagne] | Controlled Trial on the Effect of 10 Days Low-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) on Motor Signs in Parkinson's Disease |
| 000B36 |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Compulsive Use of Dopaminergic Drug Therapy in Parkinson's Disease: Reward and Anti-Reward |
| 000B48 |
Merce Pineda [Espagne] ; Raquel Montero [Espagne] ; Asuncion Aracil [Espagne] ; Mar M. O'Callaghan [Espagne] ; Ana Mas [Espagne] ; Carmen Espinos [Espagne] ; Dolores Martinez-Rubio [Espagne] ; Francesc Palau [Espagne] ; Placido Navas [Espagne] ; Paz Briones [Espagne] ; Rafael Artuch [Espagne] | Coenzyme Q10-Responsive Ataxia: 2-Year-Treatment Follow-up |
| 000B91 |
Brooke K. Gerton [États-Unis] ; Brett Theeler [États-Unis] ; Ali Samii [États-Unis] | Backpack Treatment for Camptocormia |
| 000B93 |
Michael R. Pranzatelli [États-Unis] ; Elizabeth D. Tate [États-Unis] ; Jennifer A. Swan [États-Unis] ; Anna L. Travelstead [États-Unis] ; Jerry A. Colliver [États-Unis] ; Steven J. Verhulst [États-Unis] ; Carl J. Crosley [États-Unis] ; William D. Graf [États-Unis] ; Suja A. Joseph [États-Unis] ; Howard M. Kelfer [États-Unis] ; G. Praveen Raju [États-Unis] | B Cell Depletion Therapy for New-Onset Opsoclonus-Myoclonus |
| 000C01 |
| Annual Symposium on Etiology, Pathogenesis, and treatment of Parkinson's disease and other movement disorders |
| 000C18 |
Manon Bouchard [Canada] ; Sylvain Chouinard [Canada] ; Oksana Suchowersky [Canada] | Adult Cases of Congenital Muscular Torticollis Successfully Treated with Botulinum Toxin |
| 000C24 |
Pauline Belujon [États-Unis] ; Daniel J. Lodge [États-Unis] ; Anthony A. Grace [États-Unis] | Aberrant Striatal Plasticity is Specifically Associated With Dyskinesia Following Levodopa Treatment |
| 000C41 |
Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande] | A Double-Blind, Placebo-Controlled Study to Assess the Mitochondria-Targeted Antioxidant MitoQ as a Disease-Modifying Therapy in Parkinson's Disease |
| 000C66 |
PENG HUANG [États-Unis] ; Christopher G. Goetz [États-Unis] ; Robert F. Woolson [États-Unis] ; Barbara Tilley [États-Unis] ; Douglas Kerr [États-Unis] ; Yuko Palesch [États-Unis] ; Jordan Elm [États-Unis] ; Bernard Ravina [États-Unis] ; Kenneth J. Bergmann [États-Unis] ; Karl Kieburtz [États-Unis] | Using Global Statistical Tests in Long-Term Parkinson's Disease Clinical Trials |
| 000C68 |
Leon Poltawski [Royaume-Uni] ; Hazel Edwards [Royaume-Uni] ; Amy Todd [Royaume-Uni] ; Tim Watson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Cherry Ann James [Royaume-Uni] | Ultrasound Treatment of Cutaneous Side-Effects of Infused Apomorphine : A Randomized Controlled Pilot Study |
| 000C74 |
Livia Brusa [Italie] ; Antonio Orlacchio [Italie] ; Vincenzo Moschella [Italie] ; Cesare Iani [Italie] ; Giorgio Bernardi [Italie] ; Nicola Biagio Mercuri [Italie] | Treatment of the Symptoms of Huntington's Disease : Preliminary Results Comparing Aripiprazole and Tetrabenazine |
| 000C85 |
Matthew Menza [États-Unis] ; Roseanne Defronzo Dobkin [États-Unis] ; Humberto Marin [États-Unis] ; Margery H. Mark [États-Unis] ; Michael Gara [États-Unis] ; Steven Buyske [États-Unis] ; Karina Bienfait [États-Unis] ; Allison Dicke [États-Unis] | The Impact of Treatment of Depression on Quality of Life, Disability and Relapse in Patients with Parkinson's Disease |
| 000D11 |
Davide Manca [Italie] ; Giovanni Cossu [Italie] ; Daniela Murgia [Italie] ; Andrea Molari [Italie] ; Paola Ferrigno [Italie] ; Emanuele Marcia [Italie] ; Maurizio Melis [Italie] | Reversible Encephalopathy and Axonal Neuropathy in Parkinson's Disease During Duodopa Therapy |
| 000D25 |
Giuseppe Frazzitta [Italie] ; Roberto Maestri [Italie] ; Davide Uccellini [Italie] ; Gabriella Bertotti [Italie] ; Paola Abelli [Italie] | Rehabilitation Treatment of Gait in Patients with Parkinson's Disease with Freezing: A Comparison Between Two Physical Therapy Protocols Using Visual and Auditory Cues with or Without Treadmill Training |
| 000D27 |
Susanne A. Schneider [Royaume-Uni] ; Vrajesh Udani [Inde] ; Charulata Sawant Sankhla [Inde] ; Kailash P. Bhatia [Royaume-Uni] | Recurrent Acute Dystonic Reaction and Oculogyric Crisis Despite Withdrawal of Dopamine Receptor Blocking Drugs |
| 000D30 |
Robert A. Hauser [États-Unis] ; Kelly E. Lyons [États-Unis] ; Terry Mcclain [États-Unis] ; Summer Carter [États-Unis] ; David Perlmutter [États-Unis] | Randomized, Double-Blind, Pilot Evaluation of Intravenous Glutathione in Parkinson's Disease |
| 000D35 |
Victor S. C. Fung [Australie] ; Lilie Herawati [Australie] ; YING WAN [États-Unis] | Quality of Life in Early Parkinson's Disease Treated with Levodopa/Carbidopa/Entacapone |
| 000D51 |
Samyra H. J. Keus [Pays-Bas] ; Marten Munneke [Pays-Bas] ; Maarten J. Nijkrake [Pays-Bas] ; Gert Kwakkel [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] | Physical Therapy in Parkinson's Disease : Evolution and Future Challenges |
| 000D60 |
Younbyoung Chae [Corée du Sud] ; Hyejung Lee [Corée du Sud] ; Hackjin Kim [Corée du Sud] ; Chang-Hwan Kim [Corée du Sud] ; Dae-Il Chang [Corée du Sud] ; Kyung-Mi Kim [Corée du Sud] ; Hi-Joon Park [Corée du Sud] | Parsing Brain Activity Associated with Acupuncture Treatment in Parkinson's Diseases |
| 000D64 |
Ilana Schlesinger [Israël] ; Orna Benyakov [Israël] ; Ilana Erikh [Israël] ; Suheir Suraiya [Israël] ; Yitzhak Schiller [Israël] | Parkinson's Disease Tremor is Diminished with Relaxation Guided Imagery |
| 000D67 |
Cathérine C. S. Delnooz [Pays-Bas] ; Martin W. I. M. Horstink [Pays-Bas] ; Marina A. Tijssen [Pays-Bas] ; Bart P. C. Van De Warrenburg [Pays-Bas] | Paramedical Treatment in Primary Dystonia: A Systematic Review |
| 000D69 |
Angelika Nebe [Allemagne] ; Georg Ebersbach [Allemagne] | Pain Intensity On and Off Levodopa in Patients with Parkinson's Disease |
| 000D79 |
Johannes Levin [Allemagne] ; Siegbert Krafczyk [Allemagne] ; Peter Valkovic [Slovaquie] ; Thomas Eggert [Allemagne] ; Jens Claassen [Allemagne] ; Kai Bötzel [Allemagne] | Objective Measurement of Muscle Rigidity in Parkinsonian Patients Treated with Subthalamic Stimulation |
| 000D82 |
Diederik E. Tenback [Pays-Bas] ; Peter N. Van Harten [Pays-Bas] ; Jim Van Os [Pays-Bas, Royaume-Uni] | Non-Therapeutic Risk Factors for Onset of Tardive Dyskinesia in Schizophrenia: A Meta-Analysis |
| 000E13 |
Shigeki Hirano [États-Unis] ; Thomas Eckert [États-Unis, Allemagne] ; Toni Flanagan [États-Unis] ; David Eidelberg [États-Unis] | Metabolic Networks for Assessment of Therapy and Diagnosis in Parkinson's Disease |
| 000E20 |
Robert A. Hauser [États-Unis] ; Mark F. Lew [États-Unis] ; Howard I. Hurtig [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; Cheryl J. Fitzer-Attas [Israël] | Long-term Outcome of Early Versus Delayed Rasagiline Treatment in Early Parkinson's Disease |
| 000E24 |
Robert A. Hauser [États-Unis] ; Peggy Auinger [États-Unis] ; David Oakes [États-Unis] | Levodopa Response in Early Parkinson's Disease |
| 000E40 |
Erik L. Johnsen [Danemark] ; Poul H. Mogensen [Danemark] ; Niels Aa. Sunde [Danemark] ; Karen Ostergaard [Danemark] | Improved Asymmetry of Gait in Parkinson's Disease with DBS : Gait and Postural Instability in Parkinson's Disease Treated with Bilateral Deep Brain Stimulation in the Subthalamic Nucleus |
| 000E47 |
Stefano Zoccolella [Italie] ; Claudia Dell'Aquila [Italie] ; Giovanni Abruzzese [Italie] ; Angelo Antonini [Italie] ; Ubaldo Bonuccelli [Italie] ; Margherita Canesi [Italie] ; Silvano Cristina [Italie] ; Roberta Marchese [Italie] ; Claudio Pacchetti [Italie] ; Roberto Zagaglia [Italie] ; Giancarlo Logroscino [Italie] ; Giovanni Defazio [Italie] ; Paolo Lamberti [Italie] ; Paolo Livrea [Italie] | Hyperhomocysteinemia in Levodopa-Treated Patients with Parkinson's Disease Dementia |
| 000E77 |
Xavier Vasques [France] ; Laura Cif [France] ; Victoria Gonzalez [France] ; Claire Nicholson [France] ; Philippe Coubes [France] | Factors Predicting Improvement in Primary Generalized Dystonia Treated by Pallidal Deep Brain Stimulation |
| 000E94 |
M. Mar Trujillo-Martin [Espagne] ; Pedro Serrano-Aguilar [Espagne] ; Fernando Monton-Alvarez [Espagne] ; Romen Carrillo-Fumero [Espagne] | Effectiveness and Safety of Treatments for Degenerative Ataxias: A Systematic Review |
| 000E95 |
Pablo Arias [Espagne] ; Marcelo Chouza [Espagne] ; Jamile Vivas [Espagne] ; Javier Cudeiro [Espagne] | Effect of Whole Body Vibration in Parkinson's Disease : A Controlled Study |
| 000E98 |
Eric S. Molho [États-Unis] ; Nitendra Agarwal [États-Unis] ; Katy Regan [États-Unis] ; Donald S. Higgins [États-Unis] ; Stewart A. Factor [États-Unis] | Effect of Cervical Dystonia on Employment: A Retrospective Analysis of the Ability of Treatment to Restore Premorbid Employment Status |
| 000F00 |
Muruvet Elkay [États-Unis] ; Kenneth Silver [États-Unis] ; Richard D. Penn [États-Unis] ; Arif Dalvi [États-Unis] | Dystonic Storm due to Batten's Disease Treated with Pallidotomy and Deep Brain Stimulation |
| 000F04 |
Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse] | Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease |
| 000F26 |
Thomas Müller [Allemagne] ; Wilfried Kuhn [Allemagne] | Cysteine Elevation in Levodopa-Treated Patients with Parkinson's Disease |
| 000F34 |
Katie Kompoliti [États-Unis] ; WENQIN FAN [États-Unis] ; Sue Leurgans [États-Unis] | Complementary and Alternative Medicine Use in Gilles de la Tourette Syndrome |
| 000F65 |
Neema Kasravi [Canada] ; Mandar S. Jog [Canada] | Botulinum Toxin in the Treatment of Lingual Movement Disorders |
| 000F75 |
Laura Marsh [États-Unis] ; Kevin Biglan [États-Unis] ; Melissa Gerstenhaber [États-Unis] ; James R. Williams [États-Unis] | Atomoxetine for the Treatment of Executive Dysfunction in Parkinson's Disease : A Pilot Open-Label Study |
| 000F82 |
| Annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders |
| 000F90 |
Maarten J. Nijkrake [Pays-Bas] ; Samyra H. J. Keus [Pays-Bas] ; Rob A. B. Oostendorp [Pays-Bas] ; Sebastiaan Overeem [Pays-Bas] ; Wim Mulleners [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; Marten Munneke [Pays-Bas] | Allied Health Care in Parkinson's Disease : Referral, Consultation, and Professional Expertise |
| 000F97 |
Ludger Grote [Suède] ; Lena Leissner [Suède] ; Jan Hedner [Suède] ; Jan Ulfberg [Suède] | A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of Intravenous Iron Sucrose and Placebo in the Treatment of Restless Legs Syndrome |
| 000F99 |
Adrienne Curtis [Royaume-Uni] ; Ian Mitchell [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] | A Pilot Study Using Nabilone for Symptomatic Treatment in Huntington's Disease |
| 001007 |
Patric Blomstedt [Suède] ; Marwan I. Hariz [Suède, Royaume-Uni] ; Stephen Tisch [Australie] ; Monica Holmberg [Suède] ; Tommy A. Bergenheim [Suède] ; Lars Forsgren [Suède] | A Family with a Hereditary Form of Torsion Dystonia from Northern Sweden Treated with Bilateral Pallidal Deep Brain Stimulation |
| 001008 |
Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis] | A Comparison of Treatment Thresholds in Two Large Parkinson's Disease Clinical Trial Cohorts |
| 001033 |
Clauder Trenkwalder [Allemagne] ; Wayne A. Hening [États-Unis] ; Pasquale Montagna [Italie] ; Wolfgang H. Oertel [Allemagne] ; Richard P. Allen [États-Unis] ; Arthur S. Walters [États-Unis] ; Joao Costa [Portugal] ; Karin Stiasny-Kolster [Allemagne] ; Cristina Sampaio [Portugal] | Treatment of Restless Legs Syndrome : An Evidence-Based Review and Implications for Clinical Practice |
| 001034 |
Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C. Warren Olanow [États-Unis] | Treatment of Levodopa-Induced Motor Complications |
| 001035 |
Olalla Bello [Espagne] ; Jose Andres Sanchez [Espagne] ; Miguel Fernandez-Del-Olmo [Espagne] | Treadmill Walking in Parkinson's Disease Patients : Adaptation and Generalization Effect |
| 001039 |
Sandra Dehning [Allemagne] ; Jan-Hinnerk Mehrkens [Allemagne] ; Norbert Müller [Allemagne] ; Kai Bötzel [Allemagne] | Therapy-Refractory Tourette Syndrome : Beneficial Outcome with Globus Pallidus Internus Deep Brain Stimulation |
| 001040 |
JI YOUN KIM [Corée du Sud] ; EUN JOO CHUNG [Corée du Sud] ; WON YONG LEE [Corée du Sud] ; HEE YOUNG SHIN [Corée du Sud] ; GYEONG HAN LEE [Corée du Sud] ; Yearn-Seong Choe [Corée du Sud] ; Yong Choi [Corée du Sud] ; BYEONG JOON KIM [Corée du Sud] | Therapeutic Effect of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease : Analysis of [11C] Raclopride PET Study |
| 001059 |
Stanley Fahn [États-Unis] | The History of Dopamine and Levodopa in the Treatment of Parkinson's Disease |
| 001070 |
Christos Tsironis [Grèce] ; Marios Marselos [Grèce] ; Angelos Evangelou [Grèce] ; Spiridon Konitsiotis [Grèce] | The Course of Dyskinesia Induction by Different Treatment Schedules of Levodopa in Parkinsonian Rats : Is Continuous Dopaminergic Stimulation Necessary? |
| 001073 |
Anthony H. V. Schapira [Royaume-Uni] | The Clinical Relevance of Levodopa Toxicity in the Treatment of Parkinson's Disease |
| 001086 |
Robert A. Hauser [États-Unis] ; Lisa M. Shulman [États-Unis] ; Joel M. Trugman [États-Unis] ; John W. Roberts [États-Unis] ; Akihisa Mori [Japon] ; Rocco Ballerini [États-Unis] ; Neil M. Sussman [États-Unis] | Study of Istradefylline in Patients with Parkinson's Disease on Levodopa with Motor Fluctuations |
| 001106 |
Gian Luca Fomi [Italie] ; Manuela Balocco [Italie] ; Laura Cremonesi [Italie] ; Giovanni Abbruzzese [Italie] ; Roberto Carlo Parodi [Italie] ; Roberta Marchese [Italie] | Regression of Symptoms After Selective Iron Chelation Therapy in a Case of Neurodegeneration with Brain Iron Accumulation |
| 001163 |
Frank J. M. Van Eijkeren [Pays-Bas] ; Ruud S. J. Reijmers [Pays-Bas] ; Mirjam J. Kleinveld [Pays-Bas] ; Angret Minten [Pays-Bas] ; Jan Pieter Ter Bruggen [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] | Nordic Walking Improves Mobility in Parkinson's Disease |
| 001167 |
Maryka Quik [États-Unis] ; Kathryn O'Leary [États-Unis] ; Caroline M. Tanner [États-Unis] | Nicotine and Parkinson's Disease : Implications for Therapy |
| 001187 |
Alex R. Paciorkowski [États-Unis] ; Melany Westwell [États-Unis] ; Sylvia Ounpuu [États-Unis] ; Katharine Bell [États-Unis] ; Jeanne Kagan [États-Unis] ; Cindy Mazzarella [États-Unis] ; Robert M. Greenstein [États-Unis] | Motion Analysis of a Child with Niemann-Pick Disease Type C Treated with Miglustat |
| 001201 |
Beata Tarnacka [Pologne] ; Wojciech Szeszkowski [Pologne] ; Marek Golebiowski [Pologne] ; Anna Czlonkowska [Pologne] | MR Spectroscopy in Monitoring the Treatment of Wilson's Disease Patients |
| 001204 |
Mitchell F. Brin [États-Unis] ; Cynthia L. Comella [États-Unis] ; Joseph Jankovic [États-Unis] ; Francis Lai [États-Unis] ; Markus Naumann [Allemagne] | Long-Term Treatment with Botulinum Toxin Type A in Cervical Dystonia Has Low Immunogenicity by Mouse Protection Assay |
| 001210 |
Mercedes Serrano [Espagne] ; Belen Perez-Duenas [Espagne] ; Aida Ormazabal [Espagne] ; Rafael Artuch [Espagne] ; Jaume Campistol [Espagne] ; Rosa J. Torres [Espagne] ; Angels Garcia-Cazorla [Espagne] | Levodopa Therapy in a Lesch-Nyhan Disease Patient : Pathological, Biochemical, Neuroimaging, and Therapeutic Remarks |
| 001211 |
Jose L. Lanciego [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Francisco J. Blesa [Espagne] ; Lydia Alvarez-Erviti [Espagne] ; Jorge Guridi [Espagne] ; Pedro Barroso-Chinea [Espagne] ; Yoland Smith [États-Unis] ; Jose A. Obeso [Espagne] | Lesion of the Centromedian Thalamic Nucleus in MPTP-Treated Monkeys |
| 001213 |
Anna Czlonkowska [Pologne] ; Maria Rodo [Pologne] ; Grazyna Gromadzka [Pologne] | Late Onset Wilson's Disease : Therapeutic Implications |
| 001221 |
Ingo Borggraefe [Allemagne] ; Andreas Meyer-Heim [Suisse] ; Anita Kumar [Allemagne] ; Jan Simon Schaefer [Allemagne] ; Steffen Berweck [Allemagne] ; Florian Heinen [Allemagne] | Improved Gait Parameters After Robotic-Assisted Locomotor Treadmill Therapy in a 6-Year-Old Child with Cerebral Palsy |
| 001229 |
Masashi Hamada [Japon] ; Yoshikazu Ugawa [Japon] ; Sadatoshi Tsuji [Japon] | High-Frequency rTMS over the Supplementary Motor Area for Treatment of Parkinson's Disease |
| 001230 |
Alfonso Fasano [Italie] ; Caria Piano [Italie] ; Celestino De Simone [Italie] ; Beatrice Cioni [Italie] ; Daniela Di Giuda [Italie] ; Massimiliano Zinno [Italie] ; Antonio Daniele [Italie] ; Mario Meglio [Italie] ; Alessandro Giordano [Italie] ; Anna Rita Bentivoglio [Italie] | High Frequency Extradural Motor Cortex Stimulation Transiently Improves Axial Symptoms in a Patient with Parkinson's Disease |
| 001231 |
Tadashi Hamasaki [Japon] ; Kazumichi Yamada [Japon] ; Jun-Ichi Kuratsu [Japon] | Hemidystonia Secondary to Thalamic Hemorrhage Treated with GPi Stimulation |
| 001244 |
Alfonso Fasano [Italie] ; Paolo Mazzone [Italie] ; Carla Piano [Italie] ; Davide Quaranta [Italie] ; Francesco Soleti [Italie] ; Anna Rita Bentivoglio [Italie] | GPi-DBS in Huntington's Disease : Results on Motor Function and Cognition in a 72-Year-Old Case |
| 001245 |
Jose A. Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Beatriz Benitez-Temino [Espagne] ; Franscisco J. Blesa [Espagne] ; Jorge Guridi [Espagne] ; Concepcio Marin [Espagne] ; Manuel Rodriguez [Espagne] | Functional Organization of the Basal Ganglia : Therapeutic Implications for Parkinson's Disease |
| 001251 |
HU LIANG LOW [Canada, Royaume-Uni] ; Christopher R. Honey [Canada] | Focal Childhood-Onset, Action Induced Primary Hip Dystonia Treated with Pallidal Deep Brain Stimulation |
| 001256 |
Young H. Sung [Corée du Sud] ; Sun J. Chung [Corée du Sud] ; Sung R. Kim [Corée du Sud] ; Myoung C. Lee [Corée du Sud] | Factors Predicting Response to Dopaminergic Treatment for Resting Tremor of Parkinson's Disease |
| 001262 |
Barbara Leinweber [Allemagne] ; J. Carsten Möller [Allemagne] ; Andre Scherag [Allemagne] ; Ulrike Reuner [Allemagne] ; Peter Günther [Allemagne] ; Christoph J. G. Lang [Allemagne] ; Hartmut H. J. Schmidt [Allemagne] ; Christoph Schrader [Allemagne] ; Oliver Bandmann [Royaume-Uni] ; Anna Czlonkowska [Pologne] ; Wolfgang H. Oertel [Allemagne] ; Harald Hefter [Allemagne] | Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German Patients with Treated Wilson's Disease |
| 001316 |
David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France] | Comparison of Desipramine and Citalopram Treatments for Depression in Parkinson's Disease : A Double-Blind, Randomized, Placebo-Controlled Study |
| 001325 |
Minori Enomoto [Japon] ; Yuichi Inoue [Japon] ; Kazuyoshi Namba [Japon] ; Takashi Munezawa [Japon] ; Masato Matsuura [Japon] | Clinical Characteristics of Restless Legs Syndrome in End-Stage Renal Failure and Idiopathic RLS Patients |
| 001344 |
Martin J. Hecht [Allemagne] ; Henning Stolze [Allemagne] ; Matthias Auf Dem Brinke [Allemagne] ; Ralf Giess [Allemagne] ; Thoams Treig [Allemagne] ; Martin Winterholler [Allemagne] ; Jorg Wissel [Allemagne] | Botulinum Neurotoxin Type A Injections Reduce Spasticity in Mild to Moderate Hereditary Spastic Paraplegia : Report of 19 Cases |
| 001374 |
Kenichi Kashihara [Japon] ; Takaki Imamura [Japon] | Amantadine May Reverse Punding in Parkinson's Disease- : Observation in a Patient |
| 001381 |
Alfonso Fasano [Italie] ; Cesare Colosimo [Italie] ; Hiroaki Miyajima [Japon] ; Pietro Attilio Tonali [Italie] ; Thomas J. Re [Italie] ; Anna Rita Bentivoglio [Italie] | Aceruloplasminemia : A Novel Mutation in a Family with Marked Phenotypic Variability |
| 001389 |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Wemer Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline as a Disease Modifying Therapy in Parkinson's Disease (The ADAGIO Study) : Rationale, Design, and Baseline Characteristics |
| 001407 |
Susann Junghanns [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Gregor Simonis [Allemagne] ; Christian Oelwein [Allemagne] ; Rainer Koch [Allemagne] ; Ruth H. Strasser [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] | Valvular heart disease in parkinson's disease patients treated with dopamine agonists : A reader-blinded monocenter echocardiography study |
| 001417 |
J Rgen H. Olsen [Danemark] ; Karina Tangerud [Danemark] ; Lene Wermuth [Danemark] ; Kirsten Frederiksen [Danemark] ; S Ren Friis [Danemark] | Treatment with levodopa and risk for malignant melanoma |
| 001418 |
Mette Brandt-Christensen [Danemark] ; Kajsa Kvist [Danemark] ; Flemming Morkeberg Nilsson [Danemark] ; Per Kragh Andersen [Danemark] ; Lars Vedel Kessing [Danemark] | Treatment with Antiparkinson and Antidepressant Drugs : A Register-Based, Pharmaco-epidemiological Study |
| 001419 |
Calvin Melmed [Canada] ; Daniel Moros [États-Unis] ; Howard Rutman [États-Unis] | Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5 ,5 -diphenyl-barbituric acid) |
| 001422 |
Cara W. J. Verdellen [Pays-Bas] ; Cees A. L. Hoogduin [Pays-Bas] ; Ger P. J. Keijsers [Pays-Bas] | Tic suppression in the treatment of tourette's syndrome with exposure therapy : The rebound phenomenon reconsidered |
| 001439 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten-Year Follow-Up of Parkinson's Disease Patients Randomized to Initial Therapy with Ropinirole or Levodopa |
| 001440 |
Ikwunga Wonodi [États-Unis] ; Gloria Reeves [États-Unis] ; Dana Carmichael [États-Unis] ; Ilene Verovsky [États-Unis] ; Matthew T. Avila [États-Unis] ; Amie Elliott [États-Unis] ; L. Elliot Hong [États-Unis] ; Helene M. Adami [États-Unis] ; Gunvant K. Thaker [États-Unis] | Tardive dyskinesia in children treated with atypical antipsychotic medications |
| 001443 |
Paolo Barone [Italie] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Zoe Clarke [Royaume-Uni] | Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease |
| 001444 |
PRAMOD KUMAR PAL [Inde] ; Sanjib Sinha [Inde] ; Shibu Pillai [Inde] ; Arun B. Taly [Inde] ; Rojin G. Abraham [Inde] | Successful Treatment of Tremor in Wilson's Disease by Thalamotomy : A Case Report |
| 001454 |
Wolfgang H. Oertel [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Marco Zucconi [Italie] ; Heike Benes [Allemagne] ; Diego Garcia Borreguero [Espagne] ; Claudio Bassetti [Suisse] ; Markku Partinen [Finlande] ; Luigi Ferini-Strambi [Italie] ; Karin Stiasny-Kolster [Allemagne] | State of the Art in Restless Legs Syndrome Therapy : Practice Recommendations for Treating Restless Legs Syndrome |
| 001470 |
Carmine Vitale [Italie] ; Stefano Marconi [Italie] ; Luigi Di Maio [Italie] ; Giuseppe De Michele [Italie] ; Katia Longo [Italie] ; Vincenzo Bonavita [Italie] ; Paolo Barone [Italie] | Short-Term Continuous Infusion of Apomorphine Hydrochloride for Treatment of Huntington's Chorea : A Double Blind, Randomized Cross-Over Trial |
| 001472 |
Jordan J. Elm [États-Unis] ; Cornelia Kamp [États-Unis] ; Barbara C. Tilley [États-Unis] ; Paulo Guimaraes [États-Unis] ; Debbie Fraser [États-Unis] ; Patricia Deppen [États-Unis] ; Alicia Brocht [États-Unis] ; Chris Weaver [États-Unis] ; Susan Bennett [États-Unis] | Self-reported adherence versus pill count in Parkinson's disease : The NET-PD experience |
| 001475 |
Christopher G. Goetz [États-Unis] ; Philippe Damier [France] ; Christine Hicking [Allemagne] ; Eugene Laska [États-Unis] ; Thomas Müller [Allemagne] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne] | Sarizotan as a treatment for dyskinesias in Parkinson's disease : A double-blind placebo-controlled trial |
| 001476 |
Björn Holmberg [Suède] ; Jan-Ove Johansson [Suède] ; Werner Poewe [Autriche] ; Gregor Wenning [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Eduardo Tolosa [Espagne] ; Adriana Cardozo [Espagne] ; Nil Dizdar [Suède] ; Olivier Rascol [France] ; Tarik Slaoui [France] | Safety and tolerability of growth hormone therapy in multiple system atrophy : A double-blind, placebo-controlled study |
| 001477 |
Nir Giladi [Israël] ; Babak Boroojerdi [Allemagne] ; Amos D. Korczyn [Israël] ; David J. Burn [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Rotigotine Transdermal Patch in Early Parkinson's Disease : A Randomized, Double-Blind, Controlled Study Versus Placebo and Ropinirole |
| 001478 |
Yoshikuni Mizuno [Japon] ; Takashi Abe [Japon] ; Kazuko Hasegawa [Japon] ; Sadako Kuno [Japon] ; Tomoyoshi Kondo [Japon] ; Mitsutoshi Yamamoto [Japon] ; Mitsuyoshi Nakashima [Japon] ; Ichiro Kanazawa [Japon] | Ropinirole is effective on motor function when used as an adjunct to levodopa in parkinson's disease : STRONG study |
| 001483 |
Joong-Seok Kim [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud] ; Sung-Chul Lim [Corée du Sud] ; Jae-Young Ahn [Corée du Sud] ; In-Uk Song [Corée du Sud] ; Yeong-In Kim [Corée du Sud] ; Bum-Soo Kim [Corée du Sud] ; Hee-Tae Kim [Corée du Sud] | Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: A possible association with oral midodrine treatment |
| 001495 |
Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis] | Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (Tesofensine) in early parkinson's disease |
| 001496 |
Anna-Gerlind Postma [Pays-Bas] ; Mart A. A. M. Heesters [Pays-Bas] ; Teus Van Laar [Pays-Bas] | Radiotherapy to the Salivary Glands as Treatment of Sialorrhea in Patients with Parkinsonism |
| 001506 |
Janis M. Miyasaki [Canada] ; Khalid Al Hassan [Canada] ; Anthony E. Lang [Canada] ; Valerie Voon [Canada] | Punding prevalence in Parkinson's disease |
| 001523 |
Theresa A. Zesiewicz [États-Unis] ; Christopher L. Ward ; Robert A. Hauser ; Jessica A. Pease Campbell ; Kelly L. Sullivan | Pregabalin (lyrica) in the treatment of essential tremor |
| 001533 |
Yoshikuni Mizuno [Japon] ; Ichiro Kanazawa [Japon] ; Sadako Kuno [Japon] ; Nobuo Yanagisawa [Japon] ; Mitsutoshi Yamamoto [Japon] ; Tomoyoshi Kondo [Japon] | Placebo-controlled, double-blind dose-finding study of entacapone in fluctuating Parkinsonian patients |
| 001564 |
Kerrie L. Schoffer [Australie] ; Robert D. Henderson [Australie] ; Karen O'Maley [Australie] ; John D. O'Sullivan [Australie] | Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease |
| 001566 |
Tjeerd Mondria [Pays-Bas] ; Henriëtte H. W. De Gier [Pays-Bas] ; Agnita J. W. Boon [Pays-Bas] | New device to control combined lingual and palatal myoclonus |
| 001572 |
Maria Fulvia De Leva [Italie] ; Andrea Varrone [Italie] ; Alessandro Filla [Italie] ; Mario Quarantelli [Italie] ; Leonilda Bilo [Italie] ; Valeria Piscitelli [Italie] ; Elena Salvatore [Italie] ; Sara Ammendola [Italie] ; Salvatore Striano [Italie] ; Giuseppe De Michele [Italie] ; Vincenzo Bonavita [Italie] ; Sabina Pappata [Italie] | Neuroimaging Follow-Up in a Case of Rasmussen's Encephalitis with Dyskinesias |
| 001581 |
Michael W. M. Schupbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltete [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France] | Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus |
| 001583 |
Alexandre Berney [Canada, Suisse] ; Michel Panisset [Canada] ; Abbas F. Sadikot [Canada] ; Alain Ptito [Canada] ; Alain Dagher [Canada] ; Maria Fraraccio [Canada] ; Ghislaine Savard [Canada] ; Marc Pell [Canada] ; Chawki Benkelfat [Canada] | Mood Stability during Acute Stimulator Challenge in Parkinson's Disease Patients Under Long-Term Treatment with Subthalamic Deep Brain Stimulation |
| 001584 |
Richard Walsh [Irlande (pays)] ; Michael Hutchinson [Irlande (pays)] | Molding the Sensory Cortex : Spatial Acuity Improves After Botulinum Toxin Treatment for Cervical Dystonia |
| 001592 |
Gregor Simonis [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Ruth H. Strasser [Allemagne] | Meta-analysis of heart valve abnormalities in parkinson's disease patients treated with dopamine agonists |
| 001602 |
Roberta Zangaglia [Italie] ; Emilia Martignoni [Italie] ; Margaret Glorioso [Italie] ; Maria Ossola [Italie] ; Giulio Riboldazzi [Italie] ; Daniela Calandrella [Italie] ; Gabriele Brunetti [Italie] ; Claudio Pacchetti [Italie] | Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study |
| 001609 |
Christopher Kenney [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis] | Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders |
| 001614 |
Anthony P. Nicholas [États-Unis] | Levodopa-induced hyperactivity in mice treated with 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 001620 |
Dariusz Koziorowski [Pologne] ; Andrzej Friedman [Pologne] | Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease |
| 001630 |
Teri R. Thomsen [Canada] ; Wendy R. Galpem [Canada] ; Abena Asante [Canada] ; Tamara Arenovich [Canada] ; Susan H. Fox [Canada] | Ipratropium Bromide Spray as Treatment for Sialorrhea in Parkinson's Disease |
| 001634 |
Claudio Lucetti [Italie] ; Paulo Del Dotto [Italie] ; Gianna Gambaccini [Italie] ; Roberto Ceravolo [Italie] ; Chiara Logi [Italie] ; Caterina Berti [Italie] ; Giuseppe Rossi [Italie] ; Maria Cristina Bianchi [Italie] ; Michela Tosetti [Italie] ; Luigi Murri [Italie] ; Ubaldo Bonuccelli [Italie] | Influences of Dopaminergic Treatment on Motor Cortex in Parkinson Disease : A MRI/MRS Study |
| 001650 |
Nadia Stefanova [Autriche] ; Martin Köllensperger [Autriche] ; Monika Hainzer [Autriche] ; Angela Cenci [Suède] ; Werner Poewe [Autriche] ; Gregor Karl Wenning [Autriche] | High dose Levodopa therapy is not toxic in multiple system atrophy: Experimental evidence |
| 001656 |
Steven E. Lo [États-Unis] ; Michael Gelb [États-Unis] ; Steven J. Frucht [États-Unis] | Geste antagonistes in idiopathic lower cranial dystonia |
| 001662 |
Ettore Accolla [Italie] ; Elena Caputo [Italie] ; Filippo Cogiamanian [Italie] ; Filippo Tamma [Italie] ; Simona Mrakic-Sposta [Italie] ; Sara Marceglia [Italie] ; Marcello Egidi [Italie] ; Paolo Rampini [Italie] ; Marco Locatelli [Italie] ; Alberto Priori [Italie] | Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulation |
| 001666 |
Anthony H. V. Schapira [Royaume-Uni] | Future Directions in the Treatment of Parkinson's Disease |
| 001679 |
Samyra H. J. Keus [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; Erik J. M. Hendriks [Pays-Bas] ; Alexandra B. Bredero-Cohen [Pays-Bas] ; Marten Munneke [Pays-Bas] | Evidence-based analysis of physical therapy in Parkinson's disease with recommendations for practice and research |
| 001702 |
Angelo Antonini [Italie] ; Ioannis U. Isaias [Italie] ; Margherita Canesi [Italie] ; Maurizio Zibetti [Italie] ; Francesca Mancini [Italie] ; Luigi Manfredi [Italie] ; Marco Dal Fante [Italie] ; Leonardo Lopiano [Italie] ; Gianni Pezzoli [Italie] | Duodenal levodopa infusion for advanced Parkinson's disease : 12-month treatment outcome |
| 001724 |
Ludy C. Shih [États-Unis] ; Daniel Tarsy [États-Unis] | Deep Brain Stimulation for the Treatment of Atypical Parkinsonism |
| 001747 |
Claudia Trenkwalder [Allemagne] ; Ralf Kohnen [Allemagne] ; Richard P. Allen [États-Unis] ; Heike Benes [Allemagne] ; Luigi Ferini-Strambi [Italie] ; Diego Garcia-Borreguero [Espagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Svenja Happe [États-Unis] ; Birgit Högl [Autriche] ; Magdolna Hornyak [Allemagne] ; Christine Klein [Allemagne] ; Alexander Nass [Allemagne] ; Pasquale Montagna [Italie] ; Wolfgang H. Oertel [Allemagne] ; Shaun O'Keeffe [Irlande (pays)] ; Walter Paulus [Allemagne] ; Werner Poewe [Autriche] ; Federica Provini [Italie] ; Peter P. Pramstaller [Italie] ; Mariusz Sieminski [Pologne] ; Karel Sonka [République tchèque] ; Karin Stiasny-Kolster [Allemagne] ; Al De Weerd [Pays-Bas] ; Thomas C. Wetter [Allemagne] ; Juliane Winkelmann [Allemagne] ; Marco Zucconi [Italie] | Clinical Trials in Restless Legs Syndrome : Recommendations of the European RLS Study Group (EURLSSG) |
| 001751 |
Paul T. Francis [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | Cholinergic and Other Neurotransmitter Mechanisms in Parkinson's Disease, Parkinson's Disease Dementia, and Dementia with Lewy Bodies |
| 001752 |
Keisuke Suzuki [Japon] ; Yasuyuki Okuma [Japon] ; Nobutaka Hattori [Japon] ; Satoshi Kamei [Japon] ; Fumihito Yoshii [Japon] ; Hiroya Utsumi [Japon] ; Yasuo Iwasaki [Japon] ; Mutsumi Iijima [Japon] ; Tomoyuki Miyamoto [Japon] ; Masayuki Miyamoto [Japon] ; Koichi Hirata [Japon] | Characteristics of sleep disturbances in japanese patients with parkinson's disease. A study using Parkinson's disease sleep scale |
| 001763 |
Claudia Trenkwalder [Allemagne] ; Heike Benes [Allemagne] ; Ludger Grote [Suède] ; Svenja Happe [Allemagne] ; Birgit Högl [Autriche] ; Johannes Mathis [Suisse] ; Gerda M. Saletu-Zyhlarz [Autriche] ; Ralf Kohnen [Allemagne] | Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome : Results from a multicenter, randomized, active controlled trial |
| 001764 |
Sebastian Paus [Allemagne] ; Tanja Schmitz-Hübsch [Allemagne] ; Ullrich Wüllner [Allemagne] ; Antje Vogel [Allemagne] ; Thomas Klockgether [Allemagne] ; Michael Abele [Allemagne] | Bright light therapy in Parkinson's disease : A pilot study |
| 001768 |
Laura Bonanni [Italie] ; Astrid Thomas [Italie] ; Sara Varanese [Italie] ; Vincenzo Scorrano [Italie] ; Marco Onofrj [Italie] | Botulinum Toxin Treatment of Lateral Axial Dystonia in Parkinsonism |
| 001778 |
Roberto Vetrugno [Italie] ; Chiara La Morgia [Italie] ; Roberto D'Angelo [Italie] ; Daniela Loi [Italie] ; Federica Provini [Italie] ; Giuseppe Plazzi [Italie] ; Pasquale Montagna [Italie] | Augmentation of restless legs syndrome with long-term tramadol treatment |
| 001779 |
Diego Garcia-Borreguero [Espagne] ; Richard P. Allen [États-Unis] ; Heike Benes [Allemagne] ; Christopher Earley [États-Unis] ; Svenja Happe [Allemagne] ; Birgit Högl [Autriche] ; Ralf Kohnen [Allemagne] ; Walter Paulus [Allemagne] ; David Rye [États-Unis] ; Juliane Winkelmann [Allemagne] | Augmentation as a Treatment Complication of Restless Legs Syndrome : Concept and Management |
| 001794 |
Regina Katzenschlager [Royaume-Uni, Autriche] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Kim Stockwell [Royaume-Uni] ; Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Mohammed Zubair [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Antiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets |
| 001797 |
| Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disese and Other Movement Disorders |
| 001809 |
Bart F. L. Van Nuenen [Pays-Bas] ; Marielle Wohlgemuth [Pays-Bas] ; Rudi E. Wong Chung [Pays-Bas] ; Wilson F. Abdo [Pays-Bas] ; Bas R. Bloem [Pays-Bas] | Acupuncture for psychogenic movement disorders : Treatment or diagnostic tool? |
| 001821 |
Spiridon Papapetropoulos [États-Unis] ; Jennifer Friedman [États-Unis] ; Craig Blackstone [États-Unis] ; Gary I. Kleiner [États-Unis] ; Brian C. Bowen [États-Unis] ; Carlos Singer [États-Unis] | A progressive, fatal dystonia-parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy |
| 001822 |
Theresa A. Zesiewicz [États-Unis] ; Christopher L. Ward [États-Unis] ; Robert A. Hauser [États-Unis] ; Jason L. Salemi [États-Unis] ; Shaila Siraj [États-Unis] ; Maria-Carmen Wilson [États-Unis] ; Kelly L. Sullivan [États-Unis] | A pilot, double-blind, placebo-controlled trial of pregabalin (lyrica) in the treatment of essential tremor |
| 001827 |
Theresa A. Zesiewicz [États-Unis] ; Christopher L. Ward [États-Unis] ; Robert A. Hauser [États-Unis] ; Juan Sanchez-Ramos [États-Unis] ; Joseph F. Staffetti [États-Unis] ; Kelly L. Sullivan [États-Unis] | A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor |
| 001829 |
Carlos Singer [États-Unis] ; Janice Lamb [Royaume-Uni] ; Amanda Ellis [Royaume-Uni] ; Gary Layton [Royaume-Uni] | A comparison of sumanirole versus placebo or ropinirole for the treatment of patients with early Parkinson's disease |
| 001838 |
| Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders |
| 001847 |
Ji-Youn Kim [Corée du Sud] ; EUN JOO CHUNG [Corée du Sud] ; SEUNG WOO PARK [Corée du Sud] ; WON YONG LEE [Corée du Sud] | Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists |
| 001851 |
Louis C. S. Tan [Singapour] ; Puay-Ngoh Lau [Singapour] ; Roland Dominic G. Jamora [Singapour] ; Edwin S. Y. Chan [Singapour] | Use of complementary therapies in patients with Parkinson's disease in singapore |
| 001862 |
Martin A. Ritter [Allemagne] ; Achim Frese [Allemagne] ; Rainer Dziewas [Allemagne] ; Stefan Knecht [Allemagne] ; Stefan Evers [Allemagne] | Treatment of cremaster synkinesias with botulinum toxin A : A video case report |
| 001863 |
Susan H. Fox [Canada] ; Anthony E. Lang [Canada] ; Jonathan M. Brotchie [Canada] | Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies : Keys to success and roads to failure |
| 001870 |
Samay Jain [États-Unis] ; Paul E. Greene [États-Unis] ; Steven J. Frucht [États-Unis] | Tetrabenazine therapy of pediatric hyperkinetic movement disorders |
| 001873 |
Kelly L. Sullivan [États-Unis] ; Joseph F. Staffetti [États-Unis] ; Robert A. Hauser [États-Unis] ; Peter B. Dunne [États-Unis] ; Theresa A. Zesiewicz [États-Unis] | Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease |
| 001875 |
Allison King [États-Unis] ; Peter Harris [États-Unis] ; James Fritzell [États-Unis] ; Roger Kurlan [États-Unis] | Syncope in children with Tourette's syndrome treated with guanfacine |
| 001877 |
Deborah A. Hall [États-Unis] ; Elizabeth Berry-Kravis [États-Unis] ; Randi J. Hagerman [États-Unis] ; Paul J. Hagerman [États-Unis] ; Cathlin D. Rice [États-Unis] ; Maureen A. Leehey [États-Unis] | Symptomatic treatment in the fragile X-associated tremor/ ataxia syndrome |
| 001903 |
Juan Carlos Gomez-Esteban [Espagne] ; Juan Jose Zarranz ; Elena Lezcano ; Fernando Velasco ; Roberto Ciordia ; Idoia Rouco ; Jose Losada ; Iker Bilbao | Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease |
| 001933 |
Laura Silveira-Moriyama [Royaume-Uni] ; Andrew H. Evans [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Punding and dyskinesias |
| 001944 |
Kenichi Sato [Japon] ; Taku Hatano [Japon] ; Kazuo Yamashiro [Japon] ; Maki Kagohashi [Japon] ; Kenya Nishioka [Japon] ; Nana Izawa [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Hideo Mori [Japon] ; Yoshikuni Mizuno [Japon] | Prognosis of parkinson's disease : Time to stage III, IV, V, and to motor fluctuations |
| 001962 |
Sergio Bagnato [Italie] ; Rocco Agostino [Italie] ; Nicola Modugno [Italie] ; Angelo Quartarone [Italie] ; Alfredo Berardelli [Italie] | Plasticity of the motor cortex in Parkinson's disease patients On and Off therapy |
| 001963 |
Mikhail P. Lomarev [États-Unis] ; Sulada Kanchana [États-Unis] ; William Bara-Jimenez [États-Unis] ; Meena Iyer [États-Unis] ; Eric M. Wassermann [États-Unis] ; Mark Hallett [États-Unis] | Placebo-controlled study of rTMS for the treatment of Parkinson's disease |
| 001968 |
Paula R. Arantes [Brésil] ; Ellison F. Cardoso [Brésil] ; Maria A. Barreiros [Brésil] ; Manoel J. Teixeira [Brésil] ; Marcia R. Goncalves [Brésil] ; Egberto R. Barbosa [Brésil] ; Sukhi Shergill Sukwinder [Royaume-Uni] ; Claudia C. Leite [Brésil] ; Edson Jr Amaro [Brésil, Royaume-Uni] | Performing functional magnetic resonance imaging in patients with Parkinson's disease treated with deep brain stimulation |
| 001971 |
Jonathan W. Mink [États-Unis] ; John Walkup [États-Unis] ; Kirk A. Frey [États-Unis] ; Peter Como [États-Unis] ; Danielle Cath [Pays-Bas] ; Mahlon R. Delong [États-Unis] ; Gerald Erenberg [États-Unis] ; Joseph Jankovic [États-Unis] ; Jorge Juncos [États-Unis] ; James F. Leckman [États-Unis] ; Neal Swerdlow [États-Unis] ; Veerle Visser-Vandewalle [Pays-Bas] ; Jerrold L. Vitek [États-Unis] | Patient selection and assessment recommendations for deep brain stimulation in tourette syndrome |
| 001988 |
Theresa A. Zesiewicz [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Robert A. Hauser [États-Unis] ; Juan Sanchez-Ramos [États-Unis] | Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease |
| 001A03 |
Eus J. W. Van Someren [Pays-Bas] ; Myrthe D. Pticek [Pays-Bas] ; Johannes D. Speelman [Pays-Bas] ; Peter R. Schuurman [Pays-Bas] ; Rianne Esselink [Pays-Bas] ; Dick F. Swaab [Pays-Bas] | New actigraph for long-term tremor recording |
| 001A04 |
Norbert Kovacs [Hongrie] ; Endre Pal [Hongrie] ; Istvan Balas [Hongrie] ; Jozsef Janszky [Hongrie] ; Ferenc Nagy [Hongrie] ; Hajnalka Merkli [Hongrie] | Neurosurgical treatment of tremor in mitochondrial encephalopathy |
| 001A28 |
Werner Poewe [Autriche] ; Erik Wolters [Pays-Bas] ; Murat Emre [Turquie] ; Marco Onofrj [Italie] ; Chuanchieh Hsu [États-Unis] ; Sibel Tekin [États-Unis] ; Roger Lane [États-Unis] | Long-term benefits of rivastigmine in dementia associated with parkinson's disease : An active treatment extension study |
| 001A43 |
Pedro Gonzalez-Alegre [États-Unis] ; Praful Kelkar [États-Unis] ; Robert L. Rodnitzky [États-Unis] | Isolated high-fequency jaw tremor relieved by botulinum toxin injections |
| 001A53 |
Hatice Kumru [Espagne] ; Joan Santamaria [Espagne] ; Francesc Valldeoriola [Espagne] ; Maria J. Marti [Espagne] ; Eduardo Tolosa [Espagne] | Increase in body weight after pramipexole treatment in Parkinson's disease |
| 001B11 |
Alexei Korchounov [Allemagne, Égypte] ; Gregory Bogomazov [Russie] | Employment, medical absenteeism, and disability perception in Parkinson's disease : A pilot double-blind, randomized, placebo-controlled study of entacapone adjunctive therapy |
| 001B16 |
J. Antonelle Demarcaida [États-Unis] ; Steven R. Schwid [États-Unis] ; William B. White [États-Unis] ; Karen Blindauer [États-Unis] ; Stanley Fahn [États-Unis] ; Karl Kieburtz [États-Unis] ; Matthew Stern [États-Unis] ; Ira Shoulson [États-Unis] | Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline |
| 001B51 |
Matthew O. Hebb [Canada] ; Paula Gaudet [Canada] ; Ivar Mendez [Canada] | Deep brain stimulation to treat hyperkinetic symptoms of cockayne syndrome |
| 001B58 |
Todd B. Sherer [États-Unis] ; Brian K. Fiske [États-Unis] ; Clive N. Svendsen [États-Unis] ; Anthony E. Lang [Canada] ; J. William Langston [États-Unis] | Crossroads in GDNF therapy for Parkinson's disease |
| 001B63 |
Kazuya Yoshida [Japon] | Coronoidotomy as treatment for trismus due to jaw-closing oromandibular dystonia |
| 001B65 |
Claudia Trenkwalder [Allemagne] ; Karin Stiasny-Kolster [Allemagne] ; Andreas Kupsch [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Juergen Koester [Allemagne] ; Juergen Reess [Allemagne] | Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome |
| 001B66 |
Lauren H. Craig [États-Unis] ; Anna Svircev [États-Unis] ; Michael Haber [États-Unis] ; Jorge L. Juncos [États-Unis] | Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease |
| 001C05 |
Nina Browner [États-Unis] ; Shaheda N. Azher [États-Unis] ; Joseph Jankovic [États-Unis] | Botulinum toxin treatment of facial myoclonus in suspected rasmussen encephalitis |
| 001C07 |
Peter N. Van Harten [Pays-Bas] ; Ad Hovestadt [Pays-Bas] | Botulinum toxin as a treatment for tardive dyskinesia |
| 001C09 |
Susanne A. Schneider [Royaume-Uni] ; Mark J. Edwards [Royaume-Uni] ; Carla Cordivari [Royaume-Uni] ; William N. Macleod [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] | Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease |
| 001C31 |
Rivka Inzelberg [Israël] ; Ubaldo Bonuccelli [Italie] ; Edna Schechtman [Israël] ; Ala Miniowich [Israël] ; Rosa Strugatsky [Israël] ; Roberto Ceravolo [Italie] ; Chiara Logi [Italie] ; Carlo Rossi [Italie] ; Colin Klein [Israël] ; J. Martin Rabey [Israël] | Association between amantadine and the onset of dementia in parkinson's disease |
| 001C43 |
Pablo Mir [Royaume-Uni, Espagne] ; Francesca Gilio [Italie] ; Mark Edwards [Royaume-Uni] ; Maurizio Inghilleri [Italie] ; Kailash P. Bhatia [Royaume-Uni] ; John C. Rothwell [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Alteration of central motor excitability in a patient with hemimasticatory spasm after treatment with botulinum toxin injections |
| 001C45 |
Christopher G. Goetz [États-Unis] ; Joanne Wuu [États-Unis] ; Linda Curgian [États-Unis] ; Sue Leurgans [États-Unis] | Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients |
| 001C72 |
Yasser Awaad [États-Unis] ; Anne Marie Michon [États-Unis] ; Sarah Minarik [États-Unis] | Use of levetiracetam to treat tics in children and adolescents with tourette syndrome |
| 001C80 |
Anthony E. Lang [Canada] | Treatment of progressive supranuclear palsy and corticobasal degeneration |
| 001C81 |
Werner Poewe [Autriche] | Treatment of dementia with lewy bodies and Parkinson's disease dementia |
| 001C82 |
Silvi Frenkel-Toledo [Israël] ; Nir Giladi [Israël] ; Chava Peretz [Israël] ; Talia Herman [Israël] ; Leor Gruendlinger [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson's disease |
| 001C85 |
David J. Burn [Royaume-Uni] ; Naomi M. Warren [Royaume-Uni] | Toward future therapies in progressive supranuclear palsy |
| 001C86 |
Yuan-Gui Huang [République populaire de Chine] ; Yun-Chun Chen [République populaire de Chine] ; FANG DU [République populaire de Chine] ; RUI LI [République populaire de Chine] ; Ge-Lin Xu [République populaire de Chine] ; WEN JIANG [République populaire de Chine] ; JING HUANG [République populaire de Chine] | Topiramate therapy for paroxysmal kinesigenic choreoathetosis |
| 001C91 |
Meg Morris [Australie] ; Robert Iansek [Australie] ; Jennifer Mcginley [Australie] ; Thomas Matyas [Australie] ; Frances Huxham [Australie] | Three-dimensional gait biomechanics in Parkinson's disease: Evidence for a centrally mediated amplitude regulation disorder |
| 001C93 |
Gregor K. Wenning [Autriche] ; Felix Geser [Autriche] ; Werner Poewe [Autriche] | Therapeutic strategies in multiple system atrophy |
| 001D22 |
Leo Verhagen Metman [États-Unis] ; Shaun T. O'Leary [États-Unis] | Role of surgery in the treatment of motor complications |
| 001D23 |
Katherine L. Widnell [États-Unis] ; Cynthia Comella [États-Unis] | Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations |
| 001D43 |
Carlos Singer [États-Unis] ; Spiridon Papapetropoulos [États-Unis] ; Neil I. Spielholz [États-Unis] | Primary writing tremor : Report of a case successfully treated with botulinum toxin a injections and discussion of underlying mechanism |
| 001D53 |
Katherine A. Grosset [Royaume-Uni] ; Donald G. Grosset [Royaume-Uni] | Patient-perceived involvement and satisfaction in Parkinson's disease : Effect on therapy decisions and quality of life |
| 001D66 |
YUE HUANG [Australie] ; Raymond Garrick [Australie] ; Raymond Cook [Australie] ; Dudley O'Sullivan [Australie] ; John Morris [Australie] ; Glenda M. Halliday [Australie] | Pallidal stimulation reduces treatment-induced dyskinesias in "minimal-change" multiple system atrophy |
| 001D68 |
Cheryl Waters [États-Unis] | Other pharmacological treatments for motor complications and dyskinesias |
| 001D70 |
Theresa A. Zesiewicz [États-Unis] ; Kelly L. Sullivan [États-Unis] ; John L. Maldonado [États-Unis] ; William O. Tatum [États-Unis] ; Robert A. Hauser [États-Unis] | Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease |
| 001D83 |
C. Warren Olanow [États-Unis] ; Joseph Jankovic [États-Unis] | Neuroprotective therapy in Parkinson's disease and motor complications : A search for a pathogenesis-targeted, disease-modifying strategy |
| 001D91 |
Dirk Dressler [Allemagne] ; M. Lange [Allemagne] ; Hans Bigalke [Allemagne] | Mouse diaphragm assay for detection of antibodies against botulinum toxin type B |
| 001D94 |
Robert M. Silva [États-Unis] ; Chia-Yi Kuan [États-Unis] ; Pasko Rakic [États-Unis] ; Robert E. Burke [États-Unis] | Mixed lineage kinase-c-jun N-terminal kinase signaling pathway : A new therapeutic target in Parkinson's disease |
| 001E04 |
Inger Marie Skogseid [Norvège] ; Jo R Islien [Norvège] ; Bj Rgulf Claussen [Norvège] ; Emilia Kerty [Norvège] | Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia |
| 001E16 |
Djamel Ben Smail [France] ; Claire Jacq [France] ; Pierre Denys [France] ; Bernard Bussel [France] | Intrathecal baclofen in the treatment of painful, disabling spasms in Friedreich's ataxia |
| 001E47 |
Hans-Christian Jabusch [Allemagne] ; Dorothea Zschucke [Allemagne] ; Alexander Schmidt [Allemagne] ; Stephan Schuele [États-Unis] ; Eckart Altenmüller [Allemagne] | Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients |
| 001E53 |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Evidence-based medical review update : Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 |
| 001E55 |
Adrian Cristian [États-Unis] ; Meredith Katz [États-Unis] ; Eileen Cutrone [États-Unis] ; Ruth H. Walker [États-Unis] | Evaluation of acupuncture in the treatment of Parkinson's disease : A double-blind pilot study |
| 001E66 |
Anna Lena Törnqvist [Suède] ; Lucyna Schalen [Suède] ; Stig Rehncrona [Suède] | Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson's disease treated with subthalamic deep brain stimulation |
| 001E83 |
Michael S. Okun [États-Unis] ; Hubert H. Fernandez [États-Unis] ; Kelly D. Foote [États-Unis] | Deep brain stimulation of the GPi treats restless legs syndrome associated with dystonia |
| 001E89 |
Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease : A prospective study using single-dose challenges |
| 001F03 |
Maria V. Recio [États-Unis] ; Robert A. Hauser [États-Unis] ; Elan D. Louis [États-Unis] ; Harsha Radhashakar [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Theresa A. Zesiewicz [États-Unis] | Chorea in a patient with cerebral palsy : Treatment with levetiracetam |
| 001F32 |
Daniel Weintraub [États-Unis] ; Knashawn H. Morales [États-Unis] ; Paul J. Moberg [États-Unis] ; Warren B. Bilker [États-Unis] ; Catherine Balderston [États-Unis] ; John E. Duda [États-Unis] ; Ira R. Katz [États-Unis] ; Matthew B. Stern [États-Unis] | Antidepressant studies in Parkinson's disease : A review and meta-analysis |
| 001F73 |
Giuseppe Brisinda [Italie] ; Anna Rita Bentivoglio [Italie] ; Giorgio Maria [Italie] ; Alberto Albanese [Italie] | Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms |
| 001F74 |
Joseph Jankovic [États-Unis] | Treatment of cervical dystonia with botulinum toxin |
| 001F77 |
Lorenzo Priano [Italie] ; Gianni Albani [Italie] ; Andrea Brioschi [Italie] ; Sara Calderoni [Italie] ; Leonardo Lopiano [Italie] ; Mario Rizzone [Italie] ; Roberta Cavalli [Italie] ; Maria Rosa Gasco [Italie] ; Francesco Scaglione [Italie] ; Franco Fraschini [Italie] ; Bruno Bergamasco [Italie] ; Alessandro Mauro [Italie] | Transdermal apomorphine permeation from microemulsions: A new treatment in Parkinson's Disease |
| 001F86 |
Yasin Temel [Pays-Bas] ; Veerle Visser-Vandewalle [Pays-Bas] | Surgery in Tourette syndrome |
| 001F88 |
Theresa A. Zesiewicz [États-Unis] ; Elan D. Louis [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Martin Menkin [États-Unis] ; Peter B. Dunne [États-Unis] ; Robert A. Hauser [États-Unis] | Substantial improvement in a Meige's syndrome patient with levetiracetam treatment |
| 001F93 |
Federica Provini [Italie] ; Roberto Vetrugno [Italie] ; Francesca Pastorelli [Italie] ; Carolina Lombardi [Italie] ; Giuseppe Plazzi [Italie] ; Anna Federica Marliani [Italie] ; Elio Lugaresi [Italie] ; Pasquale Montagna [Italie] | Status dissociatus after surgery for tegmental ponto-mesencephalic cavernoma: A state-dependent disorder of motor control during sleep |
| 002006 |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study |
| 002010 |
Arthur S. Walters [États-Unis] ; William G. Ondo [États-Unis] ; Tilman Dreykluft [Allemagne] ; Ron Grunstein [Australie] ; Daniel Lee [États-Unis] ; Kapil Sethi [États-Unis] | Ropinirole is effective in the treatment of Restless Legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled Study |
| 002012 |
Leonard A. Smith [États-Unis] ; Melody J. Jensen [États-Unis] ; Vicki A. Montgomery [États-Unis] ; Douglas R. Brown [États-Unis] ; S. Ashrat Ahmed [États-Unis] ; Theresa J. Smith [États-Unis] | Roads from vaccines to therapies |
| 002017 |
Jan L. De Bleecker [Belgique] ; Veerle L. Vervaet [Belgique] ; Angela De Sarro [Italie] | Reversible orofacial dyskinesia after ofloxacin treatment |
| 002027 |
Gurutz Linazasoro [Espagne] | Recent failures of new potential symptomatic treatments for Parkinson's disease: Causes and solutions |
| 002036 |
Bart Post [Pays-Bas] ; Johannes H. T. M. Koelman [Pays-Bas] ; Marina A. J. Tijssen [Pays-Bas] | Propriospinal myoclonus after treatment with ciprofloxacin |
| 002051 |
Marco Mucchiut [Italie] ; Enrico Belgrado [Italie] ; Daniela Cutuli [Italie] ; Angelo Antonini [Italie] ; Paolo Bergonzi [Italie] | Pramipexole-treated Parkinson's disease during pregnancy |
| 002073 |
Shilpa Jain [Royaume-Uni] ; Jill Dawson [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; E. Diane Playford [Royaume-Uni] | Occupational therapy in multiple system atrophy: A pilot randomized controlled trial |
| 002078 |
Susan Fox [Royaume-Uni] ; Montague Silverdale ; Mark Kellett ; Rhys Davies ; Malcolm Steiger [Royaume-Uni] ; Nicholas Fletcher [Royaume-Uni] ; Alan Crossman [Royaume-Uni] ; Jonathan Brotchie | Non-subtype-selective Opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease |
| 002080 |
Carla Cordivari [Royaume-Uni] ; V. Peter Misra [Royaume-Uni] ; Santiago Catania [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | New therapeutic indications for botulinum toxins |
| 002091 |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, États-Unis] ; Warren Olanow [Finlande] ; Peter Jenner [Royaume-Uni] | Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naïve primates |
| 002092 |
Hans-Holger Capelle [Allemagne] ; Johannes C. Wohrle [Allemagne] ; Ralf Weigel [Allemagne] ; Hansjörg B Zner [Allemagne] ; Eva Grips [Allemagne] ; Joachim K. Krauss [Allemagne] | Movement disorders after intervertebral disc surgery: Coincidence or causal relationship? |
| 002095 |
Kirsten E. Zeuner [États-Unis] ; Holly A. Shill [États-Unis] ; Young H. Sohn [États-Unis] ; Fiona M. Molloy [États-Unis] ; Bonnie C. Thornton [États-Unis] ; James M. Dambrosia [États-Unis] ; Mark Hallett [États-Unis] | Motor training as treatment in focal hand dystonia |
| 002112 |
Svenja Happe [Allemagne] ; Tobias Tings [Allemagne] ; Kathrin Helmschmied [Allemagne] ; Karin Neubert [Allemagne] ; Wolfgang Wuttke [Allemagne] ; Walter Paulus [Allemagne] ; Claudia Trenkwalder [Allemagne] | Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease |
| 002113 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio ; Fabrizio Stocchi | Levodopa in the treatment of Parkinson's disease: Current controversies |
| 002114 |
Michael S. Okun [États-Unis] ; Jerrold L. Vitek [États-Unis] | Lesion therapy for Parkinson's disease and other movement disorders: Update and controversies |
| 002130 |
Niels Hjort [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] | Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus |
| 002138 |
Jürgen Andrich [Allemagne] ; Carsten Saft [Allemagne] ; Anneliese Arz [Allemagne] ; Birgit Schneider [Allemagne] ; Markus W. Agelink [Allemagne] ; Peter H. Kraus [Allemagne] ; Wilfried Kuhn [Allemagne] ; Thomas Müller [Allemagne] | Hyperhomocysteinaemia in treated patients with Huntington's disease |
| 002139 |
Frank J. Erbguth [Allemagne] | Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin |
| 002150 |
Aijaz A. Khan [Royaume-Uni] ; Jon D. Sussman [Royaume-Uni] | Focal dystonia after removal of a parietal meningioma |
| 002203 |
Dirk Dressier [Allemagne] | Clinical presentation and management of antibody-induced failure of botulinum toxin therapy |
| 002224 |
William J. Newman [États-Unis] ; Thomas L. Davis [États-Unis] ; Bismal B. Padaliya [États-Unis] ; Cassondra D. Covington [États-Unis] ; Chandler E. Gill [États-Unis] ; Anna I. Ahramovitch [États-Unis] ; P. David Charles [États-Unis] | Botulinum toxin type A therapy during pregnancy |
| 002225 |
Markus Naumann [Allemagne] ; Wolfgang Jost [Allemagne] | Botulinum toxin treatment of secretory disorders |
| 002226 |
Barbara Illowsky Karp [États-Unis] | Botulinum toxin treatment of occupational and focal hand dystonia |
| 002233 |
M. Zouhair Atassi [États-Unis] | Basic immunological aspects of botulinum toxin therapy |
| 002250 |
Peter H. Kraus [Allemagne] ; Peter Klotz [Allemagne] ; Arndt Hoffmann [Allemagne] ; Johannes Lewe [Allemagne] ; Horst Przuntek [Allemagne] | Analysis of the course of Parkinson's disease under dopaminergic therapy : Performance of "fast tapping" is not a suitable parameter |
| 002257 |
Susan Hollan [Hongrie] ; Laszlo Vecsei [Hongrie] ; D. Kalman Magyar [Hongrie] | Adverse effects of dopamine potentiation by long-term treatment with selegiline |
| 002283 |
Gurutz Linazasoro [Espagne] ; Nadège Van Blercom [Espagne] ; Asier Lasa [Espagne] | Unilateral subthalamic deep brain stimulation in advanced Parkinson's disease |
| 002285 |
Jan Herzog [Allemagne] ; Jens Volkmann [Allemagne] ; Paul Krack [Allemagne] ; Florian Kopper [Allemagne] ; Monika Potter [Allemagne] ; Delia Lorenz [Allemagne] ; Meike Steinbach [Allemagne] ; Stefan Klebe [Allemagne] ; Wolfgang Hamel [Allemagne] ; Bettina Schrader [Allemagne] ; Dieter Weinert [Allemagne] ; Dieter Müller [Allemagne] ; Hubertus M. Mehdorn [Allemagne] ; Günther Deuschl [Allemagne] | Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease |
| 002287 |
Francisco Cardoso [Brésil] ; Débora Maia [Brésil] ; Mauro César Q. S. Cunningham [Brésil] ; Guilherme Valenca [Brésil] | Treatment of sydenham chorea with corticosteroids |
| 002289 |
Roy R. Reeves [États-Unis] ; Vincent Liberto [États-Unis] | Treatment of essential blepharospasm with quetiapine |
| 002290 |
Philip C. Su [Taïwan] ; Ham-Min Tseng [Taïwan] ; Hon-Man Liu [Taïwan] ; Ruoh-Fang Yen [Taïwan] ; Horng-Huei Liou [Taïwan] | Treatment of advanced Parkinson's Disease by subthalamotomy: One-year results |
| 002291 |
Francisco Grandas [Espagne] ; Jaime Kulisevsky [Espagne] | Treatment of Parkinson's disease in Spain |
| 002292 |
Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France] | Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue |
| 002297 |
John M. Walshe [Royaume-Uni] | The story of penicillamine: A difficult birth |
| 002298 |
Anjan Chatterjee [États-Unis] ; Steven J. Frucht [États-Unis] | Tetrabenazine in the treatment of severe pediatric chorea |
| 002306 |
Pedro J. Garcia-Ruiz [Espagne] ; Vicente Villanueva [Espagne] ; Eva Gutierrez-Delicado [Espagne] ; Amaia Echeverria [Espagne] ; Antonio Perez-Higueras [Espagne] ; José M. Serratosa [Espagne] | Subthalamic lesion and paroxysmal tonic spasms |
| 002310 |
Sylvie Raoul [France] ; Mirella Faighel [France] ; Isabelle Rivier [France] ; Marc Verin [France] ; Youenn Lajat [France] ; Philippe Damier [France] | Staged lesions through implanted deep brain stimulating electrodes: A new surgical procedure for treating tremor or dyskinesias |
| 002318 |
Tomoyuki Uchiyama [Japon] ; Ryuji Sakakibara [Japon] ; Takamichi Hattori [Japon] ; Tomonori Yamanishi [Japon] | Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon |
| 002322 |
Massimo Cincotta [Italie] ; Alessandra Borgheresi [Italie] ; Lara Balzini [Italie] ; Luca Vannucchi [Italie] ; Gabriele Zeloni [Italie] ; Aldo Ragazzoni [Italie] ; Francesco Benvenuti [Italie] ; Gaetano Zaccara [Italie] ; Graziano Arnetoli [Italie] ; Ulf Ziemann [Allemagne] | Separate ipsilateral and contralateral corticospinal projections in congenital mirror movements: Neurophysiological evidence and significance for motor rehabilitation |
| 002343 |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor |
| 002345 |
Charles H. Adler [États-Unis] ; John N. Caviness [États-Unis] ; Joseph G. Hentz [États-Unis] ; Marlene Lind [États-Unis] ; Judy Tiede [États-Unis] | Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease |
| 002352 |
Werner Poewe [Autriche] | Psychosis in Parkinson's disease |
| 002354 |
USHA KANT MISRA [Inde] ; Jayantee Kalita [Inde] ; Anita Mahadevan [Inde] ; SUSARLA KRISHNA SHANKAR [Inde] | Pseudoathetosis in a patient with leprosy |
| 002378 |
Silvia Folgar [Argentine] ; Emilia Mabel Gatto [Argentine] ; Gabriela Raina [Argentine] ; Federico Micheli [Argentine] | Parkinsonism as a manifestation of multiple sclerosis |
| 002383 |
Ali Samii [États-Unis] ; Debra D. Dahlen [États-Unis] ; Alexander M. Spence [États-Unis] ; Nicole C. Maronian [États-Unis] ; Eric E. Kraus [États-Unis] ; Vanda A. Lennon [États-Unis] | Paraneoplastic movement disorder in a patient with non-Hodgkin's lymphoma and CRMP-5 autoantibody |
| 002384 |
Marcelo Merello [Argentine] ; Jorge Balej [Argentine] ; Ramon Leiguarda [Argentine] | Pallidotomy in Parkinson's disease improves single-joint, repetitive, ballistic movements, but fails to modify multijoint, repetitive, gestural movements |
| 002387 |
Claudia Trenkwalder [Allemagne] ; Victor Collado Seidel [Allemagne] ; Jörg Kazenwadel [Suisse] ; Thomas C. Wetter [Allemagne] ; Wolfgang Oertel [Allemagne] ; Roland Selzer [Allemagne] ; Ralf Kohnen [Allemagne] | One-year treatment with standard and sustained-release levodopa: Appropriate long-term treatment of restless legs syndrome? |
| 002399 |
Gregor K. Wenning [Autriche] ; Felix Geser [Autriche] ; Michaela Stampfer-Kountchev [Autriche] ; Francois Tison [Autriche] | Multiple system atrophy: An update |
| 002406 |
Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] | Mirtazapine in essential tremor: A double-blind, placebo-controlled pilot study |
| 002419 |
Jau-Shin Lou [États-Unis] ; Greg Kearns [États-Unis] ; Theodore Benice [États-Unis] ; Barry Oken [États-Unis] ; Gary Sexton [États-Unis] ; John Nutt [États-Unis] | Levodopa improves physical fatigue in Parkinson's disease: A double-blind, placebo-controlled, crossover study |
| 002421 |
Wolfgang N. Löscher [Autriche] ; Eugen Trinka [Autriche] | Late delayed postradiation spinal myoclonus or psychogenic movement disorder? |
| 002438 |
Melih Vural [Turquie] ; Sibel Özekmekci [Turquie] ; Hülya Apaydin [Turquie] ; Attila Altinel [Turquie] | High-dose piracetam is effective on cerebellar ataxia in a patient with cerebellar cortical atrophy |
| 002444 |
John Yianni [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Nir Giladi [Israël] ; Marieta Auca [Israël] ; Ralph Gregory [Royaume-Uni] ; Carole Joint [Royaume-Uni] ; Dipankar Nandi [Royaume-Uni] ; John Stein [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] | Globus pallidus internus deep brain stimulation for dystonic conditions: A prospective audit |
| 002449 |
William G. Ondo [États-Unis] ; Christine Hunter [États-Unis] | Flumazenil, a GABA antagonist, may improve features of Parkinson's Disease |
| 002450 |
Juha-Matti Savola [Finlande] ; Michael Hill [Royaume-Uni] ; Mia Engstrom [Finlande] ; Hannele Merivuori [Finlande] ; Siegfried Wurster [Finlande] ; Steven G. Mcguire [Royaume-Uni] ; Susan H. Fox [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Fipamezole (JP-1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease |
| 002457 |
Jay S. Schneider [États-Unis] ; Timothy V. Wade [États-Unis] | Experimental parkinsonism is associated with increased pallidal GAD gene expression and is reversed by site-directed antisense gene therapy |
| 002465 |
Kathy Steece-Collier [États-Unis] ; Timothy J. Collier [États-Unis] ; Paul D. Danielson [États-Unis] ; Roger Kurlan [États-Unis] ; David M. Yurek [États-Unis] ; John R. Jr Sladek [États-Unis] | Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in Parkinsonian rats |
| 002466 |
Ryoichi Hayashi [Japon] ; Takao Hashimoto [Japon] ; Kenji Tako [Japon] | Efficacy of propranolol in hyperthyroid-induced chorea: A case report |
| 002467 |
Marc Ziegler [France] ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of Piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6-month, randomized, placebo-controlled study |
| 002468 |
Ryoichi Hayashi [Japon] ; Takao Hashimoto [Japon] ; Tsuyoshi Tada [Japon] ; Shu-Ichi Ikeda [Japon] | Effects of unilateral pallidotomy on voluntary movement, and simple and choice reaction times in Parkinson's disease |
| 002477 |
Prithiva Navan [Royaume-Uni] ; Leslie J. Findley [Royaume-Uni] ; Jim A. R. Jeffs [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest Tremor and UPDRS part III in Parkinson's disease |
| 002479 |
Carsten Buhmann [Allemagne] ; Alexandra Bussopulos [Allemagne] ; Matthias Oechsner [Allemagne] | Dopaminergic response in Parkinsonian phenotype of Machado-Joseph Disease |
| 002495 |
Daphna Joel [Israël] ; Liat Ayalon [Israël] ; Ricardo Tarrasch [Israël] ; Ina Weinei [Israël] | Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: A potential novel treatment in a rat model of Huntington's disease |
| 002501 |
David J. Burn [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] | Current treatment of Dementia with lewy bodies and Dementia associated with Parkinson's disease |
| 002510 |
Montse Alegret [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne] ; Pere Vendrell [Espagne] ; Carme Junque [Espagne] ; José Martinez [Espagne] ; Jordi Rumia [Espagne] | Cognitive effects of unilateral posteroventral pallidotomy: A 4-year follow-up study |
| 002514 |
Nancy Belanger [Canada] ; Laurent Gregoire [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Paul J. Bedard [Canada] | Chronic treatment with small doses of cabergoline prevents Dopa-induced dyskinesias in Parkinsonian monkeys |
| 002515 |
Walter Pirker [Autriche] ; Claude Back [Autriche] ; Willibald Gerschlager [Autriche] ; Franco Laccone [Allemagne] ; Francois Alesch [Autriche] | Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2 |
| 002518 |
Cathy Chuang [États-Unis] ; Anne Constantino [États-Unis] ; Casilda Balmaceda [États-Unis] ; David Eidelberg [États-Unis] ; Steven J. Frucht [États-Unis] | Chemotherapy-induced Parkinsonism responsive to levodopa: An underrecognized entity |
| 002519 |
Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada] | Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications |
| 002524 |
Antje M. Smala [Allemagne] ; E. Annika Spottke [Allemagne] ; Olaf Machat [Allemagne] ; Uwe Siebert [États-Unis] ; Dieter Meyer [Allemagne] ; Rudolf Köhne-Volland [Allemagne] ; Martin Reuther [Allemagne] ; Janeen Duchane [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; Karin B. Berger [Allemagne] ; Richard C. Dodel [Allemagne] | Cabergoline versus levodopa monotherapy: A decision analysis |
| 002528 |
Brad A. Racette [États-Unis] ; Laura Good [États-Unis] ; Sandy Sagitto [États-Unis] ; Joel S. Perlmutter [États-Unis] | Botulinum toxin B reduces sialorrhea in parkinsonism |
| 002529 |
Michela Barichella [Italie] ; Agnieszka M. Marczewska [Italie] ; Claudio Mariani [Italie] ; Andrea Landi [Italie] ; Antonella Vairo [Italie] ; Gianni Pezzoli [Italie] | Body weight gain rate in patients with Parkinson's disease and deep brain stimulation |
| 002530 |
George J. Counelis [États-Unis] ; Tanya Simuni [États-Unis] ; Mark S. Forman [États-Unis] ; Jurg L. Jaggi [États-Unis] ; John Q. Trojanowski [États-Unis] ; Gordon H. Baltuch [États-Unis] | Bilateral subthalamic nucleus deep brain stimulation for advanced PD: Correlation of intraoperative MER and postoperative MRI with neuropathological findings |
| 002531 |
Jay C. Erickson [États-Unis] ; Bahman Jabbari [États-Unis] ; Marc P. Difazio [États-Unis] | Basal ganglia injury as a complication of the ketogenic diet |
| 002532 |
Noël L. W. Keijsers [Pays-Bas] ; Martin W. I. M. Horstink [Pays-Bas] ; Stan C. A. M. Gielen [Pays-Bas] | Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks |
| 002535 |
Isabelle Benatru [France] ; Stéphane Thobois [France] ; Nathalie Andre-Obadia [France] ; Pierre-Marie Gonnaud [France] ; Yara Beaugendre [France] ; Colette Berger [France] ; Michel Gonce [Belgique] ; Emmanuel Broussolle [France] | Atypical propriospinal myoclonus with possible relationship to α interferon therapy |
| 002545 |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Nadège Van Blercom [France] ; JING XIE [France] ; Elena Moro [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease |
| 002546 |
Renato P. Munhoz [Canada] ; Ritsuko Hanajima [Canada] ; Peter Ashby [Canada] ; Anthony E. Lang [Canada] | Acute effect of transcutaneous electrical nerve stimulation on Tremor |
| 002551 |
Shingo Okabe [Japon] ; Yoshikazu Ugawa [Japon] ; Ichiro Kanazawa [Japon] | 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's Disease |
| 002553 |
| Management of Parkinson's disease: an evidence-based review |
| 002554 |
| Deep Brain Stimulation for Movement Disorders |
| 002562 |
William G. Ondo [États-Unis] ; LING LING CHAN [États-Unis] ; Joel K. Levy [États-Unis] | Vascular parkinsonism : Clinical correlates predicting motor improvement after lumbar puncture |
| 002563 |
Francisco Escamilla-Sevilla [Espagne] ; Adolfo Minguez-Castellanos [Espagne] ; Ventura Arjona-Moron [Espagne] ; Jose Maria Martin-Linares [Espagne] ; Juan Carlos Sanchez-Alvarez [Espagne] ; Angel Ortega-Morenoa [Espagne] ; Teresa Garcia-Gomez [Espagne] | Unilateral pallidal stimulation for segmental cervical and truncal dystonia: Which side? |
| 002564 |
Simon G. Parkin [Royaume-Uni] ; Ralph P. Gregory [Royaume-Uni] ; Richard Scott [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Peter Silbum [Australie] ; Bruce Hall [Australie] ; Richard Boyle [Australie] ; Carole Joint [Royaume-Uni] ; Tipu Z. Aziz [Royaume-Uni] | Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: A case series of 115 patients |
| 002565 |
Padraic J. Grattan-Smith [Australie] ; Ron A. Wevers [Pays-Bas] ; Gerry C. Steenbergen-Spanjers [Pays-Bas] ; Victor S. C. Fung [Australie] ; John Earl [Australie] ; Bridget Wilcken [Australie] | Tyrosine hydroxylase deficiency: Clinical manifestations of catecholamine insufficiency in infancy |
| 002571 |
Pierre Pollak [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Elena Moro [France] ; Alexandre Mendes [France] ; Stephan Chabardes [France] ; Adnan Koudsie [France] ; Alim-Louis Benabid [France] | Treatment results: Parkinson's disease |
| 002572 |
Michael S. Okun [États-Unis] ; Kenneth M. Heilman [États-Unis] ; Jerrold L. Vitek [États-Unis] | Treatment of pseudobulbar laughter after gamma knife thalamotomy |
| 002573 |
Manavdeep Grewal [Canada] ; Raed Hawa [Canada] ; Colin Shapiro [Canada] | Treatment of periodic limb movements in sleep with selegiline HCl |
| 002574 |
| Treatment of depression in idiopathic Parkinson's disease |
| 002581 |
Tamar C. Rubinstein [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | The power of cueing to circumvent dopamine deficits: A review of physical therapy treatment of gait disturbances in Parkinson's disease |
| 002582 |
Ronald K. B. Pearce [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jorgen Scheel-Krüger [Danemark] ; Peter Jenner [Royaume-Uni] | The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets |
| 002584 |
Sujana Reddy [États-Unis] ; Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis] ; Paul J. Feustel [États-Unis] | The effect of quetiapine on psychosis and motor function in Parkinsonian patients with and without dementia |
| 002585 |
Louis C. Tan [États-Unis] ; Peter H. Protell [États-Unis] ; J. William Langston [États-Unis] ; Daniel M. Togasaki [États-Unis] | The Hyperkinetic Abnormal Movements Scale: A tool for measuring levodopa-induced Abnormal Movements in squirrel monkeys |
| 002586 |
Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Lucas Kempf [États-Unis] ; Steven B. Wilkinson [États-Unis] ; William C. Koller [États-Unis] | Thalamic stimulation for midbrain tremor after partial hemangioma resection |
| 002591 |
Katherine H. O. Deane [Royaume-Uni] ; Caroline Ellis-Hill [Royaume-Uni] ; Diana Jones [Royaume-Uni] ; Renata Whurr [Royaume-Uni] ; Yoav Ben-Shlomo [Royaume-Uni] ; E. Diane Playford [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] | Systematic review of paramedical therapies for Parkinson's disease |
| 002595 |
| Surgical treatment for Parkinson's disease: Neural transplantation |
| 002596 |
| Surgical treatment for Parkinson's disease: Deep brain surgery |
| 002597 |
Paul Krack [France] ; Jonathan Dostrovsky [Canada] ; Igor Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis] ; Fred Lenz [États-Unis] ; Andres Lozano [Canada] ; Jerry Vitek [États-Unis] | Surgery of the motor thalamus: Problems with the present nomenclatures |
| 002598 |
Robert Schauer [Autriche] ; Markus Singer [Autriche] ; Leopold Saltuari [Autriche] ; Markus Kofler [Autriche] | Suppression of cortical myoclonus by levetiracetam |
| 002600 |
H. Christopher Hyson [Canada] ; Andrew M. Johnson [Canada] ; Mandar S. Jog [Canada] | Sublingual atropine for sialorrhea secondary to parkinsonism: A pilot study |
| 002601 |
Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Alan Crossman [Royaume-Uni] ; Jonathan Brotchie [Royaume-Uni] | Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease |
| 002603 |
Johannes D. Speelman [Pays-Bas] ; Richard Schuurman [Pays-Bas] ; Rob M. A. De Bie [Pays-Bas] ; Rianne A. J. Esselink [Pays-Bas] ; D. Andries Bosch [Pays-Bas] | Stereotactic neurosurgery for tremor |
| 002608 |
| Speech therapy in Parkinson's disease |
| 002617 |
Brad A. Racette [États-Unis] ; Mikula Stambuk [États-Unis] ; Joel S. Perlmutter [États-Unis] | Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024) |
| 002618 |
Charles H. Adler [États-Unis] ; Stewart A. Factor [États-Unis] ; Mitchell Brin [États-Unis] ; Kapil D. Sethi [États-Unis] | Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia |
| 002620 |
Jörg Müller [Autriche] ; Gregor K. Wenning [Autriche] ; Jörg Wissel [Autriche] ; Angelika Baldauf [Autriche] ; Klaus Seppi [Autriche] ; Christian Brenneis [Autriche] ; Werner Poewe [Autriche] | Riluzole therapy in cervical dystonia |
| 002621 |
Johannes Schiefer [Allemagne] ; G. Bernhard Landwehrmeyer [Allemagne] ; Hans-Gerd Lüesse [Allemagne] ; Arne Sprünken [Allemagne] ; Christiane Puls [Allemagne] ; Anna Milkereit [Allemagne] ; Eva Milkereit [Allemagne] ; Christoph M. Kosinski [Allemagne] | Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease |
| 002622 |
Giorgio Fabiani [Brésil] ; Hélio A. G. Teive [Brésil] ; Francisco M. B. Germiniani [Brésil] ; Daniel S. Sa [Brésil] ; Lineu César Werneck [Brésil] | Reversible Parkinsonian syndrome in systemic and brain vasculitis |
| 002623 |
Laurent Vercueil [France] ; Paul Krack [France] ; Pierre Pollak [France] | Results of deep brain stimulation for dystonia: A critical reappraisal |
| 002624 |
Peter Hagell [Suède] ; Sara Nordling [Suède] ; Jan Reimer [Suède] ; Martin Grabowski [Suède] ; Ulf Persson [Suède] | Resource use and costs in a Swedish cohort of patients with Parkinson's disease |
| 002626 |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of Piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: A behavioural and biochemical investigation |
| 002627 |
Roger A. Barker [Royaume-Uni] | Repairing the brain in Parkinson's disease: Where next? |
| 002629 |
Padraig O'Suilleabhain [États-Unis] ; Richard B. Jr Dewey [États-Unis] | Randomized trial comparing primidone initiation schedules for treating essential tremor |
| 002630 |
Susan H. Fox [Royaume-Uni] ; Mark Kellett [Royaume-Uni] ; A. Peter Moore [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia |
| 002631 |
Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande] | Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's Disease |
| 002633 |
Alastair Gray [Royaume-Uni] ; Lain Mcnamara [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Peter Bain [Royaume-Uni] ; Joanna Wilson [Royaume-Uni] ; Richard Scott [Royaume-Uni] | Quality of life outcomes following surgical treatment of Parkinson's disease |
| 002645 |
Philip C. Su [Taïwan] ; Ham-Min Tseng [Taïwan] ; Horng-Huei Liou [Taïwan] | Postural asymmetries following unilateral subthalamotomy for advanced Parkinson's disease |
| 002647 |
Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Postoperative management of subthalamic nucleus stimulation for Parkinson's disease |
| 002648 |
Patricia Dowsey-Limousin [Royaume-Uni] | Postoperative management of Vim DBS for tremor |
| 002653 |
Christopher G. Goetz [États-Unis] ; Sue Leurgans [États-Unis] ; Rema Raman [États-Unis] | Placebo-associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's disease |
| 002654 |
William G. Ondo [États-Unis] ; Amit Verma [États-Unis] | Physiological assessment of paroxysmal dystonia secondary to subacute sclerosing panencephalitis |
| 002656 |
| Physical and occupational therapy in Parkinson's disease |
| 002662 |
Alfredo Berardelli [Italie] ; Antonio Curra [Italie] | Pathophysiology and treatment of cranial dystonia |
| 002664 |
Hélio A. G. Teive [Brésil] ; Francisco M. B. Germiniani [Brésil] ; Lineu César Werneck [Brésil] | Parkinsonian syndrome induced by amlodipine: Case report |
| 002666 |
Giulio Cicarelli [Italie] ; Maria Teresa Pellecchia [Italie] ; Giuseppe De Michele [Italie] ; Gilberto Pizzolato [Italie] ; Paolo Barone [Italie] | Paradoxical response to apomorphine in a case of atypical parkinsonism |
| 002671 |
Ruth Djaldetti [Israël] ; Rivkah Inzelberg [Israël] ; Nir Giladi [Israël] ; Amos D. Korczyn [Israël] ; Yehudit Peretz-Aharon [Israël] ; Martin J. Rahey [Israël] ; Yuval Herishano [Israël] ; Silvia Honigman [Israël] ; Sami Badarny [Israël] ; Eldad Melamed [Israël] | Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease |
| 002672 |
William G. Ondo [États-Unis] ; Joel K. Levy [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis] | Olanzapine treatment for dopaminergic-induced hallucinations |
| 002678 |
J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas] | Neurosurgical treatment modalities in Parkinson's disease |
| 002680 |
Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France] | Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence |
| 002692 |
Rajeev Kumar [États-Unis] | Methods for programming and patient management with deep brain stimulation of the globus pallidus for the treatment of advanced Parkinson's disease and dystonia |
| 002694 |
Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada] | Mechanisms of deep brain stimulation |
| 002695 |
Alim-Louis Benabid [France] ; Abdelhamid Benazzous [France] ; Pierre Pollak [France] | Mechanisms of deep brain stimulation |
| 002696 |
Jerrold L. Vitek [États-Unis] | Mechanisms of deep brain stimulation: Excitation or inhibition |
| 002700 |
| MAO-B inhibitors for the treatment of Parkinson's disease |
| 002702 |
G-Y. R. Hsiung [Canada] ; S. K. Das [Canada] ; R. Ranawaya [Canada] ; A.-L. Lafontaine [Canada] ; O. Suchowersky [Canada] | Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period |
| 002704 |
Elena Meseguer [Espagne] ; Rocio Taboada [Espagne] ; Vicenta Sanchez [Espagne] ; Maria Angeles Mena [Espagne] ; Victor Campos [Espagne] ; Justo Garcia De Yebenes [Espagne] | Life-threatening parkinsonism induced by Kava-Kava |
| 002705 |
| Levodopa |
| 002706 |
Miriam Velez [Pérou] ; Carlos Cosentino [Pérou] ; Luis Torres [Pérou] | Levodopa-responsive rubral (Holmes') tremor |
| 002707 |
Gurutz Linazasoro [Espagne] ; Nadege Van Blercom [Espagne] ; Asier Lasa [Espagne] | Levodopa-induced ocular dyskinesias in Parkinson's disease |
| 002708 |
Petr Kanovsky [République tchèque] ; Dagmar Kubova [République tchèque] ; Martin Bares [République tchèque] ; Hana Hortova [République tchèque] ; Hana Streitova [République tchèque] ; Ivan Rektor [République tchèque] ; Vladimir Znojil [République tchèque] | Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two-year, prospective follow-up |
| 002710 |
Marie-Paule Muriel [France] ; Gaël Orieux [France] ; Etienne C. Hirsch [France] | Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in Parkinsonian rats |
| 002711 |
Anjan Chatterjee [États-Unis] ; Elan D. Louis [États-Unis] ; Steven Frucht [États-Unis] | Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis |
| 002719 |
Jens Volkmann [Allemagne] ; Jan Herzog [Allemagne] ; Florian Kopper [Allemagne] ; Güntner Deuschl [Allemagne] | Introduction to the programming of deep brain stimulators |
| 002720 |
J. J. Bob Van Hilten [Pays-Bas] ; Willem-Johan T. Van De Beek [Pays-Bas] ; Johan H. C. Voormolen [Pays-Bas] ; Elmer M. Delhaas [Pays-Bas] | Intrathecal baclofen treatment of dystonia in reflex sympathetic dystrophy |
| 002723 |
Pierre Pollak [France] ; Paul Krack [France] ; Valérie Fraix [France] ; Alexandre Mendes [France] ; Elena Moro [France] ; Stephan Chabardes [France] ; Alim-Louis Benabid [France] | Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease |
| 002727 |
Valerie E. Kelly [États-Unis] ; Allie S. Hyngstrom [États-Unis] ; Melissa M. Rundle [États-Unis] ; Amy J. Bastian [États-Unis] | Interaction of levodopa and cues on voluntary reaching in Parkinson's disease |
| 002740 |
Carole Joint [Royaume-Uni] ; Dipankar Nandi [Royaume-Uni] ; Simon Parkin [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] | Hardware-related problems of deep brain stimulation |
| 002757 |
Anne-Catherine Bachoud-Levi [France] ; Philippe Hantraye [France] ; Marc Peschanski [France] | Fetal neural grafts for Huntington's disease: A prospective view |
| 002764 |
Georg Becker [Allemagne] ; Daniela Berg [Allemagne] ; Niels Kruse [Allemagne] ; Ute Schröder [Allemagne] ; Monika Warmuth-Metz [Allemagne] ; Peter Rieckmann [Allemagne] ; Markus Naumann [Allemagne] ; Karlheinz Reiners [Allemagne] | Evidence for shoulder girdle dystonia in selected patients with cervical disc prolapse |
| 002765 |
J. Carsten Moller [Allemagne] ; Karin Stiasny [Allemagne] ; Volker Hargutt [Allemagne] ; Werner Cassel [Allemagne] ; Heiko Tietze [Allemagne] ; J. Hermann Peter [Allemagne] ; H.-Peter Krüger [Allemagne] ; Wolfgang H. Oertel [Allemagne] | Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: A pilot study |
| 002779 |
Willibald Gerschlager [Royaume-Uni] ; Peter Brown [Royaume-Uni] | Effect of treatment with intravenous immunoglobulin on quality of life in patients with stiff-person syndrome |
| 002787 |
| Drugs to treat urinary frequency, urgency, and/or urge incontinence |
| 002788 |
| Drugs to treat gastrointestinal motility problems |
| 002789 |
| Drugs to treat dementia and psychosis |
| 002790 |
| Drugs to treat autonomic dysfunction in Parkinson's disease |
| 002793 |
Monica J. Ling [Australie] ; Arun Aggarwal [Australie] ; John G. L. Morris [Australie] | Dopa-responsive parkinsonism secondary to right temporal lobe haemorrhage |
| 002797 |
J. E. Rice [Australie] ; R. Antic [Australie] ; Philip D. Thompson [Australie] | Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease |
| 002804 |
Günther Deuschl [Allemagne] ; Peter Bain [Royaume-Uni] | Deep brain stimulation for trauma: Patient selection and evaluation |
| 002805 |
Jens Volkmann [Allemagne] ; Reiner Benecke [Allemagne] | Deep brain stimulation for dystonia: Patient selection and evaluation |
| 002806 |
Anthony E. Lang [Canada] ; Hakan Widner [Suède] | Deep brain stimulation for Parkinson's disease: Patient selection and evaluation |
| 002809 |
| DA agonists: Non-Ergot derivatives: Ropinirole |
| 002810 |
| DA agonists: Non-Ergot derivatives: Pramipexole |
| 002811 |
| DA agonists: Non-Ergot derivatives: Piribedil |
| 002812 |
| DA agonists: Non-Ergot derivatives: Apomorphine |
| 002813 |
| DA agonists: Ergot derivatives: Pergolide |
| 002814 |
| DA agonists: Ergot derivatives: Lisuride |
| 002815 |
| DA agonists: Ergot derivatives: Dihydroergocryptine (DHEC) |
| 002816 |
| DA agonists: Ergot derivatives: Cabergoline |
| 002819 |
Christoph Pohl [Allemagne] ; Jörg Happe [Allemagne] ; Thomas Klockgether [Allemagne] | Cooling improves the writing performance of patients with writer's cramp |
| 002834 |
Joanne E. Nash [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Characterisation of striatal NMDA receptors involved in the generation of Parkinsonian symptoms: Intrastriatal microinjection studies in the 6-OHDA-lesioned rat |
| 002842 |
Dirk Dressler [Royaume-Uni] ; Hans Bigalke [Allemagne] | Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy |
| 002848 |
Pablo Martinez-Martin [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne] ; Manuela Pilleri [Espagne] ; José Luis Molinuevo [Espagne] ; Jordi Rumia [Espagne] ; Enric Ferrer [Espagne] | Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease |
| 002849 |
Rob M. A. De Bie [Pays-Bas] ; P. Richard Schuurman [Pays-Bas] ; Rianne A. J. Esselink [Pays-Bas] ; D. Andries Bosch [Pays-Bas] ; Johannes D. Speelman [Pays-Bas] | Bilateral pallidotomy in Parkinson's disease: A retrospective study |
| 002850 |
David J. Burn [Royaume-Uni] | Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease |
| 002858 |
Alice J. Manson [Royaume-Uni] ; Kirsten Turner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients |
| 002859 |
| Anticholinergic therapies in the treatment of Parkinson's disease |
| 002867 |
Marcelo Merello [Argentine] ; Maria I. Nouzeilles [Argentine] ; Gabriel Piran Arce [Argentine] ; Ramon Leiguarda [Argentine] | Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis |
| 002870 |
| |
| 002879 |
A. Saverino [Italie] ; C. Solaro [Italie] ; E. Capello [Italie] ; C. Trompetto [Italie] ; G. Abbruzzese [Italie] ; A. Schenone [Italie] | Tremor associated with benign IgM paraproteinaemic neuropathy successfully treated with gabapentin |
| 002880 |
Frithjof Tergau [Allemagne] ; Stephan Wischer [Allemagne] ; Christian Wolf [Allemagne] ; Walter Paulus [Allemagne] | Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine |
| 002881 |
Han-Cheng Wang [Taïwan] ; YOLOUNG HSIEH [Taïwan] | Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy |
| 002882 |
Carla Cordivari [Royaume-Uni] ; V. Peter Misra [Royaume-Uni] ; Santiago Catania [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of dystonic clenched fist with botulinum toxin |
| 002884 |
J. Thomas Hutton [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Jorge L. Juncos [États-Unis] ; William C. Koller [États-Unis] ; Rajesh Pahwa [États-Unis] ; Peter A. Lewitt [États-Unis] ; Ali Samii [Canada] ; Joseph K. C. Tsui [Canada] ; Donald B. Calne [Canada] ; Cheryl H. Waters [États-Unis] ; Vincent P. Calabrese [États-Unis] ; James P. Bennett [États-Unis] ; Richard Barrett [États-Unis] ; Jerry L. Morris [États-Unis] | Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N-0923 TDS: A double-blind, placebo-controlled study |
| 002894 |
William Ondo [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Michael Almaguer [États-Unis] ; Joseph Jankovic [États-Unis] ; Richard K. Simpson [États-Unis] | Thalamic deep brain stimulation: Effects on the nontarget limbs |
| 002896 |
Adrian Handforth [États-Unis] ; Scott E. Krahl [États-Unis] | Suppression of harmaline-induced tremor in rats by vagus nerve stimulation |
| 002899 |
Mahmut Edip Gürol [Turquie] ; Mustafa Ertas [Turquie] ; Hasmet Ayhan Hanagasi [Turquie] ; Hüseyin Alparslan Sahin [Turquie] ; Gencay Gürsoy [Turquie] ; Murat Emre [Turquie] | Stiff leg syndrome: Case report |
| 002910 |
Paul J. Reading [Royaume-Uni] ; Anna K. Luce [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] | Rivastigmine in the treatment of Parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial |
| 002911 |
Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Feger [France] | Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain |
| 002919 |
William Koller [États-Unis] ; Andrew Lees (neurologue) [Royaume-Uni] ; Miroslava Doder [Royaume-Uni] ; Mariese Hely [Australie] | Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations |
| 002930 |
Virgilio Gerald H. Evidente [Philippines] | Piribedil for restless legs syndrome: A pilot study |
| 002931 |
Jon H. Falkenberg [États-Unis] ; Paul A. Laizzo [États-Unis] ; Linda K. Mcloon [États-Unis] | Physiological assessment of muscle strength in vitro after direct injection of Doxorubicin into rabbit sternocleidomastoid muscle |
| 002947 |
Thomas Trottenberg [Allemagne] ; Wassilios Meissner [Allemagne] ; Guy Arnold [Allemagne] ; Karl-Max Einhaupl [Allemagne] ; Andreas Kupsch [Allemagne] ; Christian Kabus [Allemagne] ; Thomas Funk [Allemagne] | Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome |
| 002949 |
P. H. Gordon [États-Unis] ; S. J. Frucht [États-Unis] | Neuroleptic malignant syndrome in advanced Parkinson's disease |
| 002952 |
Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Micheal P. Hill [Royaume-Uni] ; David Peggs [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni] | Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct : Evidence from the effects of the Alpha2 adrenoceptor antagonist idazoxan |
| 002954 |
M. Seijo Martinez [Espagne] ; M. Fontoira [Espagne] ; G. Celester [Espagne] ; M. Castro Del Rio [Espagne] ; J. Permuy [Espagne] ; A. Iglesias [Espagne] | Myoclonus of peripheral origin: Case secondary to a digital nerve lesion |
| 002955 |
R. Richard Sloop [États-Unis] ; Dorothee Cole [États-Unis] ; Milan C. Patel [États-Unis] | Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals |
| 002961 |
Tobias E. Eichhorn [Allemagne] ; Wolfgang H. Oertel [Allemagne] | Macrogol 3350/Electrolyte improves constipation in Parkinson's disease and multiple system atrophy |
| 002964 |
Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France] | Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease |
| 002966 |
Fabrizio Stocchi [Italie] ; Laura Vacca [Italie] ; Alfredo Berardelli [Italie] ; Francesca De Pandis [Italie] ; Stefano Ruggieri [Italie] | Long-duration effect and the postsynaptic compartment : Study using a dopamine agonist with a short half-life |
| 002973 |
Paolo Del Dotto [Italie] ; Nicola Pavese [Italie] ; Gianna Gambaccini [Italie] ; Silvia Bernardini [Italie] ; Leonard Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis] ; Ubaldo Bonuccelli [Italie] | Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study |
| 002980 |
Olivier Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France] | Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease |
| 002991 |
Marwan I. Hariz [Suède] ; Folke Johansson [Suède] | Hardware failure in Parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency |
| 002992 |
Nihal Tas [Turquie] ; Gülcin Kaymak Karatas [Turquie] ; Vesile Sepici [Turquie] | Hand orthosis as a writing aid in Writer's cramp |
| 002A07 |
Andrew Siderowf [États-Unis] ; Stephen M. Gollump [États-Unis] ; Matthew B. Stern [États-Unis] ; Gordon H. Baltuch [États-Unis] ; Howard A. Riina [États-Unis] | Emergence of complex, involuntary movements after Gamma knife radiosurgery for essential tremor |
| 002A15 |
Jorg Müller [Autriche] ; Georg Ebersbach [Autriche] ; Jorg Wissel [Autriche] ; Werner Poewe [Autriche] | Dynamic balance function in phasic cervical dystonia following Botulinum toxin therapy |
| 002A16 |
L. Alvarez [Cuba] ; R. Macias [Cuba] ; J. Guridi [Espagne] ; G. Lopez [Cuba] ; E. Alvarez [Cuba] ; C. Maragoto [Cuba] ; J. Teijeiro [Cuba] ; A. Torres [Cuba] ; N. Pavon [Cuba] ; M. C. Rodriguez-Oroz [Espagne] ; L. Ochoa [Cuba] ; H. Hetherington [États-Unis] ; J. Juncos [États-Unis] ; M. R. Delong [États-Unis] ; J. A. Obeso [Espagne] | Dorsal subthalamotomy for Parkinson's disease |
| 002A18 |
Orhan Barlas [Turquie] ; Hasmet A. Hanagasi [Turquie] ; Murat Imer [Turquie] ; Hüseyin A. Sahin [Turquie] ; Serra Sencer [Turquie] ; Murat Emre [Turquie] | Do unilateral ablative lesions of the subthalamic nucleu in parkinsonian patients lead to hemiballism? |
| 002A20 |
Douglas J. Lanska [États-Unis] ; Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] | Development of instruments for abnormal movements: Postural sway and gait analyses. Part 10 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000 |
| 002A21 |
Douglas J. Lanska [États-Unis] ; Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] | Development of instruments for abnormal movements: Dynamometers, the dynamograph, and tremor recorders. Part 9 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000 |
| 002A24 |
G. Wihl [Allemagne] ; J. Volkmann [Allemagne] ; N. Allert [Allemagne] ; R. Lehrke [Allemagne] ; V. Sturm [Allemagne] ; H.-J. Freund [Allemagne] | Deep brain stimulation of the internal pallidum did not improve chorea in a patient with neuro-acanthocytosis |
| 002A28 |
Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie] | Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease |
| 002A30 |
Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Steven B. Wilkinson [États-Unis] ; Alexander I. Tröster [États-Unis] ; John Overman [États-Unis] ; Jennifer Kieltyka [États-Unis] ; William C. Koller [États-Unis] | Comparison of thalamotomy to deep brain Stimulation of the thalamus in Essential tremor |
| 002A33 |
Stewart A. Factor [États-Unis] ; Joseph H. Friedman [États-Unis] ; Margaret C. Lannon [États-Unis] ; David Oakes [États-Unis] ; Keith Bourgeois [États-Unis] | Clozapine for the treatment of drug-induced psychosis in Parkinson's disease : Results of the 12 week open label extension in the PSYCLOPS trial |
| 002A37 |
Lorraine O. Ramig [États-Unis] ; Shimon Sapir [États-Unis] ; Cynthia Fox [États-Unis] ; Stefanie Countryman [États-Unis] | Changes in vocal loudness following intensive voice Treatment (LSVT®) in individuals with Parkinson's disease : A comparison with untreated patients and normal age-matched controls |
| 002A44 |
JINWHAN CHO [Corée du Sud] ; KON CHU [Corée du Sud] ; Beom S. Jeon [Corée du Sud] | Case of essential palatal tremor: Atypical features and remarkable benefit from botulinum toxin injection |
| 002A51 |
Mareina Kudo [Japon] ; Satoshi Goto [Japon] ; Shigeyuki Nishikawa [Japon] ; Tadashi Hamasaki [Japon] ; Naohiro Soyama [Japon] ; Yukitaka Ushio [Japon] ; Shuji Mita [Japon] ; Yoshifumi Hirata [Japon] | Bilateral thalamic stimulation for Holmes' tremor caused by unilateral brainstem lesion |
| 002A53 |
Daisuke Muta [Japon] ; Satoshi Goto [Japon] ; Shigeyuki Nishikawa [Japon] ; Tadashi Hamasaki [Japon] ; Yukitaka Ushio [Japon] ; Nobuhiro Inoue [Japon] ; Shuji Mita [Japon] | Bilateral pallidal stimulation for idiopathic segmental axial dystonia advanced from Meige syndrome refractory to bilateral thalamotomy |
| 002A54 |
Simon Parkin [Royaume-Uni] ; Tipu Aziz [Royaume-Uni] ; Ralph Gregory [Royaume-Uni] ; Peter Bain [Royaume-Uni] | Bilateral internal globus pallidus stimulation for the treatment of spasmodic torticollis |
| 002A65 |
F. Carella [Italie] ; S. Genitrini [Italie] ; M. Bressanelli [Italie] ; P. Soliveri [Italie] ; D. Servello [Italie] ; G. Broggi [Italie] ; S. Piacentini [Italie] ; G. Geminiani [Italie] ; F. Girotti [Italie] | Acute effects of bilateral subthalamic nucleus stimulation on clinical and kinematic parameters in Parkinson's disease |
| 002A68 |
Satoshi Goto [Japon] ; Naoko Kunitoku [Japon] ; Tadashi Hamasaki [Japon] ; Shigeyuki Nishikawa [Japon] ; Yukitaka Ushio [Japon] | Abolition of postapoplectic hemichorea by Vo-complex thalamotomy: Long-term follow-up study |
| 002A73 |
| |
| 002A75 |
| Abstracts of the sixth international congress of Parkinson's disease and movement disorders, Barcelona, Spain, June 11-15, 2000 |
| 002A76 |
| Abstracts from International Conference 1999: Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Orlando, FL, USA, November 16-18, 1999 |
| 002A78 |
C. W. Olanow [États-Unis] ; A. H. V. Schapira [Royaume-Uni] ; T. Roth [États-Unis] | Waking up to sleep episodes in Parkinson's disease |
| 002A83 |
D. S. Latchman [Royaume-Uni] ; R. S. Coffin [Royaume-Uni] | Viral vectors in the treatment of Parkinson's disease |
| 002A88 |
D. Dressler [Allemagne] ; M. Wittstock [Allemagne] ; R. Benecke [Allemagne] | Treatment of persistent hemiballism with botulinum toxin type A |
| 002A89 |
M. S. Baron [États-Unis] ; J. L. Vitek [États-Unis] ; R. A. E. Bakay [États-Unis] ; J. Green [États-Unis] ; W. M. Mcdonald [États-Unis] ; S. A. Cole [États-Unis] ; M. R. Delong [États-Unis] | Treatment of advanced Parkinson's Disease by unilateral posterior GPi pallidotomy : 4-Year results of a pilot study |
| 002A91 |
Silvana Tesei [Italie] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Anna Zecchinelli [Italie] ; Claudio B. Mariani [Italie] ; Gianni Pezzoli [Italie] | Tolerability of paroxetine in Parkinson's disease : A prospective study |
| 002A96 |
Hasmet A. Hanagasi [Turquie] ; Gülüstü Kaptanoglu [Turquie] ; Hüseyin A. Sahin [Turquie] ; Murat Emre [Turquie] | The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa |
| 002B05 |
I. Reuter [Royaume-Uni] ; S. Harder [Allemagne] ; M. Engelhardt [Allemagne] ; H. Baas [Allemagne] | The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa |
| 002B07 |
S. Frucht [États-Unis] ; S. Fahn [États-Unis] | The clinical spectrum of posthypoxic myoclonus |
| 002B12 |
F. Birklein [Allemagne] ; F. Erbguth [Allemagne] | Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A : A preliminary observation |
| 002B13 |
S. A. Factor [États-Unis] ; D. L. Brown [États-Unis] ; E. S. Molho [États-Unis] | Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease |
| 002B17 |
T. A. Zesiewicz [États-Unis] ; M. Helal [États-Unis] ; R. A. Hauser [États-Unis] | Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's Disease |
| 002B21 |
Alessandro Di Rocco [États-Unis] ; John D. Rogers [États-Unis] ; Richard Brown [États-Unis] ; Peter Werner [États-Unis] ; Teodoro Bottiglieri [États-Unis] | S-Adenosyl-methionine improves depression in patients with Parkinson's disease in an open-label clinical trial |
| 002B22 |
N. A. Leopold [États-Unis] | Risperidone treatment of drug-related psychosis in patients with Parkinsonism |
| 002B23 |
Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique] | Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial |
| 002B25 |
Kevin J. Black [États-Unis] ; Jonathan W. Mink [États-Unis] | Response to levodopa challenge in Tourette syndrome |
| 002B35 |
K. F. Bhattacharya [Royaume-Uni] ; I. Giannakikou [Royaume-Uni] ; N. Munroe [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] | Primary anticholinergic-responsive pisa syndrome |
| 002B38 |
S. Vanhatalo [Finlande] ; R. Paetau [Finlande] ; K. Mustonen [Finlande] ; J. Hernesniemi [Finlande] ; R. Riikonen [Finlande] | Posttraumatic tremor and arnold chiari malformation : No sign of compression, but cure after surgical decompression |
| 002B40 |
C. G. Goetz [États-Unis] ; T. Q. Vu ; P. M. Carvey ; S. Leurgans | Posthypoxic myoclonus in the rat : Natural history, stability, and serotonergic influences |
| 002B46 |
Pieter Joost Van Wattum [États-Unis] ; Phillip B. Chappell [États-Unis] ; Daniel Zelterman [États-Unis] ; Lawrence D. Scahill [États-Unis] ; James F. Leckman [États-Unis] | Patterns of response to acute naloxone infusion in Tourette's syndrome |
| 002B47 |
A. Brashear [États-Unis] ; K. Bergan [États-Unis] ; J. Wojcieszek [États-Unis] ; E. R. Siemers [États-Unis] ; W. Ambrosius [États-Unis] | Patients' perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type A |
| 002B52 |
P. Martinez-Martin [Espagne] ; F. Valldeoriola [Espagne] ; J. L. Molinuevo [Espagne] ; F. A. Nobbe [Espagne] ; J. Rumia [Espagne] ; E. Tolosa [Espagne] | Pallidotomy and quality of life in patients with Parkinson's disease : An early study |
| 002B58 |
Nagako Murase [Japon] ; Ryuji Kaji [Japon] ; Takashi Sakamoto [Japon] ; Hineki Shimazu [Japon] ; Shinnichi Matumoto [Japon] ; Nobuo Kohar [Japon] ; Hiroshi Shibasaki [Japon] ; Jun Kimura [États-Unis] | Nicotine-sensitive writer's cramp |
| 002B69 |
Robert A. Hauser [États-Unis] ; Mervat N. Wahba [États-Unis] ; Theresa A. Zesiewicz [États-Unis] ; W. Mcdowell Anderson [États-Unis] | Modafinil treatment of pramipexole-associated somnolence |
| 002B73 |
C. F. L. Souza-Lima [Brésil] ; H. Ballalai Ferraz [Brésil] ; C. A. Braz [Brésil] ; A. M. Araüjo [Brésil] ; G. Mastrocola Manzano [Brésil] | Marked improvement in a stiff-limb patient treated with intravenous immunoglobulin |
| 002B76 |
S. Frucht [États-Unis] ; S. Fahn [États-Unis] ; S. Chin [États-Unis] ; V. Dhawan [États-Unis] ; D. Eidelberg [États-Unis] | Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration |
| 002B83 |
Doron Merims [Israël] ; Ronit Galili-Mosberg [Israël] ; Eldad Melamed [Israël] | Is there addiction to levodopa in patients with Parkinson's disease? |
| 002B87 |
Ruth H. Walker [États-Unis] ; Fabio O. Danisi [États-Unis] ; David M. Swope [États-Unis] ; Robert R. Goodman [États-Unis] ; Isabelle M. Germano [États-Unis] ; Mitchell F. Brin [États-Unis] | Intrathecal baclofen for dystonia: Benefits and complications during six years of experience |
| 002B88 |
Esther Cubo [États-Unis] ; Kathleen M. Shannon [États-Unis] ; Richard D. Penn [États-Unis] ; Jeffrey S. Kroin [États-Unis] | Internal globus pallidotomy in dystonia secondary to Huntington's disease |
| 002B91 |
T. E. Kimber [Australie] ; P. D. Thompson [Australie] | Increased blink rate in advanced Parkinson's disease : A form of 'off'-period dystonia? |
| 002B93 |
M. D. Welsh [États-Unis] ; T. Dorflinger [États-Unis] ; D. Chernik [États-Unis] ; C. Waters [États-Unis] | Illness Impact and Adjustment to Parkinson's disease : Before and after treatment with tolcapone |
| 002B94 |
A. J. Manson [Royaume-Uni] ; E. Iakovidou [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Idazoxan is ineffective for levodopa-induced dyskinesias in Parkinson's disease |
| 002B98 |
P. Hagell [Suède] ; L. Crabb [Royaume-Uni] ; O. Pogarell [Allemagne] ; A. Schrag [Royaume-Uni] ; H. Widner [Suède] ; D. J. Brooks [Royaume-Uni] ; W. H. Oertel [Allemagne] ; N. P. Quinn [Royaume-Uni] ; O. Lindvall [Suède] | Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease |
| 002C00 |
W. Ondo [États-Unis] ; C. Hunter [États-Unis] ; K. Dat Vuong [États-Unis] ; K. Schwartz [États-Unis] ; Joseph Jankovic [États-Unis] | Gabapentin for Essential tremor : A multiple-dose, double-blind, placebo-controlled trial |
| 002C04 |
Francisco Cardoso [Brésil] ; José Teotonio De Oliveira [Brésil] ; Marzia Puccioni-Sohler [Brésil] ; Alexandre R. Fernandes [Brésil] ; James Pitagoras De Mattos [Brésil] ; Iscia Lopes-Cendes [Brésil] | Eyelid dystonia in Machado-Joseph disease |
| 002C10 |
Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Endogenous dopaminergic tone and dopamine agonist action |
| 002C17 |
H. H. Fernandez [États-Unis] ; J. H. Friedman ; J. Grace [États-Unis] ; S. Beason-Hazen [États-Unis] | Donepezil for Huntington's disease |
| 002C23 |
N. L. W. Keijsers [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; J. I. Hoff [Pays-Bas] ; C. C. A. M. Gielen [Pays-Bas] | Detection and assessment of the severity of levodopa-induced dyskinesia in patients with Parkinson's disease by neural networks |
| 002C29 |
A. D. Siderowf [États-Unis] ; R. G. Holloway [États-Unis] ; M. B. Stern [États-Unis] | Cost-effectiveness analysis in Parkinson's disease : Determining the value of interventions |
| 002C32 |
H. H. Fernandez [États-Unis] ; M. C. Lannon [États-Unis] ; J. H. Friedman [États-Unis] ; B. P. Abbott [États-Unis] | Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease |
| 002C37 |
J. Kulisevsky [Espagne] ; C. Garcia-Sanchez [Espagne] ; M. L. Berthier [Espagne] ; M. Barbanoj [Espagne] ; B. Pascual-Sedano [Espagne] ; A. Gironell [Espagne] ; A. Estevez-Gonzalez [Espagne] | Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease : A two-year follow-up study of previously untreated patients |
| 002C38 |
David Devos [France] ; Luc Defebvre [France] ; Alain Destée [France] ; Jacques Caron [France] | Choreic movements induced by cibenzoline : An Ic class antiarrhythmic effect? |
| 002C42 |
Dirk Dressler [Allemagne] ; Uwe Zettl [Allemagne] ; Reiner Benecke [Allemagne] ; Hans Bigalke [Allemagne] | Can intravenous immunoglobulin improve antibody-mediated botulinum toxin therapy failure? |
| 002C44 |
E.-K. Tan [États-Unis] ; Joseph Jankovic [États-Unis] ; W. Ondo [États-Unis] | Bruxism in Huntington's disease |
| 002C45 |
H. Apaydin [Turquie] ; S. Ertan [Turquie] ; S. Özekmekci [Turquie] | Broad bean (Vicia faba) : A natural source of L-dopa : Prolongs "on" periods in patients with Parkinson's disease who have "on-off" fluctuations |
| 002C46 |
A. Rapaport [Israël] ; M. Sadeh [Israël] ; D. Stein [Israël] ; J. Levine [Israël] ; P. Sirota [Israël] ; T. Mosheva [Israël] ; S. Stir [Israël] ; A. Elitzur [Israël] ; I. Reznik [Israël] ; D. Geva [Israël] ; J. M. Rabev [Israël] | Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia |
| 002C47 |
D. Dressier [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni] | Botulinum toxin antibody testing : Comparison between the mouse protection assay and the mouse lethality assay |
| 002C52 |
E. Luginger [Autriche] ; G. K. Wenning [Autriche] ; S. Bosch [Autriche] ; Werner Poewe [Autriche] | Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's Disease |
| 002C54 |
J. H. Friedman [États-Unis] ; S. A. Factor | Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease |
| 002C57 |
Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Apomorphine : An underutilized therapy for Parkinson's disease |
| 002C67 |
V. G. H. Evidente [États-Unis, Philippines] ; C. H. Adler [États-Unis] ; J. N. Caviness [États-Unis] ; J. G. Hentz [États-Unis] ; K. Gwinn-Hardy [États-Unis] | Amantadine is beneficial in restless legs syndrome |
| 002C82 |
K. Kompoliti [États-Unis] ; C. G. Goetz [États-Unis] ; S. Leurgans [États-Unis] ; M. Morrissey [États-Unis] ; I. M. Siegel [États-Unis] | "On" freezing in Parkinson's disease : Resistance to visual cue walking devices |
| 002C93 |
M. Merello [Argentine] ; M. I. Nouzeilles [Argentine] ; G. Kuzis [Argentine] ; A. Cammarota [Argentine] ; L. Sabe [Argentine] ; O. Betti [Argentine] ; S. Starkstein [Argentine] ; R. Leiguarda [Argentine] | Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum : A prospective randomized comparison |
| 002C94 |
R. M. A. De Bie [Pays-Bas] ; P. R. Schuurman [Pays-Bas] ; P. S. De Haan [Pays-Bas] ; D. A. Bosch [Pays-Bas] ; J. D. Speelman [Pays-Bas] | Unilateral pallidotomy in advanced Parkinson's disease : A retrospective study of 26 patients |
| 002C96 |
P. Kanovsky [République tchèque] ; H. Streitova [République tchèque] ; M. Bares [République tchèque] ; H. Hortova [République tchèque] | Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A : Evidence of a long-lasting effect |
| 002C97 |
J. L. Montastruc [France] ; Olivier Rascol [France] ; J.-M. Senard [France] | Treatment of Parkinson's disease should begin with a dopamine agonist |
| 002C98 |
S. A. Factor [États-Unis] ; E. S. Molho [États-Unis] | Transient benefit of amantadine in Parkinson's disease : The facts about the myth |
| 002D01 |
B. Henry [Royaume-Uni] ; S. H. Fox [Royaume-Uni] ; D. Peggs [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Royaume-Uni] | The α2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-Parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease |
| 002D04 |
W. J. Weiner [États-Unis] | The initial treatment of Parkinson's disease should begin with levodopa |
| 002D09 |
S. Spieker [Allemagne] ; P.-A. Löschmann [Allemagne] ; T. Klockgether [Allemagne] | The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations |
| 002D11 |
B. Safirstein [États-Unis] ; L. M. Shulman [États-Unis] ; W. J. Weiner [États-Unis] | Successful treatment of hemichorea with olanzapine |
| 002D14 |
A. Lagueny [France] ; F. Tison [France] ; P. Burbaud [France] ; G. Le Masson [France] ; P. Kien [France] | Stimulus-sensitive spinal segmental myoclonus improved with injections of botulinum toxin type A |
| 002D15 |
A. Dalvi [États-Unis] ; L. Winfield [États-Unis] ; QIPING YU [États-Unis] ; L. Cote [États-Unis] ; R. R. Goodman [États-Unis] ; S. L. Pullman [États-Unis] | Stereotactic posteroventral pallidotomy : Clinical methods and results at 1-year follow up |
| 002D16 |
M. S. Moreau [France] ; A. Severac Cauquil [France] ; M. C. Costes Salon [France] | Static and dynamic balance function in spasmodic torticollis |
| 002D17 |
A. Thomas [Italie] ; M. Onofrj [Italie] | Sporadic acetazolamide-responsive episodic ataxia |
| 002D25 |
D. Mathen [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] | SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia |
| 002D27 |
W. Ondo [États-Unis] ; MD [États-Unis] | Ropinirole for restless legs syndrome |
| 002D28 |
V. G. H. Evidente [États-Unis, Philippines] ; K. Gwinn-Hardy [États-Unis] ; J. N. Caviness [États-Unis] ; C. H. Adler [États-Unis] | Risperidone is effective in severe hemichorea/hemiballismus |
| 002D29 |
H. D. Rosas [États-Unis] ; W. J. Koroshetz [États-Unis] ; B. G. Jenkins [États-Unis] ; Y. I. Chen [États-Unis] ; D. L. Hayden [États-Unis] ; M. F. Beal [États-Unis] ; M. E. Cudkowicz [États-Unis] | Riluzole therapy in Huntington's Disease (HD) |
| 002D32 |
A. Schrag [Royaume-Uni] ; L. Schelosky [Allemagne] ; U. Scholz [Allemagne] ; Werner Poewe [Autriche] | Reduction of parkinsonian signs in patients with parkinson's disease by dopaminergic versus anticholinergic single-dose challenges |
| 002D34 |
H. H. Fernandez [États-Unis] ; J. H. Friedman [États-Unis] ; C. Jacques [États-Unis] ; M. Rosenfeld [États-Unis] | Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease |
| 002D40 |
A. Minguez-Castellanos [Espagne] ; C. Carnero-Pardo [Espagne] ; A. Gomez-Camello [Espagne] ; A. Ortega-Moreno [Espagne] ; T. Garcia-Gomez [Espagne] ; V. Arjona [Espagne] ; J. M. Martin-Linares [Espagne] | Primary writing tremor treated by chronic thalamic stimulation |
| 002D48 |
G. Lera [Argentine] ; J. Zirulnik [Argentine] | Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced Parkinsonism |
| 002D51 |
G. J. Brewer [États-Unis] | Penicillamine should not be used as initial therapy in Wilson's disease |
| 002D52 |
J. M. Walshe [Royaume-Uni] | Penicillamine : The treatment of first choice for patients with Wilson's disease |
| 002D60 |
L. E. Davis [États-Unis] ; J. C. Adair [États-Unis] | Parkinsonism from methanol poisoning : Benefit from treatment with anti-Parkinson drugs |
| 002D63 |
N. A. Leopold [États-Unis] ; W. Bara-Jimenez [États-Unis] ; M. Hallett [États-Unis] | Parkinsonism after a wasp sting |
| 002D67 |
D. Tarsy [États-Unis] ; E. R. First [États-Unis] | Painful cervical dystonia : Clinical features and response to treatment with botulinum toxin |
| 002D72 |
Pierre Pollak [France] | Neurosurgical treatment of dyskinesias : Pathophysiological consideration |
| 002D76 |
K. R. Müller-Vahl [Allemagne] ; U. Schneider [Allemagne] ; H. M. Emrich [Allemagne] | Nabilone increases choreatic movements in Huntington's disease |
| 002D81 |
Joseph Jankovic [États-Unis] ; L. Ben-Arie [États-Unis] ; K. Schwartz [États-Unis] ; KIM CHEN [États-Unis] ; M. Khan [États-Unis] ; E. C. Lai [États-Unis] ; J. K. Krauss [États-Unis] ; R. Grossman [États-Unis] | Movement and reaction times and fine coordination tasks following pallidotomy |
| 002D85 |
S. Ohara [Japon] ; J. Tsuyuzaki [Japon] ; R. Hayashi [Japon] | Mexiletine in the treatment of blepharospasm : Experience with the first three patients |
| 002D86 |
N. Giladi [Israël] ; H. Shabtai [Israël] | Melatonin-induced withdrawal emergent dyskinesia and akathisia |
| 002D87 |
D. Kunz [Allemagne] ; F. Bes [Allemagne] | Melatonin as a therapy in REM sleep behavior disorder patients : An open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation |
| 002D88 |
F. Le Doze [France] ; M. Moulin [France] ; G.-L. Defer [France] | Meige's syndrome in a patient treated with ranitidine |
| 002D93 |
N. Giladi [Israël] ; E. Melamed [Israël] | Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism |
| 002E02 |
F. Stocchi [Italie] ; C. Farina [Italie] ; G. Nordera [Italie] ; S. Ruggieri [Italie] | Implantable venous access system for apomorphine infusion in complicated Parkinson's disease |
| 002E21 |
A. S.-I. Pakiam [Canada] ; A. E. Lang [Canada] | Essential palatal tremor : Evidence of heterogeneity based on clinical features and response to sumatriptan |
| 002E23 |
W. C. Koller [États-Unis] ; K. E. Lyons [États-Unis] ; S. B. Wilkinson [États-Unis] ; R. Pahwa [États-Unis] | Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor |
| 002E24 |
| Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated Parkinsonian patients |
| 002E25 |
R. B. Innis [États-Unis] ; K. L. Marek [États-Unis] ; K. Sheff [États-Unis] ; S. Zoghbi [États-Unis] ; J. Castronuovo [États-Unis] ; A. Feigin [États-Unis] ; J. P. Seibyl [États-Unis] | Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]β-CIT |
| 002E26 |
R. Chen [États-Unis, Canada] ; B. I. Karp [États-Unis] ; S. R. Goldstein [États-Unis] ; W. Bara-Jimenez [États-Unis] ; Z. Yaseen [États-Unis] ; M. Hallett [États-Unis] | Effect of muscle activity immediately after botulinum toxin injection for writer's cramp |
| 002E27 |
J. S. P. Van Den Berg [Pays-Bas] ; M. W. I. M. Horstink [Pays-Bas] ; F. H. J. Van Den Hoogen [Pays-Bas] ; W. J. G. Oyen [Pays-Bas] | Dystonia; a central nervous system presentation of Sjögren's syndrome |
| 002E34 |
M. M. Pinter [Autriche] ; M. Murg [Autriche] ; F. Alesch [Autriche] ; B. Freundl [Autriche] ; R. J. Helscher [Autriche] ; H. Binder [Autriche] | Does deep brain stimulation of the nucleus ventralis intermedius affect postural control and locomotion in Parkinson's disease? |
| 002E36 |
I. H. Richard [États-Unis] ; A. Maughn [États-Unis] ; R. Kurlan [États-Unis] | Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series |
| 002E43 |
G.-L. Defer [France] ; H. Widner [Suède] ; R.-M. Marie [France] ; P. Remy [France] ; M. Levivier [Belgique] | Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD) |
| 002E50 |
P. Chariot [France] ; P. Brugieres [France] ; M.-C. Eliezer-Vanerot [France] ; C. Geny [France] ; M. Binaghi [France] ; P. Cesaro [France] | Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy |
| 002E51 |
H. R. Siebner [Allemagne] ; A. Ceballos-Baumann [Allemagne] ; H. Standhardt [Autriche] ; C. Auer [Allemagne] ; B. Conrad [Allemagne] ; F. Alesch [Autriche] | Changes in handwriting resulting from bilateral high-frequency stimulation of the subthalamic nucleus in Parkinson's disease |
| 002E52 |
O. Lindvall [Suède] | Cerebral implantation in movement disorders : State of the art |
| 002E54 |
M. J. Rosenfeld [États-Unis] ; J. H. Friedman [États-Unis] | Catatonia responsive to lorazepam : A case report |
| 002E63 |
A. Schrag [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Atypical and typical cranial dystonia following dental procedures |
| 002E65 |
E. Grünblatt [Israël] ; S. Mandel [Israël] ; T. Berkuzki [Israël] ; M. B. H. Youdim [Israël] | Apomorphine protects against MPTP-induced neurotoxicity in mice |
| 002E66 |
M. Merello [Argentine] ; J. Balej [Argentine] ; M. Delfino [Argentine] ; A. Cammarota [Argentine] ; O. Betti [Argentine] ; R. Leiguarda [Argentine] | Apomorphine induces changes in GPi spontaneous outflow in patients with Parkinson's disease |
| 002E67 |
E. Moro [Italie] ; A. Albanese [Italie, Suisse] | Apomorphine and levodopa challenge in patients with a focal midbrain lesion |
| 002E71 |
B. I. Karp [États-Unis, Canada] ; S. R. Goldstein [États-Unis, Canada] ; R. Chen [États-Unis, Canada] ; A. Samii [États-Unis] ; W. Bara-Jimenez [États-Unis, Canada] ; M. Hallett [États-Unis, Canada] | An open trial of clozapine for dystonia |
| 002E73 |
R. Ceravolo [Italie] ; S. Salvetti [Italie] ; P. Piccini [Royaume-Uni] ; C. Lucetti [Italie] ; G. Gambaccini [Italie] ; U. Bonuccelli [Italie] | Acute and chronic effects of clozapine in essential tremor |
| 002E78 |
J.-L. Montastruc [France] ; M. Ziegler [France] ; Olivier Rascol [France] ; M. Malbezin [France] | A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease |
| 002E80 |
W. Ondo [États-Unis] ; C. Hunter [États-Unis] ; M. Almaguer [États-Unis] ; Joseph Jankovic [États-Unis] | A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease |
| 002E82 |
S. Frucht [États-Unis] ; S. Fahn [États-Unis] ; B. Ford [États-Unis] ; M. Gelb [États-Unis] | A geste antagoniste device to treat jaw-closing dystonia |
| 002E89 |
| Tremor: basic mechanisms and clinical aspects |
| 002E93 |
I. Shoulson [États-Unis] | Where do we stand on neuroprotection? Where do we go from here? |
| 002E95 |
M. R. Trimble [Royaume-Uni] ; R. Whurr [Royaume-Uni] ; G. Brookes [Royaume-Uni] ; M. M. Robertson [Royaume-Uni] | Vocal tics in Gilles de la Tourette syndrome treated with botulinum toxin injections |
| 002E96 |
F. Ovsiew [États-Unis] ; K. J. Meador [États-Unis] ; K. Sethi [États-Unis] | Verapamil for severe hyperkinetic movement disorders |
| 002E97 |
C. Sankhla [États-Unis] ; Joseph Jankovic [États-Unis] ; D. Duane [États-Unis] | Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections |
| 002E98 |
O. Lindvall [Suède] | Update on fetal transplantation : The Swedish experience |
| 002F02 |
P. Krack [France] ; A. Benazzouz [France] ; Pierre Pollak [France] ; P. Limousin [France] ; B. Piallat [France] ; D. Hoffmann [France] ; JING XIE [France] ; Alim-Louis Benabid [France] | Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation |
| 002F03 |
J. Winkelmann [Allemagne] ; T. C. Wetter [Allemagne] ; K. Stiasny [Allemagne] ; W. H. Oertel [Allemagne] ; C. Trenkwalder [Allemagne] | Treatment of restless leg syndrome with pergolide : An open clinical trial |
| 002F04 |
M. Bakar [Turquie] ; M. Zarifoglu [Turquie] ; I. Bora [Turquie] ; F. Turan [Turquie] ; C. Sen [Turquie] ; E. Ogul [Turquie] | Treatment of hereditary trembling chin with botulinum toxin |
| 002F05 |
R. Lindeboom [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; M. Aramideh [Pays-Bas] ; H. D. Speelman [Pays-Bas] ; R. J. De Haan [Pays-Bas] | Treatment of cervical dystonia : A comparison of measures for outcome assessment |
| 002F08 |
M. C. Rodriguez [Espagne] ; O. J. Guridi [Espagne] ; L. Alvarez [Cuba] ; K. Mewes [États-Unis] ; R. Macias [Cuba] ; J. Vitek [États-Unis] ; M. R. Delong [États-Unis] ; J. A. Obeso [Espagne] | The subthalamic nucleus and tremor in Parkinson's disease |
| 002F14 |
J. D. Speelman [Pays-Bas] ; P. R. Schuurman [Pays-Bas] ; R. M. A. De Bie [Pays-Bas] ; D. A. Bosch [Pays-Bas] | Thalamic surgery and tremor |
| 002F15 |
N. Syed [États-Unis] ; J. Murphy [États-Unis] ; T. Jr Zimmerman [États-Unis] ; M. H. Mark [États-Unis] ; J. I. Sage [États-Unis] | Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease |
| 002F21 |
P. Van Den Munckhof [États-Unis] ; F. A. Lenz [États-Unis] ; T. N. Chase [États-Unis] ; L. V. Metman [États-Unis] | Square-wave action dystonia in Parkinson's disease |
| 002F24 |
A. Kupsch [Allemagne] ; W. H. Oertel [Allemagne] | Selegiline, pregnancy, and Parkinson's disease |
| 002F25 |
A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; F. Stocchi [Italie] | Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study |
| 002F26 |
Olivier Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; A. D. Korczyn [Israël] ; Werner Poewe [Autriche] ; F. Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease : A 6-month interim report of a 5-year levodopa-controlled study |
| 002F30 |
J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas] | Resurgence of functional neurosurgery for Parkinson's disease : A historical perspective |
| 002F41 |
P. Hagell [Suède] ; P. Odin [Allemagne] ; E. Vinge [Suède] | Pregnancy in Parkinson's disease : A review of the literature and a case report |
| 002F42 |
UN JUNG KANG [États-Unis] | Potential of gene therapy for Parkinson's disease : Neurobiologic issues and new developments in gene transfer methodologies |
| 002F43 |
P. C. Jacob [Oman] ; R. Pratap Chand [Oman] | Posttraumatic rubral tremor responsive to clonazepam |
| 002F51 |
P. G. Wasielewski [États-Unis] ; J. M. Burns [États-Unis] ; W. C. Koller [États-Unis] | Pharmacologic treatment of tremor |
| 002F57 |
E. J. Skalabrin [États-Unis] ; E. R. Jr Laws [États-Unis] ; J. P. Jr Bennett [États-Unis] | Pallidotomy improves motor responses and widens the levodopa therapeutic window in Parkinson's disease |
| 002F58 |
A. M. Lozano [Canada] ; A. E. Lang [Canada] ; W. D. Hutchison [Canada] | Pallidotomy for tremor |
| 002F59 |
W. G. Ondo [États-Unis] ; J. M. Desaloms [États-Unis] ; Joseph Jankovic [États-Unis] ; R. G. Grossman [États-Unis] | Pallidotomy for generalized dystonia |
| 002F60 |
R. Kumar [Canada] ; A. M. Lozano [Canada] ; E. Montgomery [États-Unis] ; A. E. Lang [Canada] | Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease |
| 002F68 |
D. Dressler [Royaume-Uni] ; T. Scaravilli [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Nicotine nasal spray is not reliable treatment for blepharospasm : Results of a pilot study |
| 002F69 |
L. Pollak [Israël] ; J. Schiffer [Israël] ; C. Klein [Israël] ; Y. Mirovsky [Israël] ; L. Copeliovich [Israël] ; J. M. Rabey [Israël] | Neurosurgical intervention for cervical disk disease in dystonic cerebral palsy |
| 002F73 |
O. Pogarell [Allemagne] ; W. H. Oertel [Allemagne] | Neural transplantation in Parkinson's disease and its effects on rest tremor : A review of the literature |
| 002F74 |
V. P. Calabrese [Canada] ; K. A. Lloyd [Canada] ; P. Brancazio [Canada] ; E. Cefali [États-Unis] ; P. Martin [États-Unis] ; J. Jr Wall [États-Unis] ; D. Sica [États-Unis] | N-0923, a novel soluble dopamine D2 agonist in the treatment of parkinsonism |
| 002F76 |
K. Yoshida [Japon] ; R. Kaji [Japon] ; T. Kubori [Japon] ; N. Kohara [Japon] ; T. Iizuka [Japon] ; J. Kimura [Japon] | Muscle afferent block for the treatment of oromandibular dystonia |
| 002F77 |
M. R. Pranzatelli [États-Unis] ; Y.-Y. Huang [États-Unis] ; E. Tate [États-Unis] ; D. S. Goldstein [États-Unis] ; C. S. Holmes [États-Unis] ; E. M. Goldstein [États-Unis] ; K. Ketner [États-Unis] ; M. Kinast ; B. M. Lange [États-Unis] ; A. Sanz [États-Unis] ; M. I. Shevell [Canada] ; R. E. Stanford ; I. P. Taff [États-Unis] | Monoaminergic effects of high-dose corticotropin in corticotropin-responsive pediatric opsoclonus-myoclonus |
| 002F78 |
S. Ohara [Japon] ; R. Hayashi [Japon] ; H. Momoi [Japon] ; J. Miki [Japon] ; N. Yanagisawa [Japon] | Mexiletine in the treatment of spasmodic torticollis |
| 002F82 |
J. H. Carter [États-Unis] ; B. J. Stewart [États-Unis] ; P. G. Archbold [États-Unis] ; I. Inoue [États-Unis] ; J. Jaglin [États-Unis] ; M. Lannon [États-Unis] ; E. Rost-Ruffner [États-Unis] ; M. Tennis [États-Unis] ; M. P. Mcdermott [États-Unis] ; D. Amyot [Canada] ; R. Barter [États-Unis] ; L. Cornelius [États-Unis] ; C. Demong [Canada] ; J. Dobson [États-Unis] ; J. Duff [Canada] ; J. Erickson [États-Unis] ; N. Gardiner [États-Unis] ; L. Gauger [États-Unis] ; P. Gray [Canada] ; B. Kanigan [Canada] ; B. Kiryluk [États-Unis] ; P. Lewis [États-Unis] ; K. Mistura [États-Unis] ; T. Malapira [États-Unis] ; M. Pay [États-Unis] ; C. Sheldon [États-Unis] ; L. Winfield [États-Unis] ; K. Wolfington-Shallow [États-Unis] ; K. Zoog [États-Unis] | Living with a person who has Parkinson's disease : The spouse's perspective by stage of disease |
| 002F86 |
N. R. Hughes [Royaume-Uni] ; A. T. Mcknight [Royaume-Uni] ; G. N. Woodruff [Royaume-Uni] ; M. P. Hill [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Royaume-Uni] | Kappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism |
| 002F88 |
A. Dalvi [États-Unis] ; S. Fahn [États-Unis] ; B. Ford [États-Unis] | Intrathecal baclofen in the treatment of dystonic storm |
| 002F95 |
J.-P. Nguyen [France] ; B. Pollin [France] ; A. Feve [France] ; C. Geny [France] ; P. Cesaro [France] | Improvement of action tremor by chronic cortical stimulation |
| 003005 |
P. Krack [Allemagne] ; S. Schneider [Allemagne] ; G. Deuschl [Allemagne] | Geste device in tardive dystonia with retrocollis and opisthotonic posturing |
| 003013 |
J. A. Loeb [États-Unis] | Functional improvement in a patient with cerebral calcinosis using a bisphosphonate |
| 003021 |
C. L. Comella [États-Unis] ; K. M. Shannon [États-Unis] ; J. Jaglin [États-Unis] | Extensor truncal dystonia : Successful treatment with botulinum toxin injections |
| 003027 |
J. S. Schneider [États-Unis] ; A. Pope-Coleman [États-Unis] ; M. Van Velson [États-Unis] ; F. Menzaghi [États-Unis] ; G. K. Lloyd [États-Unis] | Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys |
| 003028 |
V. G. H. Evidente [États-Unis] ; C. H. Adler [États-Unis] ; J. N. Caviness [États-Unis] ; K. A. Gwinn [États-Unis] | Effective treatment of orthostatic tremor with gabapentin |
| 003029 |
C. M. Gudex [Danemark] ; M. R. Hawthorne [Royaume-Uni] ; A. G. Butler [Royaume-Uni] ; P. Duffey [Royaume-Uni] | Effect of dystonia and botulinum toxin treatment on health-related quality of life |
| 003030 |
Olivier Rascol [France] ; K. Sieradzan [Royaume-Uni] ; H. Peyro-Saint-Paul [France] ; C. Thalamas [France] ; C. Brefel-Courbon [France] ; J. M. Senard [France] ; P. Ladure [France] ; J. L. Montastruc [France] ; A. Lees [Royaume-Uni] | Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy |
| 003035 |
R. Pahwa [États-Unis] ; K. Lyons [États-Unis] ; J. P. Hubble [États-Unis] ; K. Busenbark [États-Unis] ; J. D. Rienerth [États-Unis] ; A. Pahwa [États-Unis] ; W. C. Koller [États-Unis] | Double-blind controlled trial of gabapentin in essential tremor |
| 003038 |
A. P. Payne [Royaume-Uni] ; R. G. Sutcliffe [Royaume-Uni] ; J. M. Campbell [Royaume-Uni] ; G. Favor [Royaume-Uni] ; D. Russell [Royaume-Uni] ; N. K. Bennett [Royaume-Uni] ; D. J. Clarke [Royaume-Uni] ; R. Branton [Royaume-Uni] ; R. W. Davies [Royaume-Uni] ; E. Simpson [Royaume-Uni] ; C. Tsang [Royaume-Uni] ; R. H. Baxendale [Royaume-Uni] | Disordered locomotion in the AS/AGU mutant rat and the effects of L-dopa or fetal midbrain grafts |
| 003043 |
B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; S. Papadopoulos [France] ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France] ; B. Pidoux [France] ; P. Cornu [France] ; D. Dormont [France] ; C. Marsault [France] | Deep brain stimulation in Parkinson's disease : Opposite effects of stimulation in the pallidum |
| 003044 |
R. K. B. Pearce [Royaume-Uni] ; T. Banerji ; P. Jenner ; C. D. Marsden | De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset |
| 003046 |
C. W. Olanow [États-Unis] ; C. Mytilineou [États-Unis] ; W. Tatton [États-Unis] | Current status of selegiline as a neuroprotective agent in Parkinson's disease |
| 003052 |
P. A. Lewitt [États-Unis] | Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease |
| 003055 |
A. Brashear [États-Unis] ; W. T. Ambrosius [États-Unis] ; G. J. Eckert [États-Unis] ; E. R. Siemers [États-Unis] | Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A |
| 003057 |
R. M. Trosch [États-Unis] ; J. H. Friedman [États-Unis] ; M. C. Lannon [États-Unis] ; R. Pahwa [États-Unis] ; D. Smith [États-Unis] ; L. C. Seeberger [États-Unis] ; C. F. O'Brien [États-Unis] ; P. A. Lewitt [États-Unis] ; W. C. Koller [États-Unis] | Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience |
| 003058 |
I. Maurer [Allemagne] ; T. Grunwald [Allemagne] ; C. E. Elger [Allemagne] | Clozapine treatment of delayed-onset paroxysmal hemidystonia |
| 003059 |
H. H. Fernandez [États-Unis] ; R. Durso [États-Unis] | Clozapine for dopaminergic-induced paraphilias in Parkinson's disease |
| 003067 |
P. Katlovsky [République tchèque] ; H. Streitova [République tchèque] ; J. Dufek [République tchèque] ; V. Znojil [République tchèque] ; P. Daniel [République tchèque] ; I. Rektor [République tchèque] | Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A |
| 003072 |
I. Goikhman [Israël] ; N. Zelnik [Israël] ; N. Peled [Israël] ; S. Michowiz [Israël] | Bobble-head doll syndrome : A surgically treatable condition manifested as a rare movement disorder |
| 003077 |
G.-M. Hariz [Suède] ; A. T. Bergenheim [Suède] ; M. I. Hariz [Suède] ; M. Lindberg [Suède] | Assessment of ability/disability in patients treated with chronic thalamic stimulation for tremor |
| 003084 |
J. W. Lance [Australie] ; I. Hickie [Brésil] ; D. Wakefield [Australie] ; J. G. Colebatch [Australie] ; F. Cardoso [Brésil] ; M. Vidailhet [France] | An akinetic-rigid syndrome, depression, and stereotypies in a young man |
| 003085 |
P. J. Blanchet [États-Unis] ; S. Konitsiotis [États-Unis] ; T. N. Chase [États-Unis] | Amantadine reduces levodopa-induced dyskinesias in Parkinsonian monkeys |
| 003087 |
M. F. Mendez [États-Unis] ; A. Mirea | Adult head-banging and stereotypic movement disorders |
| 003088 |
J. M. Brotchie [Royaume-Uni] | Adjuncts to dopamine replacement : A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease |
| 003094 |
L. V. Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; P. Van Den Munckhof [États-Unis] ; P. Del Dotto [États-Unis] ; R. Natte [États-Unis] ; T. N. Chase [États-Unis] | A trial of dextromethorphan in Parkinsonian patients with motor response complications |
| 003095 |
P. A. Lapchak [États-Unis] | A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease |
| 003096 |
R. A. Hauser [États-Unis] ; E. Molho [États-Unis] ; H. Shale [États-Unis] ; S. Pedder [États-Unis] ; E. E. Dorflinger [États-Unis] | A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients |
| 003097 |
R. B. Jr Dewey [États-Unis] ; D. M. Maraganore [États-Unis] ; J. E. Ahlskog [États-Unis] ; J. Y. Matsumoto [États-Unis] | A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease |
| 003099 |
F. Delecluse [Belgique] ; J. A. Elosegi [Belgique] ; J.-M. Gerard [Belgique] | A case of tardive tremor successfully treated with clozapine |
| 003103 |
| |
| 003104 |
| |
| 003105 |
| |
| 003116 |
S. Ohara [Japon] ; J. Miki [Japon] ; H. Momoi [Japon] ; H. Unno [Japon] ; M. Shindo [Japon] ; N. Yanagisawa [Japon] | Treatment of spasmodic torticollis with mexiletine : A case report |
| 003121 |
E. J. Pappert [États-Unis] ; J. W. Lipton [États-Unis] ; C. G. Goetz [États-Unis] ; Z. D. Ling [États-Unis] ; G. T. Stebbins [États-Unis] ; P. M. Carvey [États-Unis] | The stability of carbidopa in solution |
| 003125 |
P. Lewitt [États-Unis] ; D. Oakes [États-Unis] ; L. Cui [États-Unis] | The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α-tocopherol |
| 003126 |
S. A. Factor [États-Unis] ; J. H. Friedman [États-Unis] | The emerging role of clozapine in the treatment of movement disorders |
| 003127 |
J. P. Larsen [Norvège] ; J. Boas [Danemark] | The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability : An interim analysis of a Norwegian-Danish 5-year study |
| 003129 |
F. Lobbezoo [Canada] ; G. J. Lavigne [Canada] ; R. Tanguay [Canada] ; J. Y. Montplaisir [Canada] | The effect of the catecholamine precursor L-dopa on sleep bruxism : A controlled clinical trial |
| 003139 |
G. Ebersbach [Autriche] ; F. Tracik [Autriche] ; J. Wissel [Autriche] ; Werner Poewe [Autriche] | Tardive jaw tremor |
| 003143 |
N. J. Diederich [Luxembourg (pays), États-Unis] ; C. L. Comella [États-Unis] ; G. Matge [Luxembourg (pays)] ; G. Becker [Luxembourg (pays)] ; F. Schiltz [Luxembourg (pays)] ; H. Metz [Luxembourg (pays)] | Sustained effect of high-dose intrathecal baclofen in primary generalized dystonia : A 2-year follow-up study |
| 003144 |
M. Poyurovsky [Israël] ; M. Schneidman [Israël] ; A. Weizman [Israël] | Successful treatment of fluoxetine-induced dystonia with low-dose mianserin |
| 003146 |
A. Burleigh-Jacobs [États-Unis] ; F. B. Horak [États-Unis] ; J. G. Nutt [États-Unis] ; J. A. Obeso [Espagne] | Step initiation in Parkinson's disease : Influence of levodopa and external sensory triggers |
| 003148 |
B. Ford [États-Unis] ; S. L. Pullman [États-Unis] ; A. Khandji [États-Unis] ; R. Goodman [États-Unis] | Spinal myoclonus induced by an intrathecal catheter |
| 003152 |
M. Zappia [Italie] ; R. Montesanti [Italie] ; R. Colao [Italie] ; D. Branca [Italie] ; G. Nicoletti [Italie] ; U. Aguglia [Italie] ; A. Quattrone [Italie] | Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease |
| 003153 |
V. Müller [Allemagne] ; B. Mohr [Allemagne] ; R. Rosin [Allemagne] ; F. Pulvermüller [Allemagne] ; F. Müller [Allemagne] ; N. Birbaumer [Allemagne, Italie] | Short-term effects of behavioral treatment on movement initiation and postural control in Parkinson's disease : A controlled clinical study |
| 003155 |
D. Dressler [Allemagne] ; R.-O. Oeljesch Ger [Allemagne] ; E. Rüther [Allemagne] | Severe tardive dystonia: Treatment with continuous intrathecal baclofen administration |
| 003156 |
A. Albanese ; G. Maria [Italie] ; A. Bentivoglio ; T. Brisinda [Italie] ; E. Cassetta [Italie] ; P. Tonali | Severe constipation in Parkinson's disease relieved by botulinum toxin |
| 003157 |
R. A. Hauser [États-Unis] ; T. A. Zesiewicz [États-Unis] | Sertraline for the treatment of depression in Parkinson's disease |
| 003161 |
G. Meco [Italie] ; A. Alessandri [Italie] ; P. Giustini [Italie] ; V. Bonifati [Italie] | Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: An open-label, long-term study |
| 003162 |
L. Derex [France] ; P. Trouillas [France] | Reversible parkinsonism, hypophosphoremia, and hypocalcemia under vitamin D therapy |
| 003166 |
J. Wissel [Allemagne, Autriche] ; F. Masuhr [Allemagne] ; L. Schelosky [Allemagne] ; G. Ebersbach [Allemagne, Autriche] ; Werner Poewe [Autriche] | Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor |
| 003192 |
C. E. Clarke [Royaume-Uni] ; C. Sampaio [Portugal] | Movement disorders cochrane collaborative review group |
| 003194 |
J. G. Nutt [États-Unis] ; J. H. Carter [États-Unis] ; E. S. Lea [États-Unis] ; W. R. Woodward [États-Unis] | Motor fluctuations during continuous Levodopa infusions in patients with Parkinson's disease |
| 003196 |
M. Gu [Royaume-Uni] ; M. T. Gash [Royaume-Uni] ; J. M. Cooper [Royaume-Uni] ; G. K. Wenning [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; A. H. V. Schapira [Royaume-Uni] | Mitochondrial respiratory chain function in multiple system atrophy |
| 003198 |
G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. T. Savino [Argentine] ; M. Mora [Argentine] ; F. J. E. Stefano [Argentine] ; O. Gershanik [Argentine] | Mechanism of action of clozapine-induced modification of motor behavior in an animal model of the "super-off" phenomenon |
| 003201 |
J. H. Friedman [États-Unis] | Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone |
| 003202 |
W. H. Jost [Allemagne] ; K. Schimrigk [Allemagne] | Long-term results with cisapride in Parkinson's disease |
| 003211 |
A. Strafella [Canada] ; P. Ashby [Canada] ; M. Munz [Canada] ; J. O. Dostrovsky [Canada] ; A. M. Lozano [Canada] ; A. E. Lang [Canada] | Inhibition of voluntary activity by thalamic stimulation in humans : Relevance for the control of tremor |
| 003218 |
K. Ikeda [Japon] ; M. Kinoshita [Japon] ; K. Aoki [Japon] ; A. Tomatsuri [Japon] | Hydrocephalic parkinsonism due to Paget's disease of bone : Dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy |
| 003221 |
A. M. Lozano [Canada] ; R. Kumar [Canada] ; R. E. Gross [Canada] ; N. Giladi [Israël] ; W. D. Hutchison [Canada] ; J. O. Dostrovsky [Canada] ; A. E. Lang [Canada] | Globus pallidus internus pallidotomy for generalized dystonia |
| 003223 |
P. Chana [Chili] ; A. De Marinis [Chili] ; N. Barrientos [Chili] | Gabapentin and motor fluctuations in Parkinson's disease |
| 003234 |
C. G. Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; L. M. Blasucci [États-Unis] ; M. S. Grobman [États-Unis] | Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease |
| 003236 |
I. Soykan [États-Unis] ; I. Sarosiek [États-Unis] ; J. Shifflett [États-Unis] ; G. F. Wooten [États-Unis] ; R. W. Mccallum [États-Unis] | Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease |
| 003237 |
J. F. Lipinski [États-Unis] ; F. R. Sallee [États-Unis] ; C. Jackson [États-Unis] ; G. Sethuraman [États-Unis] | Dopamine agonist treatment of Tourette disorder in children : Results of an open-label trial of pergolide |
| 003238 |
A. Rajput [États-Unis] ; A. Kishore [Canada] ; B. Snow [Canada] ; C. F. Bolton [Canada] ; A. H. Rajput [Canada] | Dopa-responsive, nonprogressive, juvenile parkinsonism : Report of a case |
| 003246 |
C. Sampaio [Portugal] ; J. J. Ferreira [Portugal] ; F. Simoes [Portugal] ; M. J. Rosas [Portugal] ; M. Magalhaes [Portugal] ; A. P. Correia [Portugal] ; A. Bastos-Lima [Portugal] ; R. Martins [Portugal] ; A. Castro-Caldas [Portugal] | DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-dysport and botox-assuming a ratio of 4:1 |
| 003250 |
W. Ashraf [États-Unis] ; R. F. Pfeiffer [États-Unis] ; F. Park [États-Unis] ; J. Lof [États-Unis] ; E. M. M. Quigley [États-Unis] | Constipation in Parkinson's disease : Objective assessment and response to psyllium |
| 003254 |
R. Pahwa [États-Unis] ; K. Lyons [États-Unis] ; D. Mcguire [États-Unis] ; P. Silverstein [États-Unis] ; F. Zwiebel [États-Unis] ; M. Robischon [États-Unis] ; W. C. Koller [États-Unis] | Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease : Pharmacokinetic and quality-of-life measures |
| 003255 |
D. Tarsy [États-Unis] | Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin |
| 003259 |
S. B. Blunt [Royaume-Uni] ; R. J. M. Lane [Royaume-Uni] ; N. Turjanski [Royaume-Uni] ; G. D. Perkin [Royaume-Uni] | Clinical features and management of two cases of Encephalitis lethargica |
| 003261 |
G. Gomez Arevalo [Argentine] ; R. Jorge [Argentine] ; S. Garcia [Argentine] ; O. Scipioni [Argentine] ; O. Gershanik [Argentine] | Clinical and pharmacological differences in early- versus late-onset Parkinson's disease |
| 003271 |
N. Giladi [Israël] ; S. Honigman [Israël] | Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease |
| 003272 |
R. Liguori [Italie] ; C. Cordivari [Italie] ; E. Lugaresi [Italie] ; P. Montagna [Italie] | Botulinum toxin a improves muscle spasms and rigidity in Stiff-Person syndrome |
| 003273 |
D. D. Truong [États-Unis] ; P. A. Cullis [États-Unis] ; C. F. O'Brien [États-Unis] ; M. Koller [États-Unis] ; T. P. Villegas [États-Unis] ; J. D. Wallace [États-Unis] | BotB (botulinum toxin type B): Evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study) |
| 003274 |
H. G. Mussell [États-Unis] ; L. S. Dure [États-Unis] ; A. K. Percy [États-Unis] ; P. S. Grabb [États-Unis] | Bobble-head doll syndrome : Report of a case and review of the literature |
| 003275 |
P. R. Schuurman [Pays-Bas] ; R. M. A. De Bie [Pays-Bas] ; J. D. Speelman [Pays-Bas] ; D. A. Bosch [Pays-Bas] | Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients |
| 003294 |
N. Andreu [France] ; C. Damase-Michel [France] ; J.-M. Senard [France] ; Olivier Rascol [France] ; J.-L. Montastruc [France] | A dose-ranging study of selegiline in patients with Parkinson's disease : Effect on platelet monoamine oxidase activity |
| 003295 |
P. G. Como [États-Unis] ; A. J. Rubin [États-Unis] ; C. F. O'Brien [États-Unis] ; K. Lawler [États-Unis] ; C. Hickey [États-Unis] ; A. E. Rubin [États-Unis] ; R. Henderson [États-Unis] ; M. P. Mcdermott [États-Unis] ; T. Mcdermott [États-Unis] ; K. Steinberg [États-Unis] ; I. Shoulson [États-Unis] | A controlled trial of fluoxetine in nondepressed patients with Huntington's disease |
| 003299 |
| |
| 003300 |
| |
| 003304 |
P. Girlanda [Italie] ; A. Quartarone ; S. Sinicropi ; C. Nicolosi ; C. Massina | Unilateral injection of botulinum toxin in blepharospasm : single fiber electromyography and blink reflex study |
| 003308 |
R. Lindeboom [Pays-Bas] ; R. J. De Haan ; M. Aramideh [Pays-Bas] ; J. W. M. Brans [Pays-Bas] ; J. D. Speelman [Pays-Bas] | Treatment outcomes in cervical dystonia : A clinimetric study |
| 003309 |
B. L. Scott [États-Unis] ; R. W. Evans [États-Unis] ; Joseph Jankovic [États-Unis] | Treatment of palatal myoclonus with sumatriptan |
| 003310 |
J. A. Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of nonoccupational limb and trunk dystonia with botulinum toxin |
| 003311 |
F. Stocchi [Italie] ; M. F. De Pandis [Italie] ; F. A. Delfino [Italie] ; T. Anselmo [Italie] ; D. Frongillo [Italie] | Transient atrial fibrillation after subcutaneous apomorphine bolus |
| 003312 |
M. Y. Neufeld [Israël] ; P. Nisipeanu [Israël] ; V. Chistik [Israël] ; A. D. Korczyn [Israël] | The electroencephalogram in acetazolamide-responsive periodic ataxia |
| 003319 |
C. Raftopoulos [Belgique] ; S. Dethy ; M. A. Laute ; S. Goldman ; A. B. Naini ; S. Przedborski ; J. Hildebrand | Slow increase of homovanillic acid in cerebrospinal fluid after levodopa administration |
| 003323 |
M. H. Thaut [États-Unis] ; G. C. Mcintosh ; R. R. Rice ; R. A. Miller [États-Unis] ; J. Rathbun [États-Unis] ; J. M. Brault [États-Unis] | Rhythmic auditory stimulation in gait training for Parkinson's disease patients |
| 003325 |
P. E. Greene [États-Unis] ; S. Fahn [États-Unis] | Response to botulinum toxin F in seronegative botulinum toxin A-resistant patients |
| 003328 |
A. Tan [États-Unis] ; M. Salgado [États-Unis] ; S. Fahn [États-Unis] | Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa |
| 003333 |
A. Freese [États-Unis] ; M. Stern [États-Unis] ; M. G. Kaplitt ; W. M. O'Connor [États-Unis] ; M. V. Abbey ; M. J. O'Connor [États-Unis] ; M. J. During [États-Unis] | Prospects for gene therapy in Parkinson's disease |
| 003336 |
R. Pahwa [États-Unis] ; J. Marjama [États-Unis] ; D. Mcguire [États-Unis] ; K. Lyons [États-Unis] ; F. Zwiebel ; P. Silverstein ; R. Ward ; W. C. Koller [États-Unis] | Pharmacokinetic comparison of Sinemet and atamet (generic carbidopa/levodopa) : A single-dose study |
| 003338 |
C. H. Adler [États-Unis] ; R. S. Zimmerman ; M. K. Lyons ; F. Simeone ; M. F. Brin | Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease |
| 003352 |
E. J. Pappert [États-Unis] ; C. Buhrfiend ; J. W. Lipton ; P. M. Carvey ; G. T. Stebbins ; C. G. Goetz | Levedopa stability in solution : time course, environmental effects, and practical recommendations for clinical use |
| 003357 |
B. R. Bloem [Pays-Bas] ; D. J. Beckley [États-Unis] ; J. G. Van Dijk [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; M. P. Remler [États-Unis] ; R. A. C. Roos [Pays-Bas] | Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease |
| 003376 |
F. Tison [France] ; L. Wiart [France] ; M. Guatterie [France] ; N. Fouillet [France] ; V. Lozano [France] ; P. Henry [France] ; M. Barat [France] | Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease |
| 003377 |
L. V. Metman [États-Unis] ; P. J. Blanchet [États-Unis] ; D. De Jong [États-Unis] ; M. M. Mouradian [États-Unis] ; T. N. Chase [États-Unis] | Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease |
| 003378 |
K. D. Pfann [États-Unis] ; R. D. Penn ; K. M. Shannon ; M. B. Shapiro ; D. M. Corcos [États-Unis] | Effect of stimulation in the ventral intermediate nucleus of the thalamus on limb control in Parkinson's disease : A case study |
| 003379 |
P. J. Blanchet [Canada] ; R. Grondin ; P. J. Bedard | Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates |
| 003384 |
L. J. Born [États-Unis] ; R. H. Harned ; L. F. Fikkers ; R. F. Pfeiffer [États-Unis] ; E. M. M. Quigley [États-Unis] | Cricopharyngeal dysfunction in Parkinson's disease : role in dysphagia and response to myotomy |
| 003385 |
| Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD) |
| 003387 |
K. J. Bharucha [États-Unis] ; K. D. Sethi [États-Unis] | Complex movement disorders induced by fluoxetine |
| 003388 |
A. Ikeda [Japon] ; .. Shibasaki [Japon] ; K. Tashiro [Japon] ; Y. Mizuno [Japon] ; J. Kimura [Japon] | Clinical trial of piracetam in patients with myoclonus : nationwide multiinstitution study in Japan |
| 003397 |
G. Geminiani [Italie] ; V. Fetoni [Italie] ; S. Genitrini [Italie] ; P. Giovannini [Italie] ; F. Tamma [Italie] ; T. Caraceni [Italie] | Cabergoline in Parkinson's disease complicated by motor fluctuations |
| 003401 |
G. W. Paulson [États-Unis] ; W. Gill [États-Unis] | Botulinum toxin is unsatisfactory therapy for fibromyalgia |
| 003402 |
B. L. Scott [États-Unis] ; Joseph Jankovic [États-Unis] ; D. T. Donovan | Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome |
| 003403 |
S. Salloway [États-Unis] ; C. F. Stewart [États-Unis] ; L. Israeli ; X. Morales ; S. Resmussen [États-Unis] ; A. Blitzer [États-Unis] ; M. F. Brin [États-Unis] | Botulinum toxin for refractory vocal tics |
| 003411 |
A. Feigin [États-Unis] ; K. Kieburtz [États-Unis] ; P. Como [États-Unis] ; C. Hickey [États-Unis] ; K. Claude [États-Unis] ; D. Abwender [États-Unis] ; C. Zimmerman [États-Unis] ; K. Steinberg [États-Unis] ; I. Shoulson [États-Unis] | Assessment of coenzyme Q10 tolerability in Huntington's disease |
| 003412 |
A. P. Sempere [Espagne] ; J. Duarte [Espagne] ; F. Garcia [Espagne] ; C. Cabezas [Espagne] ; F. Coria [Espagne] ; L. E. Claveria [Espagne] | An estimate of the risk of movement disorders associated with the chronic use of clebopride |
| 003413 |
L. Smith [Royaume-Uni] ; M. De Salvia [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden | An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets |
| 003415 |
A. Benazzouz [France] ; T. Boraud [France] ; J. Feger [France] ; P. Burbaud [France] ; B. Bioulac [France] ; C. Gross [France] | Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment |
| 003416 |
P. J. Blanchet [États-Unis] ; L. V. Metman [États-Unis] ; M. M. Mouradian [États-Unis] ; T. N. Chase [États-Unis] | Acute pharmacologic blockade of dyskinesias in Parkinson's disease |
| 003419 |
P. Limousin [France] ; Pierre Pollak [France] ; D. Hoffmann [France] ; ABDELHAMID BENAZZOUZ [France] ; J. E. Perret [France] ; Alim-Louis Benabid [France] | Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients |
| 003420 |
Joseph Jankovic [États-Unis] ; K. Schwartz [États-Unis] ; W. Clemence [États-Unis] ; A. Aswad ; J. Mordaunt | A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor |
| 003421 |
T. Van Laar [Pays-Bas] ; C. Neef [Pays-Bas] ; M. Danhof [Pays-Bas] ; K. I. Roon [Pays-Bas] ; R. A. C. Roos [Pays-Bas] | A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease |
| 003423 |
K. Kieburtz [États-Unis] ; A. Feigin ; M. Mcdermott ; P. Como ; D. Abwender ; C. Zimmerman ; C. Hickey ; C. Orme ; K. Claude ; J. Sotack ; J. T. Greenamyre ; C. Dunn ; I. Shoulson | A controlled trial of remacemide hydrochloride in Huntington's disease |
| 003435 |
W. Diaz Neira [Espagne] ; V. Sanchez ; M. A. Mena ; J. G. De Yebenes | The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease |
| 003436 |
R. Lindeboom [Pays-Bas] ; R. De Haan ; M. Aramideh ; J. D. Speelman | The blepharospasm disability scale : an instrument for the assessment of functional health in blepharospasm |
| 003445 |
F. A. Lenz [États-Unis] ; S. L. Normand ; H. C. Kwan ; D. Andrews ; L. H. Rowland [États-Unis] ; M. W. Jones ; M. Seike [États-Unis] ; Y. C. Lin [États-Unis] ; R. R. Tasker ; J. O. Dostrovsky ; Y. E. Lenz [États-Unis] | Statistical prediction of the optimal site for thalamotomy in Parkinsonian tremor |
| 003455 |
M. Di Capua [Italie] ; E. Bertini | Remission in dihydroxyphenylalanine-responsive dystonia |
| 003462 |
T. Van Laar [Pays-Bas] ; E. N. H. Jansen ; C. Neef ; M. Danhof ; R. A. C. Roos | Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease : a study of five different suppositories |
| 003475 |
R. A. Maricle [États-Unis] ; J. G. Nutt ; J. H. Carter | Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion : preliminary findings |
| 003477 |
G. Fabbrini [Italie] ; F. Baronti ; S. Ruggieri ; G. L. Lenzi | Meningioma-induced loss of antiparkinsonian response to levodopa |
| 003479 |
J. Kulisevsky [Espagne] ; M. L. Berthier ; A. Avila | Longitudinal evolution of prefrontral leucotomy in Tourette's syndrome |
| 003480 |
R. Inzelberg [Israël] ; P. Nisipeanu ; M. J. Rabey ; A. D. Korczyn | Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease |
| 003488 |
R. D. Penn [États-Unis] ; J. M. Gianino ; M. M. York | Intrathecal baclofen for motor disorders |
| 003489 |
W. H. Oertel [Allemagne] ; R. C. Dodel | International guide to drugs for Parkinson's disease |
| 003492 |
G. Ebersbach [Allemagne] ; C. Kabus ; L. Schelosky [Allemagne] ; L. Terstegge ; Werner Poewe [Allemagne] | Hemimasticatory spasm in hemifacial atrophy : diagnostic and therapeutic aspects in two patients |
| 003501 |
T. L. Davis [États-Unis] ; M. Roznoski ; R. S. Burns | Effects of tolcapone in Parkinson's patients taking L-dihydroxyphenalalanine/carbidopa and selegiline |
| 003503 |
R. Djaldetti [Israël] ; M. Koren ; ILAN ZIV ; A. Achiron ; ELDAD MELAMED | Effect of cisapride on response fluctuations in Parkinson's disease |
| 003505 |
R. Cole [États-Unis] ; M. Hallett ; L. G. Cohen | Double-blind trial of botulinum toxin for treatment of focal hand dystonia |
| 003516 |
D. Claus [Allemagne] ; A. Druschky ; F. Erbguth | Botulinum toxin : influence on respiratory heart rate variation |
| 003517 |
D. Tarsy [États-Unis] ; S. C. Schachter | Botulinum toxin treatmenty is not effective for epilepsy partialis continua |
| 003519 |
M. H. Mark [États-Unis] ; J. I. Sage ; A. S. Walters ; R. C. Duvoisin ; D. C. Miller | Binswanger's disease presenting as levodopa-responsive parkinsonism : clinicopathologic study of three cases |
| 003520 |
P. Limousin [France] ; Pierre Pollak [France] ; ABDELHAMID BENAZZOUZ [France] ; D. Hoffmann [France] ; E. Broussolle [France] ; J. E. Perret [France] ; Alim-Louis Benabid [France] | Bilateral subthalamic nucleus stimulation for severe Parkinson's disease |
| 003521 |
O. Suchowersky [Canada] ; S. Furtado ; G. Rohs | Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease |
| 003524 |
N. J. Scolding [Royaume-Uni] ; S. M. Smith [Royaume-Uni] ; S. Sturman ; G. B. Brookes [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Auctioneer's jaw : a case of occupational oromandibular hemidystonia |
| 003527 |
S. T. Gancher [États-Unis] ; J. G. Nutt [États-Unis] ; W. R. Woodward | Apomorphine infusional therapy in Parkinson's disease : clinical utility and lack of tolerance |
| 003539 |
G. K. Wenning [Royaume-Uni] ; M. T. O'Connell ; P. N. Patsalos ; N. P. Quinn | A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease |
| 003540 |
A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine |
| 003543 |
C. Pacchetti [Italie] ; G. Albani ; E. Martignoni ; L. Godi ; E. Alfonsi ; G. Nappi | "Off" painful dystonia in Parkinson's disease treated with botulinum toxin |
| 003544 |
| |
| 003546 |
| |
| 003559 |
J. M. Trugman [États-Unis] ; R. Leadbetter ; M. E. Zalis ; R. O. Burgdorf ; G. F. Wooten [États-Unis] | Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis |
| 003564 |
R. J. Vermeulen [Pays-Bas] ; B. Drukarch [Pays-Bas] ; M. C. R. Sahadat ; C. Goosen ; E. C. Wolters [Pays-Bas] ; J. C. Stoof [Pays-Bas] | The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys |
| 003567 |
C. G. Goetz [États-Unis] ; G. T. Stebbins ; J. A. Thelen | Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial |
| 003568 |
T. Mendis [Canada] ; E. Mohr [Canada] ; A. George ; I. N. Rusk [Canada] ; P. Gray ; J. D. Grimes | Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride |
| 003570 |
J. P. Jr Bennett [États-Unis] ; E. R. Landow ; S. Dietrich ; L. A. Schuh | Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction |
| 003588 |
G. Pezzoli [Italie] ; E. Martignoni ; C. Pacchetti ; V. A. Angeleri ; P. Lamberti ; A. Muratorio ; U. Bonuccelli ; M. De Mari ; N. Foschi ; E. Cossutta ; F. Nicoletti ; F. Giammona ; M. Cansei [Italie] ; G. Scarlato [Italie] ; T. Caraceni ; E. Moscarelli | Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study |
| 003594 |
Olivier Rascol [France] ; N. Fabre [France] ; O. Blin ; J. Poulik [France] ; U. Sabatini [France] ; J.-M. Senard [France] ; M. Ane [France] ; J.-L. Montastruc [France] ; A. Rascol | Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease |
| 003595 |
J. D. Belluzzi [États-Unis] ; E. F. Domino ; J. M. May ; K. S. Bankiewicz ; D. A. Mcafee | N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease |
| 003598 |
L. V. Metman [États-Unis] ; V. H. Sethy ; J. R. Roberts ; D. Bravi ; J. I. Hoff ; M. M. Mouradian ; T. N. Chase | Motor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (Preclamol) in Parkinson's disease |
| 003600 |
M. Merello [Argentine] ; H. Garcia ; M. Nogues ; R. Leiguarda | Masticatory muscle spasms in a non-japanese patient with satoyoshi syndrome successfully treated with botulinum toxin |
| 003603 |
S. S. Rich [États-Unis] ; F. Ovsiew | Leuprolide acetate for exhibitionism in Huntington's disease |
| 003610 |
G. E. Borodic [États-Unis] ; R. Ferrante ; L. Bruce Pearce ; K. Smith [États-Unis] | Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections |
| 003614 |
L. Verhagen Metman [États-Unis] ; J. Hoff ; M. M. Mouradian ; T. N. Chase | Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa |
| 003627 |
M. Kyllerman [Suède] ; O. H. Skjeldal ; M. Lundberg ; I. Holme ; E. Jellum ; U. Von Döbeln ; A. Fossen ; G. Carlsson | Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations |
| 003628 |
P. Greene [États-Unis] ; S. Fahn [États-Unis] ; B. Diamond | Development of resistance to botulinum toxin type A in patients with torticollis |
| 003631 |
J. H. Friedman [États-Unis] | Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases |
| 003637 |
Joseph Jankovic [États-Unis] | Botulinum toxin in the treatment of dystonic tics |
| 003638 |
R. M. Trosch [États-Unis] ; S. L. Pullman | Botulinum toxin A injections for the treatment of hand tremors |
| 003642 |
R. Pratap Chand [Royaume-Uni] ; D. M. Park | Atypical blepharospasm responsive to sodium valproate |
| 003648 |
C. W. Olanow [États-Unis] ; S. Fahn ; M. Muenter ; H. Klawans ; H. Hurtig ; M. Stern ; I. Shoulson ; R. Kurlan ; J. D. Grimes ; Joseph Jankovic [États-Unis] ; M. Hoehn ; C. H. Markham ; R. Duvoisin ; O. Reinmuth ; H. A. Leonard ; E. Ahlskog ; R. Feldman ; L. Hershey ; M. D. Yahr | A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease |
| 003650 |
P. Krack [Allemagne] ; M. H. Marion | "apraxia of lid opening," a focal eyelid dystonia : clinical study of 32 patients |
| 003658 |
P. E. Greene [États-Unis] ; S. Fahn | Use of botulinum toxin Type F injections to treat torticollis in patients with immunity to Botulinum toxin Type A |
| 003662 |
D. Bravi [États-Unis] ; T. L. Davis ; M. M. Mouradian ; T. N. Chase | Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980 |
| 003664 |
M. F. Gordon [États-Unis] ; R. Diaz-Olivo ; A. L. Hunt ; S. Fahn | Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disorders |
| 003666 |
J. Guridi [Espagne] ; M. R. Luquin ; M. T. Herrero ; J. A. Obeso | The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease |
| 003672 |
C. Pacchetti [Italie] ; E. Martignoni [Italie] ; P. Bruggi [Italie] ; L. Godi [Italie] ; B. Aufdembrinke ; C. Miltenburger ; B. Voet ; G. Nappi [Italie] | Terguride in fluctuating Parkinsonian patients: a double-blind study versus placebo |
| 003674 |
H. Allain [France] ; Pierre Pollak [France] ; H. C. Neukirch [France] | Symptomatic effect of selegiline in De Novo Parkinsonian patients |
| 003677 |
A. J. Hughes [Royaume-Uni] ; S. Bishop ; B. Kleedorfer ; N. Turjanski ; W. Fernandez ; Andrew Lees (neurologue) [Royaume-Uni] ; G. M. Stern | Subcateneous apomorphine in Parkinson's disease: response to chronic administration for up to five years |
| 003680 |
B. Johnels [Suède] ; P. E. Ingvarsson [Suède] ; B. Holmberg ; M. Matousek [Suède] ; G. Steg [Suède] | Single-dose L-dopa response in early parkinson's disease : measurements with optoelectronic recording technique |
| 003681 |
D. Davis [États-Unis] ; B. Jabbari | Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A |
| 003682 |
V. V. Myllyl [Finlande] ; K. A. Sotaniemi ; J. A. Vuorinen ; E. H. Heinonen | Selegiline in De Novo Parkinsonian patients: the finnish study |
| 003683 |
W. G. Tatton [Canada] | Selegiline can mediate neuronal rescue rather than neuronal protection |
| 003685 |
C. A. Hubbard [États-Unis] ; J. M. Trugman | Reversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonists |
| 003691 |
D. Dykstra [États-Unis] ; C. Ellingham ; A. Belfie ; T. Baxter ; M. Lee ; A. Voelker | Quantitative measurement of cervical range of motion in patients with torticollis treated with botulinum A toxin |
| 003696 |
A. Feve [France] ; B. Angelard [France] ; G. Fenelon [France] ; M. Logak [France] ; A. Guillard [France] ; J. Lacau Saint-Guily | Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin |
| 003706 |
G. Linazasoro [Espagne] ; J. F. Marti Masso ; J. A. Suarez | Nocturnal akathisia in Parkinson's disease: treatment with clozapine |
| 003713 |
G. J. Gomez Arevalo [Argentine] ; O. S. Gershanik | Modulator effect of clozapine on levodopa response in Parkinson's disease: a preliminary study |
| 003714 |
M. E. Giuffra [États-Unis] ; V. H. Sethy ; T. L. Davis ; M. M. Mouradian ; T. N. Chase | Milacemide therapy for Parkinson's disease |
| 003718 |
J. Vaamonde [Suède] ; I. Legarda [Suède] ; J. Jimenez-Jimenez ; J. L. Zubieta [Suède] ; J. A. Obeso [Suède] | Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism |
| 003723 |
W. S. Metzer [États-Unis] ; S. R. Paige ; J. E. O. Newton | Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor |
| 003731 |
A. L. Burleigh [États-Unis] ; F. B. Horak [États-Unis] ; K. J. Burchiel ; J. G. Nutt | Effects of thalamic stimulation on tremor, balance, and step initiation: a single subject study |
| 003732 |
P. Brown [Royaume-Uni] ; M. J. Steiger [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; M. Salama ; T. Waegemans ; C. D. Marsden [Royaume-Uni] | Effectiveness of piracetam in cortical myoclonus |
| 003733 |
B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. Bedard | Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors |
| 003734 |
P. Lamberti [Italie] ; M. De Mari ; G. Iliceto ; M. Caldarola ; L. Serlenga | Effect of L-dopa on oculogyric crises in a case of dopa-responsive dystonia |
| 003735 |
S. A. Factor [États-Unis] ; W. J. Weiner | Early combination therapy with bromocriptine and levodopa in Parkinson's disease |
| 003737 |
J. G. Nutt [États-Unis] ; J. H. Carter ; W. Woodward ; J. P. Hammerstad ; S. T. Gancher | Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions |
| 003742 |
W. H. Jost [Allemagne] ; K. Schimrigk | Cisapride treatment of constipation in Parkinson's disease |
| 003754 |
U. Bonuccelli [Italie] ; P. Piccini [Italie] ; P. Del Dotto [Italie] ; G. Rossi ; G. U. Corsini ; A. Muratorio [Italie] | Apomorphine test for dopaminergic responsiveness: a dose assessment study |
| 003759 |
M. Guttman [Canada] ; G. Leger ; A. Reches ; A. Evans ; H. Kuwabara ; J. M. Cedarbaum ; A. Gjedde | Administration of the new COMT inhibitor OR-611 increases striatal uptake of fluorodopa |
| 003761 |
M. Vidailhet [France] ; C. Bouchard [France] ; P. J. Jedynak [France] ; M. Serdaru [France] | Acute and long-term response to apomorphine in cranial dystonia |
| 003762 |
S. A. Factor [États-Unis] | Acetazolamide therapy of menstrual-related fluctuations in Parkinson's disease |
| 003763 |
C. W. Olanow [États-Unis] | A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease |
| 003765 |
F. Sellal [France] ; E. Hirsch [France] ; P. Barth [France] ; S. Blond [France] ; C. Marescaux [France] | A case of symptomatic hemidystonia improved by ventroposterolateral thalamic electrostimulation |
| 003766 |
G. Broggi [Italie] ; S. Brock ; A. Franizini ; G. Geminiani | A case of posttraumatic tremor treated by chronic stimulation of the thalamus |
| 003767 |
| |
| 003777 |
J. D. Wirtschafter [États-Unis] ; D. P. Slovut ; L. Stordal ; J. Valentino ; L. K. Mcloon | Severe but temporary injury to rabbit orbicularis oculi muscle using dihematoporphyrin ether and laser photochemomyectomy |
| 003786 |
B. Jabbari [États-Unis] ; J. Paul ; B. Scherokman ; B. Van Dam | Posttraumatic segmental axial dystonia |
| 003800 |
J.-F. De Saint Victor [France] ; C.-L. Gervason | Levopoda-induced diphasic dyskinesias improved by subcutaneous apomorphine |
| 003801 |
M Contin [Italie] ; R. Riva ; P. Martinelli ; A. Baruzzi | Kinetic-dynamic relationship of oral levopoda : possible biphasic response after sequential doses in Parkinson's disease |
| 003804 |
F. Stocchi [Italie] ; S. Ruggieri ; A. Carta ; J. Ryatt ; N. Quinn ; P. Jenner ; C. D. Marsden ; A. Agnoli | Intravenous boluses and continuous infusions of L-DOPA methyl ester in fluctuating patients with Parkinson's disease |
| 003806 |
I. Rektor [République tchèque] ; M. Svejdova ; C. Silva-Barrat ; C. Menini | Influence of cholinergic systems on myoclonus in myoclonic epilepsies |
| 003816 |
E. Pourcher [Canada] ; B. Gomez-Mancilla ; P. J. Bedard | Ethosuximide and tremor in Parkinson's disease : a pilot study |
| 003817 |
L. Christenson [États-Unis] ; D. F. Emerich ; P. R. Sanberg | Encapsulated cell implatation for Parkinson's disease |
| 003818 |
M. Emre [Suisse] ; U. K. Rinne ; A. Rascol ; A. Lees ; Yves Agid [France] ; X. Lataste | Effects of a selective partial D1 agonist, CY 208-243, in De Novo patients with Parkinson disease |
| 003819 |
B. Gomez-Mancilla [Canada] ; J.-F. Latulippe ; R. Boucher ; P. J. Bedard | Effect of ethosuximide on rest tremor in the MPTP monkey model |
| 003820 |
D. Bravi [États-Unis] ; J. J. Anderson ; F. Dagani ; T. L. Davis ; R. Feerari ; M. Gillespie ; T. N. Chase | Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease |
| 003821 |
B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. Bedard | Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of Parkinsonism |
| 003825 |
P. J. Morrison [Royaume-Uni] ; V. H. Patterson | Cranial dystonia (Meige syndrome) in postencephalitic Parkinsonism |
| 003828 |
J. William Langston [États-Unis] ; H. Widner ; C. G. Goetz ; D. Brooks ; S. Fahn ; T. Freeman ; R. Watts | Core assessment program for intracerebral transplantations (CAPIT) |
| 003829 |
S. A. Factor [États-Unis] ; D. Brown | Clozapine prevents recurrence of psychosis in Parkinson's disease |
| 003835 |
P. E. Greene [États-Unis] ; S. Fahn | Baclofen in the treatment of idiopathic dystonia in children |
| 003840 |
J. Rivest ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden | Writer's cramp : treatment with botulinum toxin injections |
| 003847 |
I. T. Lorentz [Australie] ; S. Shanthi Subramaniam ; C. Yiannikas | Treatment of idiopathic spasmodic torticollis with botulinum toxin A : a double-blind study on twenty-three patients |
| 003849 |
S. Rittig ; J. Arentsen ; K. Soêrensen ; T. Matthiesen ; E. Dupont | The hemodynamic effects of triglycyl-lysine-vasopressin (glypressin) in patients with parkinsonism and orthostatic hypotension |
| 003850 |
P. Blum ; Joseph Jankovic [États-Unis] | Stiff-Person syndrome : an autoimmune disease |
| 003851 |
S. V. Pavlakis [États-Unis] ; S. Schneider ; K. Black ; R. J. Gould | Steroid-responsive chorea in Moyamoya disease |
| 003852 |
M. J. Steiger ; N. P. Quinn ; C. D. Marsden | Sickness due to levodopa-induced neck dyskinesias in Parkinson's disease |
| 003854 |
A. S. Walters ; W. A. Hening ; SUDHANSU CHOKROVERTY | Review and videotape recognition of idiopathic restless legs syndrome |
| 003855 |
E. Sasso ; E. Perucca ; R. Fava ; S. Calzetti | Quantitative comparison of barbiturates in essential hand and head tremor |
| 003860 |
A. J. Hughes ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden | Paroxysmal dystonic head tremor |
| 003863 |
P. M. Fitzgerald ; Joseph Jankovic [États-Unis] | Orthostatic tremor : an association with essential tremor |
| 003864 |
R. Kurlan [États-Unis] ; M. H. Kim ; D. M. Gash | Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys : assessment with a new rating scale for monkey parkinsonism |
| 003865 |
M. J. Steiger ; N. P. Quinn ; B. Toone ; C. D. Marsden | Off-period screaming accompanying motor fluctuations in Parkinson's disease |
| 003870 |
T. Z. Aziz [Royaume-Uni] ; D. Peggs ; M. A. Sambrook ; A. R. Crossman | Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonims in the primate |
| 003871 |
F. Dagani [Italie] ; R. Ferrari ; J. I. Anderson ; T. N. Chase | L-Dopa does not affect electron transfer chain enzymes and respiration of rat muscle mitochondria |
| 003889 |
M. B. Stern | Electroconvulsive therapy in untreated Parkinson's disease |
| 003891 |
P. Giovannini ; I. Piccolo ; S. Genitrini ; P. Soliveri ; F. Girotti ; G. Geminiani ; G. Scigliano ; T. Caraceni | Early-onset Parkinson's disease |
| 003904 |
S. T. Gancher ; J. G. Nutt ; W. R. Woodward | Absorption of apomorphine by various routes in parkinsonism |
| 003906 |
P. Brown ; P. D. Thompson ; J. C. Rothwell ; B. L. Day ; C. D. Marsden | A therapeutic trial of milacemide in myoclonus and the Stiff-Person syndrome |
| 003907 |
M. Hallett ; J. Ravits ; R. M. Dubinsky ; M. M. Gillespie ; AMIR MOINFAR | A double-blind trial of isoniazid for essential tremor and other action tremors |
| 003920 |
J. M. Cedarbaum ; M. Clark ; L. H. Toy ; A. Green-Parsons | Sustained-release (+)-PHNO [MK-458 (HPMC)] in the treatment of Parkinson's disease : evidence for tolerance to a selective D2-receptor agonist administered as a long-acting formulation |
| 003922 |
N. M. J. Rupniak ; S. J. Tye ; M. J. Steventon ; S. Boyce ; S. D. Iversen | Spontaneous orofacial dyskinesias in a captive cynomolgus monkey : implications for tardive dyskinesia |
| 003934 |
R. Kurlan ; J. Kersun ; H. T. Jr Ballantine ; E. D. Caine | Neurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome |
| 003936 |
M. E. Rodriguez ; M. R. Luquin ; G. Lera ; G. Delgado ; J. M. Salazar ; J. A. Obeso | Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion |
| 003953 |
M. A. Dietz ; C. G. Goetz ; G. T. Stebbins | Evaluation of a modified inverted walking stick as a treatment for Parkinsonian freezing episodes |
| 003961 |
J. H. Friedman ; M. C. Lannon | Clozapine-responsive tremor in Parkinson's disease |
| 003962 |
R. F. Pfeiffer ; J. Kang ; B. Graber ; R. Hofman ; J. Wilson | Clozapine for psychosis in Parkinson's disease |
| 003966 |
Werner Poewe [Autriche] ; G. Luef ; B. Kleedorfer ; M. Emre | Antiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's disease |
| 003969 |
C. Waters ; H. H. Itabashi ; M. L. J. Apuzzo ; L. P. Weiner | Adrenal to caudate transplantation - Postmortem study |
| 003973 |
M. Sano ; Y. Stern ; K. Marder ; R. Mayeux | A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease |
| 003981 |
B. Jabbari ; B. Scherokman ; C. H. Gunderson ; M. L. Rosenberg ; J. Miller | Treatment of movement disorders with trihexylphenidyl |
| 003983 |
Fh. Mcdowell | The use of glutethimide for treatment of essential tremor |
| 003986 |
R. J. Coleman ; K. W. Lange ; N. P. Quinn ; A. E. Loper ; J. V. Bondi ; M. Hitchens ; S. M. Stahl ; C. D. Marsden | The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+ PHNO): preliminary results |
| 003987 |
R. E. Burke ; UN JUNG KANG ; Joseph Jankovic [États-Unis] ; L. C. Miller ; S. Fahn | Tardive akathisia: an analysis of clinical features and response to open therapeutic trials |
| 003994 |
C. H. Adler ; M. B. Stern ; M. L. Brooks | Parkinsonism secondary to bilateral striatal fungal abscesses |
| 003997 |
P. A. Kempster ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Crichton ; J. P. Fkankel ; P. Shorvon | Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine |
| 003998 |
F. E. Micheli ; M. M. Fernandez Pardal ; R. Giannaula ; M. Gatto ; I. Casas Parera ; G. Paradiso ; M. Torres ; R. Pikielny ; J. Fernandez Pardal | Movement disorders and depression due to flunarizine and cinnarizine |
| 003A07 |
E. Pourcher ; A.-M. Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France] | Effects of etybenzatropine and diazepam on Levodopa-induced diphasic dyskinesias in Parkinson's disease |
| 003A08 |
E. Mohr ; G. Fabbrini ; J. Williams ; J. Schlegel ; C. Cox ; P. Fedio ; T. N. Chase | Dopamine and memory function in Parkinson's disease |
| 003A09 |
Joseph Jankovic [États-Unis] ; K. Schwartz ; C. Vander Linden | Comparison of Sinemet CR4 and standars Sinemet: double blind and long-term open trial in Parkinsonian patients with fluctuations |
| 003A18 |
J. A. Temlett ; N. P. Quinn ; P. G. Jenner ; C. D. Marsden ; E. Pourcher ; A.-M. Bonnet ; Y. Acid ; R. Markstein ; X. Lataste | Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease |
| 003A19 |
M. F. Brin ; A. Blitzer ; S. Fahn ; W. Gould ; R. E. Lovelace | Adductor laryngeal dystonia (Spastic dysphonia): treatment with local injections of botulinum toxoin (Botox) |
| 003A23 |
J. M. Walshe | Wilson's disease: yesterday, today, and tomorrow |
| 003A27 |
D. Dung Truong ; S. Fahn | Therapeutic trial with glycine in myoclonus |
| 003A43 |
G. Pezzoli ; S. Tesei ; C. Ferrante ; E. Cossutta ; A. Zecchinelli ; G. Scarlato | Madopar HBS in fluctuating Parkinsonian patients: two-year treatment |
| 003A45 |
O. S. Gershanik ; M. R. Luquin ; O. Scipioni ; J. A. Obeso | Isoniazid therapy in Parkinson's disease |
| 003A50 |
M. Hietanen ; H. Teravainen | Dementia and treatment with L-dopa in Parkinson's disease |
| 003A57 |
E. Lehkuniec ; F. Micheli ; R. De Arbelaiz ; M. Torres ; G. Paradiso | Concurrent hypnogenic and reflex paroxysmal dystonia |
| 003A58 |
S. Ruggieri ; F. Stocchi ; A. Carta ; D. Bravi ; M. Bragoni ; L. Giorgi ; A. Agnoli | Comparison between L-dopa and lisuride intravenous infusions: a clinical study |
| 003A62 |
P. Greene ; H. Shale ; S. Fahn | Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs |
| 003A76 |
M. F. Brin ; S. Fahn ; C. Moskowitz ; A. Friedman ; H. M. Shale ; P. E. Greene ; A. Blitzer ; T. List ; D. Lange ; R. E. Lovelace ; D. Mcmahon | Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm |
| 003A87 |
B. Jabbari ; M. Rosenberg ; B. Scherokman ; C. H. Gunderson ; J. W. Mcburney ; W. Mcclintock | Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction |
| 003A96 |
F. Grandas ; N. Quinn ; P. Critchley ; A. Rohan ; C. D. Marsden ; S. M. Stahl | Antiparkinsonian activity of a single oral dose of PHNO |
| 003A97 |
N. Nomoto ; S. Stahl ; P. Jenner ; C. D. Marsden | Antiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset |
| 003B02 |
W. J. Weiner ; S. A. Factor ; J. Sanchez-Ramos ; J. Berger | A double-blind evaluation of ciladopa in Parkinson's disease |
